jpp.org.injpp.org.in/public/site/...information-ghosh-et-al.docx · web view2-keyword file is...
TRANSCRIPT
Supplementary Information 1
Critical Assessment of contribution from Indian Publications: the role of in silico
designing methods leading to drugs or drug-like compounds using Text based mining &
associationPawan Kumar, Gourab Das and Indira Ghosh*
School of Computational and Integrative Sciences, Jawaharlal Nehru University, New Delhi, India
*Corresponding author; Email: [email protected]
2-Keyword and 3-Keyword file creation:
2-Keyword file is created which includes only computational bioinformatics related terms. The terms are collected from the computational drug discovery dictionary (van de Waterbeemd et al., 1997; Martin et al., 2016), words from the tables (Leelananda and Lindert, 2016; Song et al., 2009) and some are selected after manually going through the papers (Tanrikulu and Schneider, 2008; Wilson and Lill, 2011; Njogu et al., 2016; Zhang et al., 2017; Taft et al., 2008; Oprea and Matter, 2004). In addition, a few missing words (list shown below) are also included. The 2-Keyword file also includes redundant names used in literature for comprehensive selections. After clustering the all redundant names, a total of 250 selected terms emerged.
The third file, 3-Keyword.txt is created only exclusive for medicinal chemistry related terms built using the same method (discuss above) to seek additional information at the end. The terms are extracted from the medicinal chemistry dictionary (Ganellin et al., 1998;Buckle et al., 2013). This file includes 256 terms with redundant names.
List of inclusions during curation of the Keyword files :
Missing words included in the 1-Keyword.txt file areStructure-activity relationships, drug mechanisms of action, Ab initio modeling, H-Bonding, Alignment, Structure alignment, analogs synthesized, analogues designed, Biological Assay, Screening Assay, Combinatorial Chemistry library, Comparative Modeling, Compound Collection, Compound library, Small Molecule Library, Molecular Interaction Fields, screening protocol, in silico screening, Novel target, potential target, promising target, putative targets, target site, Target Selection, Target Validation, Target identification, multi drug resistance, New drug, New chemical, New molecule, pharmaceutical, pharmaceutical industry, pharmaceutical profiling, pharmaceutically tractable, Preclinical investigations, preclinical research, preclinical studies, preclinical testing, preclinical development, preclinical drug evaluations, protein ligand interaction, protein-ligand interaction, protein inhibitor interaction, protein-inhibitor interaction, quantum-chemistry, quantum descriptor, quantum mechanical, quantum molecular descriptor, Sensitivity, Structural homologue, Toxicity, Toxic chemical, Toxic, Cell based screening, Structural diversity.
Missing words included in the 2-Keyword.txt file are Ab initio modeling, H-Bonding, Alignment, Structure alignment, analogs synthesized, analogues designed, Biological Assay, Screening Assay, Combinatorial Chemistry library, Comparative Modeling, Molecular Interaction Fields, screening protocol, in silico screening, Novel target, potential target, promising target, putative targets, target site, Target Selection, Target Validation, Target identification, quantum-chemistry, quantum descriptor, quantum mechanical, quantum molecular descriptor, Sensitivity, Structural homologue, Toxicity, Toxic chemical, Toxic, Cell based screening, Structural diversity.
Method indeatils for calculation of Overlaps amongst the three set of Keyword:
1-Keyword , 2-Keyword & 3-Keywords derived from Drig design terms, Computational Biology & Bioinformatics driven terms & Medicinal chemistry associated terms are collected in these files after carefully grouping all the redundant terms together. All the clustered redundent terms are first splitted based on “|” and arranged in different files. 1-Keyword file has maximum number of individual terms (1514) followed by 2-Keyword (753) and 3-Keyword has only 557 individual terms.
Perl based regular expression
To ensure exact matching, for each word/phrase (which are separated by “|” operator) boundaries have been incorporated too. It is expected and evident that none of the publications are free from punctuations and special characters. So using Perl regex, matching lines can be easily found for the query with special characters. Technically, Perl regex uses recursive backtracking search approach for finding and matching complex patterns(Friedl, 2002).
Method for classification of disease types :
There are 22 major categories of diseases according to WHO (WHO, 2010) and disorders in the 10th revision of ICD which has been downloaded from Kyoto Encyclopedia of Genes and Genomes (KEGG) (http://www.genome.jp/kegg-bin/get_htext?br08403.keg) database (Kanehisa et al., 2017). From each class of disease redundancy, stop words and general biological words (like bacteria, infection, parasite etc.) have been removed to retain only disease related terms and grouped using “|” separator for further analysis. Each group has been searched in the filtered publications to count the availability of terms in the records.
S1-Table 1: 1-Keyword Unigram for India and World data. Table is sorted by India Unigram score
Term Normalized Unigram Score*
Term name India World 90-95
World 96-00
World 01-05
World 06-10
World 11-15
Activity 0.154 0.135 0.136 0.127 0.116 0.113
Dru(g|gs) 0.109 0.065 0.066 0.068 0.068 0.073
In vitro|In-vitro|In vivo|In-vivo 0.086 0.09 0.092 0.082 0.075 0.074
Dose|Dose ratio|Dose response curve 0.065 0.07 0.065 0.055 0.047 0.044
Enzyme|Enzyme induction 0.051 0.049 0.046 0.039 0.031 0.027
Efficacy|vivo efficacy 0.049 0.026 0.032 0.037 0.04 0.044
Toxicity|Toxic chemical|Toxic|Toxin|Toxicokinetics 0.048 0.029 0.029 0.03 0.028 0.029
Assay 0.047 0.034 0.036 0.035 0.033 0.034
Acute 0.045 0.051 0.052 0.051 0.049 0.049
Bacteria|Bacterial 0.043 0.026 0.028 0.03 0.031 0.033
Inhibito(r|rs) 0.038 0.04 0.05 0.053 0.048 0.045
Exposure 0.037 0.036 0.039 0.039 0.039 0.041
Targe(t|ts)|Targeted drug delivery 0.037 0.023 0.034 0.046 0.056 0.067
Recepto(r|rs) 0.035 0.073 0.083 0.079 0.07 0.063
Membrane 0.033 0.049 0.046 0.04 0.034 0.03
Distribution|Distribution metabolism and pharmacokinetics|DMPK 0.032 0.04 0.039 0.038 0.037 0.037
Plasma|Plasma concentratio(n|ns) 0.032 0.053 0.047 0.041 0.036 0.033
Sensitivity|Sensitivity analysis|Sensitivity of a two-class model 0.032 0.033 0.036 0.036 0.038 0.04
Absorption|Adsorption 0.031 0.013 0.013 0.016 0.017 0.017
Lead|Lead discovery|Lead identificatio(n|ns)|Lead-identificatio(n|ns) 0.031 0.019 0.024 0.028 0.031 0.034
Metabolism|Metabolit(e|es)|Metabolome 0.028 0.036 0.033 0.031 0.03 0.033
Activation 0.027 0.044 0.057 0.059 0.055 0.051
Screening|Screening cascade|Screening librar(y|ies) 0.026 0.016 0.02 0.023 0.025 0.028
Virtual Screening 0.026 0.016 0.02 0.023 0.025 0.028
Virus 0.026 0.035 0.034 0.03 0.027 0.027
Glutathione 0.024 0.006 0.007 0.007 0.006 0.006
Ligan(d|ds)|Ligand Based Design|Ligand-based design|substrate based drug discovery|substrate-based drug discovery|Ligand-based drug design
0.023 0.014 0.02 0.023 0.023 0.02
Antige(n|ns) 0.022 0.04 0.035 0.027 0.022 0.019
Cluster|Cluster analysis|cluster centroid|Classification 0.021 0.015 0.017 0.021 0.024 0.027
Systemic|systems biology 0.021 0.021 0.022 0.022 0.023 0.023
Nuclear Magnetic Resonance|NMR 0.02 0.008 0.009 0.01 0.01 0.01
Antibody|Antibody-Drug Conjugate|Bivalent Antibody|Monoclonal Antibody|Polyclonal antibodi(e|es)
0.019 0.041 0.034 0.025 0.02 0.018
Formulation|Formulation Science 0.019 0.003 0.004 0.005 0.005 0.006
Apoptosis 0.018 0.003 0.016 0.023 0.022 0.022
Phopholipidosis|Phosphatase|Phospholipas(e|es)|Phospholipi(d|ds) 0.018 0.019 0.017 0.013 0.011 0.01
Proliferation 0.018 0.02 0.024 0.025 0.026 0.027
Genom(e|es) 0.017 0.01 0.012 0.018 0.021 0.027
Affinity 0.015 0.025 0.022 0.016 0.013 0.011
Diffusion|Diffusion barrie(r|rs)|Diffusion coefficien(t|ts) 0.015 0.005 0.006 0.008 0.01 0.011
Hormon(e|es) 0.015 0.028 0.026 0.022 0.019 0.016
Injection 0.015 0.029 0.027 0.023 0.02 0.018
Insulin 0.015 0.018 0.018 0.016 0.016 0.015
Protocol 0.015 0.009 0.012 0.013 0.015 0.018
Adverse drug even(t|ts)|Adverse effec(t|ts)|Adverse-effec(t|ts)|Adverse Even(t|ts)
0.014 0.007 0.01 0.013 0.016 0.019
Cytokin(e|es) 0.014 0.012 0.022 0.021 0.019 0.02
Differentiation 0.014 0.021 0.023 0.023 0.023 0.024
Docking|Docking studies|Molecular docking|Molecular-docking|Virtual docking|Virtual-docking|Screening protocol|Scoring|Scoring function
0.014 0.002 0.004 0.005 0.006 0.007
Fragmen(t|ts)|Fragment ke(y|ys) 0.014 0.024 0.021 0.017 0.014 0.011
Kinase|Kinase cascade|Kinase-cascade|Kinase linked recepto(r|rs) 0.014 0.02 0.028 0.029 0.027 0.025
Polymerase chain reaction 0.014 0.013 0.018 0.015 0.013 0.012
Bound|Bounded functio(n|ns) 0.013 0.021 0.019 0.016 0.013 0.011
Hydrophobic|Hydrophobic feature|Hydrophobicity 0.013 0.006 0.007 0.007 0.007 0.006
MD|Molecular dynamics|Molecular dynamic|Simulation|Molecular Simulation
0.013 0.005 0.007 0.01 0.015 0.018
Nucleoside|Nucleotide 0.013 0.017 0.015 0.015 0.015 0.015
Polymorphism 0.013 0.005 0.009 0.011 0.011 0.01
Transpor(t|ts) 0.013 0.017 0.017 0.017 0.017 0.017
Diversity|Diversity-oriented synthesis 0.012 0.004 0.006 0.009 0.011 0.014
X-ray crystallography|X-ray sturctur(e|es)|crystal structur(e|es) 0.012 0.002 0.005 0.007 0.008 0.007
Analogu(e|es)|analogue-based drug discovery 0.011 0.01 0.01 0.01 0.008 0.007
Lymphocyt(e|es) 0.011 0.025 0.022 0.016 0.012 0.009
Physicochemical|Physico-chemical 0.011 0.002 0.002 0.002 0.003 0.004
Validation|validation set|Leave-one-out cross-validation|Leave-some-out cross-validation|Cross-validation
0.011 0.003 0.004 0.007 0.01 0.013
Density functional theory|DFT 0.01 0 0 0.002 0.004 0.005
Drug delivery|drug-delivery 0.01 0.001 0.001 0.002 0.003 0.004
mRNA 0.01 0.027 0.035 0.031 0.026 0.023
Phenotyp(e|es) 0.01 0.015 0.021 0.022 0.023 0.025
Similarity|Similarity ensemble approach|similarity searching 0.01 0.008 0.008 0.008 0.007 0.007
Transformation 0.01 0.009 0.009 0.009 0.009 0.009
Albumin 0.009 0.009 0.007 0.006 0.006 0.006
Bone marrow 0.009 0.012 0.012 0.01 0.009 0.009
Correlation coefficien(t|ts)|R2|Q2|Coefficient of correlation 0.009 0.005 0.007 0.007 0.007 0.008
Regression analysis 0.009 0.005 0.007 0.009 0.01 0.013
Accelerator Mass Spectrometry|Mass Spectrometry 0.008 0.004 0.007 0.011 0.013 0.015
Algorith(m|ms) 0.008 0.004 0.007 0.01 0.014 0.016
Bioavailability 0.008 0.002 0.003 0.003 0.003 0.003
Growth facto(r|rs)|Growth-facto(r|rs) 0.008 0.019 0.023 0.021 0.02 0.019
H-Bonding|Hydrogen Bonding|Hydrogen-Bonding 0.008 0.001 0.001 0.002 0.003 0.002
Lipids 0.008 0.006 0.006 0.006 0.006 0.006
Pharmaceutical|pharmaceutical industry|pharmaceutical profiling|pharmaceutically tractable
0.008 0.002 0.003 0.004 0.005 0.005
Precision|Recall 0.008 0.006 0.007 0.008 0.008 0.009
Protease|proteinase 0.008 0.009 0.009 0.008 0.007 0.005
Analog 0.007 0.008 0.008 0.007 0.006 0.007
Antagonis(t|ts) 0.007 0.024 0.023 0.018 0.014 0.011
Batch 0.007 0.001 0.001 0.003 0.003 0.003
Clearance 0.007 0.01 0.009 0.008 0.007 0.006
Drug Resistance|Drug-resistant 0.007 0.002 0.003 0.003 0.003 0.004
In silico|in-silico|in silico chemical genomi(c|cs)|Chemical genomi(c|cs)
0.007 0 0 0.001 0.002 0.003
Reverse transcription polymerase chain reaction|RT-PCR 0.007 0.002 0.008 0.012 0.011 0.008
Reversible 0.007 0.008 0.007 0.007 0.006 0.006
Selectivity 0.007 0.004 0.005 0.006 0.006 0.007
Solubility 0.007 0.001 0.002 0.002 0.003 0.003
Stem cel(l|ls) 0.007 0.003 0.006 0.009 0.014 0.018
Central Nervous System 0.006 0.009 0.009 0.008 0.007 0.007
Cytoplasm|cytosol 0.006 0.01 0.01 0.009 0.007 0.006
Elimination|Elimination rate constan(t|ts) 0.006 0.007 0.007 0.006 0.006 0.005
IC50|Inhibitory concentration 50|Half-maximal inhibitory concentratio(n|ns)|Inhibition constant|Inhibitory rate constant
0.006 0.005 0.004 0.002 0.002 0.003
Nucleus 0.006 0.014 0.014 0.013 0.011 0.009
Placebo 0.006 0.011 0.012 0.012 0.011 0.01
Adenosine triphosphatase|ATPase 0.005 0.006 0.005 0.004 0.003 0.002
Agonis(t|ts) 0.005 0.018 0.017 0.014 0.011 0.009
Hydrophilic|Hydrophilicity 0.005 0.002 0.002 0.003 0.003 0.003
Mechanism of action 0.005 0.003 0.003 0.003 0.003 0.003
Mediato(r|rs) 0.005 0.006 0.008 0.009 0.009 0.009
Mitochondria 0.005 0.005 0.005 0.006 0.005 0.006
Pathophysiology 0.005 0.005 0.006 0.007 0.007 0.008
Permeability|Permeability coefficien(t|ts) 0.005 0.006 0.006 0.005 0.005 0.005
Potenc(y|ies) 0.005 0.008 0.007 0.006 0.005 0.004
Preclinical investigations 0.005 0.004 0.005 0.006 0.008 0.01
Scaffol(d|ds)|scaffold hopping|scaffold-hopping 0.005 0 0.001 0.003 0.005 0.006
Serum albumin 0.005 0.004 0.003 0.003 0.002 0.002
Templat(e|es) 0.005 0.003 0.003 0.004 0.004 0.005
Transmembrane protein 0.005 0.004 0.008 0.01 0.01 0.01
Western blo(t|ts) 0.005 0.005 0.007 0.008 0.008 0.009
Alignment|Sequence Alignment|Structure Alignment|Structural alignment
0.004 0.002 0.003 0.003 0.004 0.004
Bile 0.004 0.006 0.005 0.004 0.004 0.003
Biomarker 0.004 0 0.001 0.002 0.005 0.01
cDNA 0.004 0.017 0.016 0.011 0.006 0.003
Cerebrospinal Flui(d|ds) 0.004 0.004 0.004 0.003 0.003 0.003
Drug design|Drug-design|Drug development|drug development process
0.004 0 0.001 0.002 0.002 0.003
HOMO/LUMO 0.004 0.001 0.001 0.001 0.001 0.001
Excretion 0.004 0.01 0.007 0.005 0.004 0.003
Genetics|Genetic algorith(m|ms) 0.004 0.003 0.004 0.006 0.005 0.007
Glutamate 0.004 0.006 0.007 0.006 0.005 0.004
Half life|Half-life 0.004 0.005 0.004 0.003 0.003 0.002
Homolog 0.004 0.001 0.003 0.003 0.003 0.003
Infusion 0.004 0.018 0.015 0.011 0.008 0.006
Mitogen|Mitogen activated protein kinase|MAPK 0.004 0.003 0.006 0.007 0.006 0.005
Novel inhibito(r|rs)|novel scaffol(d|ds)|novel dru(g|gs)|novel targe(t|ts)|novel therapeuti(c|cs)
0.004 0.001 0.001 0.003 0.004 0.006
Nucleic aci(d|ds) 0.004 0.003 0.003 0.003 0.003 0.003
Pharmacokinetics|Pharmacodynamics|Pharmacokinetic antagonism|Pharmacokinetic-pharmacodynamic relationship
0.004 0.006 0.005 0.004 0.004 0.005
QSAR|Quantitative structure-activity relationship|Quantitative structure activity relationship
0.004 0 0 0.001 0.001 0.001
Sarcoma 0.004 0.004 0.003 0.003 0.002 0.003
Wild-type|wild-type recepto(r|rs) 0.004 0.009 0.017 0.017 0.015 0.013
Amylase 0.003 0.002 0.001 0.001 0.001 0.001
Antiviral 0.003 0.003 0.003 0.004 0.004 0.005
Apical 0.003 0.004 0.005 0.004 0.004 0.003
ANN 0.003 0.001 0.002 0.003 0.003 0.004
Basis function|Basis set 0.003 0 0 0.001 0.001 0.001
Bioinformatics|Bio-informatics 0.003 0 0 0.001 0.002 0.003
Codo(n|ns) 0.003 0.005 0.006 0.004 0.003 0.002
Descripto(r|rs)|Kappa shape descripto(r|rs)|Electrotopological state descripto(r|rs)
0.003 0 0.001 0.001 0.001 0.001
Drug targe(t|ts)|Drug-targe(t|ts) 0.003 0 0 0.001 0.001 0.002
Electrocardiogram|ECG 0.003 0.005 0.004 0.004 0.004 0.003
Epitop(e|es) 0.003 0.008 0.008 0.005 0.004 0.003
Histon(e|es) 0.003 0.002 0.002 0.003 0.005 0.006
Lineage 0.003 0.004 0.004 0.004 0.005 0.006
Molecular modeling|Molecular-modeling|Molecular modelling|Molecular-modelling
0.003 0.001 0.001 0.001 0.001 0.001
Molecular Structur(e|es)|Molecular-Structur(e|es)|Molecular Conformatio(n|ns)|Molecular-Conformatio(n|ns)
0.003 0.001 0.001 0.001 0.002 0.001
Neurotransmitte(r|rs) 0.003 0.004 0.005 0.004 0.003 0.003
Patent 0.003 0.002 0.002 0.002 0.002 0.002
Potential target 0.003 0.001 0.002 0.002 0.003 0.004
Reverse transcriptas(e|es) 0.003 0.002 0.005 0.005 0.003 0.002
Single nucleotide polymorphis(m|ms) 0.003 0 0 0.002 0.004 0.005
Structure activity relationship|Structure-activity relationship 0.003 0 0.001 0.001 0.001 0.001
Sustained release 0.003 0 0 0 0 0.001
Allerge(n|ns) 0.002 0.002 0.003 0.003 0.003 0.002
Anti-convulsant|Anticonvulsant 0.002 0.001 0.001 0.001 0.001 0.001
Antihypertensive 0.002 0.003 0.003 0.002 0.002 0.002
Area under curve|area under the curve 0.002 0.001 0.001 0.001 0.002 0.003
Basic local alignment search tool|BLAST|PSI-BLAST 0.002 0.001 0.001 0.001 0.001 0.001
Beta-shee(t|ts)|beta-sheet breaker 0.002 0.001 0.001 0.001 0.001 0.001
Biomolecul(e|es) 0.002 0 0 0.001 0.001 0.002
Carcinogen 0.002 0.002 0.001 0.001 0.001 0.001
Chemokin(e|es) 0.002 0 0.003 0.004 0.005 0.005
Chemotherapeutic agen(t|ts) 0.002 0.001 0.001 0.001 0.001 0.001
Clone 0.002 0.008 0.006 0.004 0.003 0.002
Combination therap(y|ies) 0.002 0.001 0.002 0.002 0.003 0.003
Combinatorial|Combinatorial library|Combinatorial library design|Combinatorial Chemistry|Combinatorial Chemistry librar(y|ies)|Combinatorial synthesis
0.002 0 0.001 0.001 0.001 0.001
Concordance 0.002 0.001 0.002 0.002 0.002 0.003
Conjugation 0.002 0.001 0.001 0.002 0.002 0.002
Cyclic adenosine monophosphate|cAMP 0.002 0.008 0.007 0.005 0.003 0.003
Cytochrome P450|CYP450 0.002 0.002 0.003 0.003 0.002 0.002
Drug discovery|Drug-discovery|Drug discovery chemistry|Drug-discovery chemistry|Drug discovery development|Drug discovery pipeline|Drug-discovery pipeline|Drug discovery process|Drug discovery progra(m|ms)
0.002 0 0 0.001 0.002 0.002
Drug screening|Drug regulation|Drug development|Drug-screening|Drug-regulation|Drug-development
0.002 0 0.001 0.001 0.002 0.003
Drug therapy|Drug-therapy 0.002 0.002 0.002 0.002 0.001 0.001
Effective dose|Effective dose 50|ED50 0.002 0.002 0.002 0.001 0.001 0.001
Efflux|Efflux pum(p|ps) 0.002 0.003 0.003 0.003 0.002 0.002
Endoplasmic reticulum 0.002 0.003 0.003 0.003 0.003 0.004
Epidermal Growth Factor|EGFR 0.002 0.004 0.004 0.004 0.005 0.006
Epigeneti(c|cs) 0.002 0 0.001 0.002 0.004 0.006
Eukaryot(e|es) 0.002 0.001 0.002 0.002 0.002 0.002
Expressed sequence tags|Expression analysis 0.002 0 0.001 0.002 0.002 0.002
Factorial design|Fractional factorial design 0.002 0 0 0 0 0
False negative|False positive|False-negative|False-positive 0.002 0.003 0.003 0.003 0.003 0.003
Genomics 0.002 0 0.001 0.002 0.003 0.003
High throughput|High-throughput screening|High Throughput Screening|throughput screening|HTS
0.002 0 0.001 0.001 0.002 0.003
Hi(t|ts)|Hit Confirmation|hit expansion|Hit Identification 0.002 0.001 0.001 0.001 0.002 0.002
Hydrophobic interactio(n|ns)|Hydrophobic-interactio(n|ns) 0.002 0.001 0.001 0.001 0.001 0.001
Inhalation 0.002 0.003 0.003 0.003 0.002 0.002
Lumen 0.002 0.004 0.004 0.004 0.003 0.003
Microarray 0.002 0 0 0.005 0.008 0.007
MicroRNA|miRNA 0.002 0 0 0 0.002 0.007
Multi drug resistance|multidrug resistance|multiple drug resistance 0.002 0.001 0.002 0.002 0.001 0.001
New drug|new chemica(l|ls)|New molecul(e|es)|New molecular entit(y|ies)
0.002 0.001 0.001 0.001 0.001 0.001
Normalization 0.002 0.002 0.002 0.002 0.002 0.002
Open reading fram(e|es)|Open-reading fram(e|es) 0.002 0.006 0.005 0.003 0.002 0.002
PD(B|Bs)|Protein Data Ban(k|ks) 0.002 0 0 0 0 0
Pharmacophor(e|es)|pharmacophore model|pharmacophore screening|Pharmacophore generation|Pharmacophoric descripto(r|rs)
0.002 0 0 0 0.001 0.001
Plasmid DNA 0.002 0.001 0.001 0.001 0.001 0.001
Positron emission tomography 0.002 0.001 0.002 0.003 0.003 0.004
Principal component loading|Principal components analysis|PCA| 0.002 0.001 0.001 0.002 0.002 0.003
Principal component scoreProtein-protein interactio(n|ns)|PPI 0.002 0.001 0.002 0.002 0.003 0.003
Protein synthesis 0.002 0.006 0.004 0.003 0.002 0.002
Proteomics 0.002 0 0 0.002 0.003 0.003
Quality Contro(l|ls) 0.002 0.001 0.002 0.002 0.002 0.003
Registration 0.002 0.001 0.002 0.002 0.004 0.007
Secondary metabolit(e|es) 0.002 0 0 0.001 0.001 0.001
siRNA 0.002 0 0 0.001 0.004 0.005
Small inhibitory double-stranded RNA|siRNA|small interfering double-stranded RNA
0.002 0 0 0.001 0.004 0.005
Small molecule|small peptide|small-molecule|small-peptide|small molecule therapeutics
0.002 0 0 0.002 0.003 0.004
Turnover 0.002 0.005 0.005 0.005 0.004 0.004
Vesicle 0.002 0.003 0.003 0.003 0.002 0.002
1D structure|2D structure|3D structure|3D structure generation 0.001 0 0 0 0 0
3D-QSAR|three-dimensional quantitative structure-activity relationship|three-dimensional quantitative structure activity relationship
0.001 0 0 0 0 0
Ab initio calculatio(n|ns) 0.001 0 0 0.001 0.001 0.001
Adenosine diphosphate|Adenosine triphosphate 0.001 0.001 0.001 0.001 0.001 0.001
ADME|Absorption distribution metabolism and excretion|Absorption distribution metabolism and elimination|Adsorption distribution metabolism and elimination
0.001 0 0 0 0 0
Alpha-helix 0.001 0.001 0.001 0.001 0.001 0.001
Archaea 0.001 0 0.001 0.001 0.001 0.001
Atomistic 0.001 0 0 0 0.001 0.001
Audit|Audit Trail 0.001 0.001 0.002 0.002 0.002 0.002
Autoimmunity 0.001 0.001 0.001 0.002 0.002 0.002
Beta-lactamases 0.001 0 0 0 0 0
Bioequivalence 0.001 0 0 0 0 0
Biotransformation 0.001 0.001 0.001 0.001 0.001 0.001
Blood-brain barrier 0.001 0.001 0.002 0.001 0.001 0.002
Carboxylas(e|es) 0.001 0.001 0.001 0.001 0.001 0.001
Catabolism|Catabolit(e|es) 0.001 0.002 0.002 0.002 0.001 0.001
Chemical database 0.001 0 0 0 0.001 0.001
Chemical diversity|Molecular diversity|Structural diversity 0.001 0 0 0 0 0.001
Chemical structur(e|es) 0.001 0.001 0.001 0.001 0.001 0.001
Cheminformatics|chemoinformatics|Computational approach|Computational chemistry|Computer chemistry
0.001 0 0 0 0 0.001
Chirality 0.001 0 0 0 0.001 0.001
Coenzym(e|es) 0.001 0.002 0.002 0.002 0.001 0.001
CoMFA|Comparative molecular field analysis 0.001 0 0 0 0 0
Competitive antagonis(t|ts)|Competitive Inhibito(r|rs) 0.001 0.002 0.001 0.001 0.001 0
CoMSIA|Comparative molecular similarity analysis|Comparative molecular similarity indices analysis
0.001 0 0 0 0 0
Continuum 0.001 0.001 0.001 0.002 0.002 0.002
Cooperativity 0.001 0.001 0.001 0.001 0.001 0
Decarboxylase 0.001 0.002 0.002 0.001 0.001 0.001
Discriminant analysis 0.001 0.001 0.001 0.001 0.001 0.001
Disposition 0.001 0.002 0.002 0.001 0.001 0.001
Double-blinded|Double-blind study 0.001 0.001 0.001 0.001 0.001 0.001
Drug cocktai(l|ls)|drug-cocktai(l|ls)|drug combinatio(n|ns)|drug- 0.001 0.001 0.001 0.001 0.001 0.001
combinatio(n|ns)|Drug conjugat(e|es)|Drug-conjugat(e|es)Drug like|Drug-like|Drug like compound|Drug like molecule|Drug-likeness|Drug likeness|Drug-like(ness)|Drug like propert(y|ies)
0.001 0 0 0 0 0
Drug targeting|Drug-targeting 0.001 0 0 0 0 0
Effective concentratio(n|ns)|Effective drug concentratio(n|ns)|EC50 0.001 0.003 0.002 0.001 0.001 0.001
Electrostatic field and potentia(l|ls)|Molecular electrostatic potentia(l|ls)
0.001 0 0 0 0 0
Enantiome(r|rs) 0.001 0.002 0.002 0.002 0.001 0.001
Excipient 0.001 0 0 0 0 0
Exclusion Criteria 0.001 0 0 0.001 0.001 0.002
Experimental design 0.001 0.001 0.001 0.002 0.003 0.002
FDA|Federal Drug Administration 0.001 0.001 0.001 0.001 0.002 0.002
Fingerprin(t|ts)|Path fingerprin(t|ts) 0.001 0.001 0.001 0.001 0.001 0.001
Force fiel(d|ds)|Force-fiel(d|ds) 0.001 0 0 0.001 0.001 0.001
Functional-genomi(c|cs)|Functional genomi(c|cs) 0.001 0 0 0.001 0.001 0.001
Gamma aminobutyric acid|GABA 0.001 0.003 0.004 0.003 0.002 0.002
GenBank 0.001 0 0.001 0.001 0.001 0.001
Gene silencing 0.001 0 0 0.001 0.001 0.001
Glucagon 0.001 0.002 0.001 0.001 0.001 0.001
GOLPE|GRID|GRID–GOLPE|MIFs|Molecular Interaction Fiel(d|ds)
0.001 0.001 0.001 0.001 0.001 0.001
G-protein-coupled recepto(r|rs)|GPCR|G protein coupled recepto(r|rs)|G-protein|G Protein
0.001 0.003 0.005 0.004 0.004 0.003
Hamiltonian 0.001 0 0 0.001 0.001 0.001
HBA|Hydrogen Bond Acceptor|Hydrogen-Bond Acceptor 0.001 0 0 0.001 0.001 0
HBD|Hydrogen Bond Donor|Hydrogen-Bond Donor 0.001 0 0 0 0 0
Homodime(r|rs) 0.001 0.001 0.001 0.001 0.001 0.001
Homologue 0.001 0.002 0.003 0.003 0.002 0.001
Intercalation 0.001 0 0 0 0 0
Ion channe(l|ls) 0.001 0.002 0.002 0.002 0.002 0.002
Isothermal Titration Calorimetry 0.001 0 0 0 0 0
Isozym(e|es) 0.001 0.002 0.002 0.001 0.001 0
Lipophilic compounds|lipophilic efficiency|Lipophilicity|lipophilic ligand efficiency
0.001 0.001 0.001 0.001 0 0
Liver Microsomes 0.001 0.001 0.001 0.001 0 0
Logarithm of distribution|LogD|log D|Logarithm of partition|LogP|log P|lg D|lg P
0.001 0 0 0 0 0
Lysosom(e|es) 0.001 0.002 0.001 0.001 0.001 0.001
Machine learning 0.001 0 0 0 0.001 0.001
Maximum plasma concentration|Cmax 0.001 0.001 0.001 0.001 0.001 0.001
Medicinal chemistry|Medicinal-chemistry|Medicinal chemistry tool|Medicinal-chemistry tool|Medicinal chemistry in drug discovery
0.001 0 0 0 0 0
Metabolic enzym(e|es)|Metabolic blocking 0.001 0 0 0 0 0
Molecular biology|Molecular biology Research 0.001 0.002 0.002 0.002 0.002 0.001
Molecular mechanics|Molecular-mechanics 0.001 0 0 0 0 0
Molecular targe(t|ts)|Molecular-targe(t|ts) 0.001 0 0 0.001 0.001 0.001
Monte Carlo techniqu(e|es)|Monte Carlo conformational search|Monte Carlo metho(d|ds)|Monte Carlo simulatio(n|ns)
0.001 0 0.001 0.002 0.002 0.002
Mutagen|Mutagenicity 0.001 0.001 0.001 0.001 0 0
Occupancy 0.001 0.001 0.001 0.001 0.001 0.001
Oligonucleotide 0.001 0.005 0.004 0.004 0.003 0.001
Oncogen(e|es)|Proto-oncogen(e|es)|Onco-protei(n|ns) 0.001 0.005 0.004 0.003 0.003 0.003
Organelle 0.001 0.001 0.001 0.001 0.001 0.001
Partial least squar(e|es)|PLS 0.001 0 0 0.001 0.001 0.001
Partition coefficien(t|ts) 0.001 0.001 0.001 0.001 0.001 0
Pattern recognitio(n|ns) 0.001 0 0 0.001 0.001 0.001
Peptidas(e|es) 0.001 0.001 0.001 0.001 0.001 0.001
P-glycoprotein 0.001 0.001 0.001 0.001 0.001 0.001
Pharmacodynamics 0.001 0.001 0.001 0.001 0.001 0.001
Pharmacology|Polypharmacology|Poly pharmacology|Poly-pharmacology
0.001 0.002 0.002 0.002 0.002 0.002
Phylogeny 0.001 0.001 0.001 0.002 0.002 0.002
Pipeline|pipelining programs|Platform technology company 0.001 0 0 0 0.001 0.001
Poison|Poisson–Boltzmann equation 0.001 0 0 0 0 0
Potential energy surfac(e|es) 0.001 0 0 0 0.001 0.001
Prodru(g|gs)|Pro-dru(g|gs) 0.001 0.001 0.001 0.001 0.001 0.001
Prokaryot(e|es) 0.001 0 0.001 0.001 0.001 0.001
Protein binding 0.001 0.001 0.001 0.001 0.001 0.001
Quality Assurance 0.001 0.001 0.001 0.001 0.001 0.001
Quantum chemical calculatio(n|ns) 0.001 0 0 0 0 0
Quantum-chemistry|quantum chemistry|quantum descriptor|quantum-descriptor|quantum mechanical|quantum-mechanical|quantum molecular modeling|quantum molecular descriptor
0.001 0 0 0.001 0.001 0.001
Rational design|Rational-design|Rational drug|Rational drug design 0.001 0 0 0.001 0.001 0.001
Receiver-operator characteristic curve|ROC curve 0.001 0 0 0 0.001 0.001
Ribosome 0.001 0.001 0.001 0.001 0.001 0.001
RNA interference|RNAi 0.001 0 0 0.002 0.004 0.004
Root-mean-square deviation|RMSD|root-mean-square error|RMSE 0.001 0 0 0 0 0
Site-directed mutagenesis 0.001 0.002 0.003 0.002 0.001 0.001
Specific binding 0.001 0.003 0.002 0.001 0.001 0.001
Src|Src homology 0.001 0.001 0.002 0.002 0.002 0.001
Test set 0.001 0 0 0 0 0
Therapeutic area|Therapeutic class|Therapeutic index|therapeutic engineering|therapeutic ratio|Therapeutic window
0.001 0.001 0.001 0.001 0.001 0.001
Tmax 0.001 0.001 0.001 0 0 0
Training set 0.001 0 0 0 0 0.001
Ubiquitin 0.001 0.001 0.001 0.003 0.003 0.003
Volume of distributio(n|ns) 0.001 0.001 0.001 0.001 0 0
Xenobiotic 0.001 0.001 0.001 0.001 0.001 0.001
1D property descriptor|2D property|3D property 0 0 0 0 0 0
2D-QSAR|two-dimensional quantitative structure-activity relationship|two-dimensional quantitative structure activity relationship
0 0 0 0 0 0
2D substructure searching|3D searching 0 0 0 0 0 0
3-\[45-Dimethylthiazol-2-yl\]-25-diphenyltetrazolium bromide 0 0 0 0 0 0
4D-QSAR|four-dimensional quantitative structure-activity relationship|four-dimensional quantitative structure activity relationship
0 0 0 0 0 0
ABC protein|ABC transporte(r|rs)|ATP binding cassette protein 0 0 0 0 0 0
Ab initio modeling|Ab initio modelling|Ab-initio modeling|Ab-initio modelling
0 0 0 0 0 0
Absolute bioavailability 0 0 0 0 0 0
Acid dissociation constant 0 0 0 0 0 0
Action Potential 0 0.002 0.002 0.002 0.001 0.001
Active Pharmaceutical Ingredient 0 0 0 0 0 0
Active transport 0 0 0 0 0 0
Address-message concept 0 0 0 0 0 0
ADMET|Absorption distribution metabolism excretion and toxicity|Adsorption distribution metabolism excretion and toxicity
0 0 0 0 0 0
Aldehyde oxidase 0 0 0 0 0 0
Allometric scaling|Allosteric antagonist|Allosteric binding sit(e|es)|Allosteric enzym(e|es)|Allosteric Inhibito(r|rs)|Allosteric regulatio(n|ns)
0 0 0 0 0 0
Almond 0 0 0 0 0 0
AM1 calculatio(n|ns) 0 0 0 0 0 0
AMBER 0 0 0 0 0 0
Ames test 0 0 0 0 0 0
Amorphous soli(d|ds) 0 0 0 0 0 0
Amphipathic 0 0 0.001 0 0 0
Anabolism 0 0 0 0 0 0
Analog-based drug discovery 0 0 0 0 0 0
Ante-drug|Antedrug 0 0 0 0 0 0
Anti-emetic|Antiemetic 0 0 0 0 0 0
Antimetabolit(e|es) 0 0 0 0 0 0
Antisense molecule 0 0 0 0 0 0
Apo structur(e|es)|Apo-structur(e|es) 0 0 0 0 0 0
Apparent volume of distributio(n|ns) 0 0 0 0 0 0
Applicability domain|Domain of applicability 0 0 0 0 0 0
Aquapori(n|ns) 0 0 0 0.001 0.001 0.001
Association of the British Pharmaceutical Industry|ABPI 0 0 0 0 0 0
Atomic orbita(l|ls) 0 0 0 0 0 0
Atropisomer 0 0 0 0 0 0
Attrition|Attrition rate 0 0 0 0 0.001 0.001
Autacoid 0 0 0 0 0 0
Autocorrelation vector 0 0 0 0 0 0
Autoinduction 0 0 0 0 0 0
Autonomic nervous system 0 0.001 0.001 0.001 0.001 0.001
Auto phosphorylation 0 0 0 0 0 0
Autoreceptor 0 0 0 0 0 0
Backup|back-up compound 0 0 0 0 0 0
Basis set superposition error|BSSE 0 0 0 0 0 0
Basolateral 0 0.002 0.002 0.001 0.001 0.001
Belief theory 0 0 0 0 0 0
Best-in-class 0 0 0 0 0 0
Beta-barrel 0 0 0 0 0 0
Bilinear equation 0 0 0 0 0 0
Binding paramete(r|rs) 0 0 0 0 0 0
Bioisostere|Bio-isosterism 0 0 0 0 0 0
Biological agen(t|ts) 0 0 0 0 0 0
Biological Investigational Medicinal Product 0 0 0 0 0 0
Biologics license application 0 0 0 0 0 0
Bioluminescent resonance energy transfer assay|BRET 0 0 0 0 0 0
Bioprecursor prodrug 0 0 0 0 0 0
Biosimilar Medicin(e|es) 0 0 0 0 0 0
Bipartite carrier 0 0 0 0 0 0
Bit string|bitmap 0 0 0 0 0 0
Blockbuster dru(g|gs) 0 0 0 0 0 0
Bmax 0 0.002 0.001 0 0 0
Boltzmann enhanced discrimination of receiver operating characteristic
0 0 0 0 0 0
Bootstrap resampling|Bootstrapping 0 0 0 0 0 0
Caco-2 cel(l|ls) 0 0 0.001 0.001 0.001 0.001
CADD 0 0 0 0 0 0
Calculated logP valu(e|es) 0 0 0 0 0 0
Calculated molar refractivity 0 0 0 0 0 0
Candidate molecul(e|es) 0 0 0 0 0 0
Canonical structure representation|Canonical structur(e|es) 0 0 0 0 0 0
Carrier-linked prodru(g|gs)|Carrier molecul(e|es)|Carrier prodru(g|gs)|Cascade prodrug
0 0 0 0 0 0
Carrier mediated active transpor(t|ts) 0 0 0 0 0 0
Central targe(t|ts) 0 0 0 0 0 0
Certificate of Analysis 0 0 0 0 0 0
Chance correlation 0 0 0 0 0 0
Chaperone protei(n|ns) 0 0 0 0 0 0
Chemical antagonism 0 0 0 0 0 0
Chemical basis of pharmacology and therapeuti(c|cs) 0 0 0 0 0 0
Chemical biology 0 0 0 0 0 0
Chemical fingerprin(t|ts) 0 0 0 0 0 0
Chemical genomi(c|cs) 0 0 0 0 0 0
Chemistry manufacturing and controls 0 0 0 0 0 0
Chemometrics 0 0 0 0 0 0
Chemoreceptor trigger zone 0 0 0 0 0 0
Cherry picking 0 0 0 0 0 0
Chloride channel 0 0 0 0 0 0
Chronic dosing 0 0 0 0 0 0
Chemical fingerprint 0 0 0 0 0 0
Clastogen 0 0 0 0 0 0
Clinical Trial Authorisation 0 0 0 0 0 0
clog P|CLOGP valu(e|es)|CLOGP 0 0 0 0 0 0
CNDO/2 calculatio(n|ns) 0 0 0 0 0 0
Co-crystal structur(e|es) 0 0 0 0 0 0
Co-dru(g|gs) 0 0 0 0 0 0
Collinearity 0 0 0 0 0 0
Component loading 0 0 0 0 0 0
Component score 0 0 0 0 0 0
Concentration-Response Curve|Concentration Response Curve 0 0 0 0 0 0
Conformational analysis 0 0 0 0 0 0
Conformationally flexible searching 0 0 0 0 0 0
Conformation change 0 0 0 0 0 0
Confusion matrix 0 0 0 0 0 0
Congener 0 0 0 0 0 0
Connolly surface|Connolly method|connolly accessible area|connolly-accessible area
0 0 0 0 0 0
Constitutive activity 0 0 0 0 0 0
Contractile protei(n|ns) 0 0 0 0 0 0
Contract Research|Contract Research Organisation 0 0 0 0 0 0
Control of Substances Hazardous to Health|COSHH 0 0 0 0 0 0
Cortisol receptor 0 0 0 0 0 0
Counterpoise correction 0 0 0 0 0 0
Covalent drug 0 0 0 0 0 0
Craig ploi 0 0 0 0 0 0
CSSR 0 0 0 0 0 0
Cytotoxic dru(g|gs) 0 0.001 0.001 0 0 0
Data mining 0 0 0 0 0 0.001
Declaration of Helsinki 0 0 0 0 0 0
Dehydrogenases 0 0.001 0.001 0 0 0
Delayed Hypersensitivity Reaction 0 0 0 0 0 0
De novo design|De-novo design|De novo drug design|De-novo drug design
0 0 0 0 0 0
Depolarisation 0 0 0 0 0 0
Designed multiple ligan(d|ds) 0 0 0 0 0 0
Distance geometry 0 0 0 0 0 0
Distomer 0 0 0 0 0 0
DNA transcription|DNA translation 0 0 0 0 0 0
D-optimal design 0 0 0 0 0 0
Dosing regime(n|ns)|Dosing rout(e|es) 0 0 0 0 0 0.001
Double prodrug|Pro-prodrug 0 0 0 0 0 0
Double stranded RNA|dsRNA 0 0 0 0 0.001 0.001
Drug databas(e|es)|drug-databas(e|es) 0 0 0 0 0 0
Drug & disease target 0 0 0 0 0 0
Drug disposition|Drug-disposition|Drug distribution|drug-distribution 0 0 0 0 0 0
Drug efflux pum(p|ps)|Drug elimination|Drug-elimination 0 0 0 0 0 0
Drug Evaluation 0 0 0 0 0 0
Druggability|Druggable|druggable-targe(t|ts)|Druggable targe(t|ts) 0 0 0 0 0 0
Drug latentiation|Drug-latentiation 0 0 0 0 0 0
Drug mechanisms of action 0 0 0 0 0 0
Drug metabolism|Drug-metabolism 0 0 0 0 0 0
Drug Modeling|Drug-Modeling|Drug Modelling|Drug-Modelling 0 0 0 0 0 0
Drug product|Drug-product 0 0 0 0 0 0
Drug prototype|Drug-prototype 0 0 0 0 0 0
Drug receptor interaction 0 0 0 0 0 0
Drug regulation 0 0 0 0 0 0
Drug repositioning|Drug-repositioning 0 0 0 0 0 0
Drug reprofiling|Drug-reprofiling 0 0 0 0 0 0
Drug repurposing|Drug-repurposing 0 0 0 0 0 0
Drug resistant mutation|Drug resistant strain|Drug resistant tuberculosis
0 0 0 0 0 0
Drug safety|Drug-safety 0 0 0 0 0 0
Drug selection|Drug-selection 0 0 0 0 0 0
Drug substance|Drug-substance 0 0 0 0 0 0
Drug target binding forc(e|es)|Drug-target binding forc(e|es) 0 0 0 0 0 0
Drug target discovery|Drug target identification 0 0 0 0 0 0
Drug testing|Drug-testing 0 0 0 0 0 0
Drug transporte(r|rs)|Drug-transporte(r|rs) 0 0 0 0 0 0
Dual action dru(g|gs) 0 0 0 0 0 0
Dual binding sit(e|es)|Dual-binding sit(e|es) 0 0 0 0 0 0
Dual pharmacolog(y|ies) 0 0 0 0 0 0
Electron cryomicroscopy of biological macromolecules 0 0 0 0 0 0
Endogenous facto(r|rs)|Endogenous mediato(r|rs) 0 0 0 0 0 0
Energy minimization 0 0 0 0 0 0
Enrichment factor 0 0 0 0 0 0
Enterohepatic recirculation 0 0 0 0 0 0
Entropic term 0 0 0 0 0 0
Enzyme repression 0 0 0 0 0 0
Epidural injection 0 0 0 0 0 0
Equilibrium constan(t|ts)|Equilibrium solubility 0 0 0 0 0 0
Ethical dru(g|gs) 0 0 0 0 0 0
Eudismic ratio 0 0 0 0 0 0
European Agency for the Evaluation of Medicinal Products|EAEMA 0 0 0 0 0 0
Eutomer 0 0 0 0 0 0
Exogenous facto(r|rs) 0 0 0 0 0 0
Expert system 0 0 0 0 0 0
Explicit solvent|Explicit-solvent 0 0 0 0 0 0
Exploratory investigational new dru(g|gs) 0 0 0 0 0 0
Extended Hiickel calculatio(n|ns)|Hiickel calculatio(n|ns) 0 0 0 0 0 0
Extracellular flui(d|ds) 0 0.001 0.001 0 0 0
Extra thermodynamic approach 0 0 0 0 0 0
Extravascular dosing 0 0 0 0 0 0
False substrate|False-substrate 0 0 0 0 0 0
Fast follower 0 0 0 0 0 0
Fast-tracking 0 0 0 0 0 0
FBDD|Fragment based drug discovery|Fragment-based drug discovery|fragment based drug design|fragment-based drug design|fragment-based lead discovery|fragment based lead discovery|FBLD
0 0 0 0 0 0
Fc Recepto(r|rs)|Fc-Recepto(r|rs) 0 0.001 0 0 0 0
File forma(t|ts)|File-forma(t|ts)|SDF file|SDfile|Molfile|MOL file format
0 0 0 0 0 0
Finished Produc(t|ts) 0 0 0 0 0 0
First-in-class|First-in-Human Clinical Trials|First pass effec(t|ts) 0 0 0 0 0 0
Follow-on|Follow-on dru(g|gs) 0 0 0 0 0 0
Free binding energy|Binding free energy 0 0 0 0 0 0
Free energy perturbatio(n|ns)|Free energy perturbation calculatio(n|ns) 0 0 0 0 0 0
Free- Wilson analysis 0 0 0 0 0 0
Frequent hitter 0 0 0 0 0 0
Full agonist|Partial agonis(t|ts)|Inverse Agonis(t|ts)|Super Agonis(t|ts)|Silent Agonis(t|ts)|Silent Antagonis(t|ts)
0 0.001 0.001 0.001 0.001 0.001
Fundamental pharmacophor(e|es) 0 0 0 0 0 0
Gaussian-type orbita(l|ls) 0 0 0 0 0 0
Gene transcription 0 0.002 0.002 0.002 0.002 0.001
Genomic dru(g|gs)|genomic-dru(g|gs) 0 0 0 0 0 0
Genotoxin 0 0 0 0 0 0
Gibbs Free Energy|Gibbs-Free Energy 0 0 0 0 0 0
Global mode(l|ls)|Local mode(l|ls) 0 0 0 0 0 0
Glomerulus 0 0 0 0 0 0
Glucuronidation 0 0 0 0 0 0
Glucuronide 0 0.001 0.001 0.001 0.001 0
Good Clinical Practice|Good Laboratory Practice|Good Manufacturing Practice
0 0 0 0 0 0
Graph-based metho(d|ds) 0 0 0 0 0 0
Grb2 phosphorylation 0 0 0 0 0 0
Green chemistry 0 0 0 0 0 0
Growth Inhibitory concentratio(n|ns)|GI50 0 0 0 0 0 0
Guanine binding protei(n|ns) 0 0 0 0 0 0
Halogen bonding 0 0 0 0 0 0
Hammett constant|Hammett equation 0 0 0 0 0 0
Hansch analysis|Hansch equation 0 0 0 0 0 0
Hansch-Fujita|Hansch–Fujita π-constant 0 0 0 0 0 0
Hapte(n|ns) 0 0.001 0.001 0 0 0
Hard dru(g|gs)|Hard-dru(g|gs) 0 0 0 0 0 0
Hashin(g|gs) 0 0 0 0 0 0
Heavy atom coun(t|ts) 0 0 0 0 0 0
Henderson-Hasselbach equation 0 0 0 0 0 0
Heterorecepto(r|rs) 0 0 0 0 0 0
Higher Risk Agen(t|ts) 0 0 0 0 0 0
Hill Langmuir equation 0 0 0 0 0 0
Hit-to-Lead|hit-to-lead chemistry 0 0 0 0 0 0
Human ether-a-go-go related gene|hERG 0 0 0 0 0 0
Hydrophobic fragmental constant 0 0 0 0 0 0
Hyper polarisatio(n|ns) 0 0 0 0 0 0
Idiosyncratic effect|Idiosyncratic toxicology 0 0 0 0 0 0
Implicit solvent|Implicit-solvent 0 0 0 0 0 0
Indicator variable 0 0 0 0 0 0
Informatics 0 0 0 0.001 0.001 0.001
In silico screening|in-silico screening 0 0 0 0 0 0
Institutional Animal Care and Use Committee|IACUC 0 0 0 0 0 0
Intellectual property|Intellectual-property 0 0 0 0 0 0
International Chemical Identifier|InChI|InChIKey 0 0 0 0 0 0
Interstitial flui(d|ds)|Interstitial-flui(d|ds) 0 0 0 0 0 0
Intestinal epithelium 0 0 0 0 0 0
Intra-arterial dosing|Intracerebral dosing|Intramuscular dosing|Intraperitoneal dosing|Intrathecal dosing|Intravascular dosing|Intravenous dosing|Intrinsic activity|intrinsic solubility|intrinsic water
0 0 0 0 0 0
Investigational Medicinal Product 0 0 0 0 0 0
Investigational new drug|Investigational new drug application 0 0 0 0 0 0
Investigational Review Board 0 0 0 0 0 0
Investigato(r|rs) Brochure 0 0 0 0 0 0
In vitro screening|In-vitro screening|In vivo screening|In-vivo screening
0 0 0 0 0 0
Ionisable grou(p|ps)|Ionisation|Ionisation constant|Ionisation stat(e|es)|Ionisation-stat(e|es)
0 0 0 0.001 0 0
Ionotropic effec(t|ts)|Ionotropic-effec(t|ts) 0 0 0 0 0 0
Ionotropic recepto(r|rs)|Ionotropic-recepto(r|rs) 0 0 0 0 0 0
ISIS keys 0 0 0 0 0 0
Isostere 0 0 0 0 0 0
Isotopically coded affinity ta(g|gs) 0 0 0 0 0 0
Jackknifing 0 0 0 0 0 0
Kernel metho(d|ds) 0 0 0 0 0 0
Kinetic solubility 0 0 0 0 0 0
Kohonen ma(p|ps)|Kohonen neural net 0 0 0 0 0 0
Large-scale synthesis 0 0 0 0 0 0
Latentiated dru(g|gs) 0 0 0 0 0 0
Lead generatio(n|ns)|Lead-generatio(n|ns) 0 0 0 0 0 0
Lead like|lead-like 0 0 0 0 0 0
Lead optimizatio(n|ns)|Lead-optimizatio(n|ns) 0 0 0 0 0 0
Lead validation|lead-validation 0 0 0 0 0 0
Leverage 0 0 0 0 0 0
Ligand based pharmacophore|ligand-based pharmacophore 0 0 0 0 0 0
Ligand desig(n|ns) 0 0 0 0 0 0
Ligand Efficiency|Ligand-Efficiency|Ligand efficiency dependent lipophilicity|LELP
0 0 0 0 0 0
Ligand gated channe(l|ls) 0 0 0 0 0 0
Ligand lipophilic efficiency|Ligand-lipophilicity efficiency|LiPE 0 0 0 0 0 0
Linear combination of atomic orbita(l|ls)|LCAO 0 0 0 0 0 0
Linear interaction energy 0 0 0 0 0 0
Lipinski|Lipinski rules|Lipinski’s rule 0 0 0 0 0 0
Loading of a property 0 0 0 0 0 0
Lowest Effective Concentratio(n|ns) 0 0 0 0 0 0
Lsosteres 0 0 0 0 0 0
Macromolecular Crystallographic Information File|mmCIF 0 0 0 0 0 0
Madin-Darby canine kidney membrane assay|MDCK 0 0.001 0.001 0 0 0
Markush structur(e|es) 0 0 0 0 0 0
Matched Molecular Pair 0 0 0 0 0 0
Median effective dose|ED50 0 0.002 0.001 0 0 0
Medicin(e|es) and Healthcare Products Regulatory Agency|MHRA 0 0 0 0 0 0
Metabotropic glutamate receptor|Metabotropic receptor 0 0 0 0 0 0
Me-too compound|Me-too drug 0 0 0 0 0 0
Microdose 0 0 0 0 0 0
Microsomal triglyceride transfer protein|MTTP 0 0 0 0 0 0
Microtitre plate 0 0 0 0 0 0
MIFs|Molecular Interaction Fiel(d|ds) 0 0 0 0 0 0
MlNDO/3 calculatio(n|ns) 0 0 0 0 0 0
MM2 calculatio(n|ns) 0 0 0 0 0 0
MNDO calculatio(n|ns) 0 0 0 0 0 0
Molar refractivity 0 0 0 0 0 0
Molecular connectivity index|molecular connectivity indices 0 0 0 0 0 0
Molecular descripto(r|rs)|Molecular-descripto(r|rs) 0 0 0 0 0 0
Molecular desig(n|ns)|Molecular-desig(n|ns) 0 0 0 0 0 0
Molecular (dis-)similarity 0 0 0 0 0 0
Molecular graph 0 0 0 0 0 0
Molecular graphics 0 0 0 0 0 0
Molecular imaging|Molecular-imaging 0 0 0 0 0.001 0.001
Molecular interaction potentia(l|ls)|Molecular lipophilic potentia(l|ls) 0 0 0 0 0 0
Molecular orbital calculatio(n|ns) 0 0 0 0 0 0
Molecular shape 0 0 0 0 0 0
Molecular similarity searching 0 0 0 0 0 0
Molecular therapeuti(c|cs) 0 0 0 0 0 0
Molecular topology|Molecular-topology 0 0 0 0 0 0
Monooxygenase 0 0.001 0.001 0.001 0 0
Mulliken population analysis|Mulliken populatio(n|ns) 0 0 0 0 0 0
Multidimensional scaling 0 0 0 0 0 0
Multiobjective optimization|multiparameter optimisation 0 0 0 0 0 0
Multiple targe(t|ts)|multiple-targe(t|ts)|multitarget-directed ligan(d|ds)|MTDL|multitarget dru(g|gs)|multitarget drug discovery|MTDD
0 0 0 0 0 0
Multivariate statistics 0 0 0 0 0 0
Murcko assembly 0 0 0 0 0 0
Mutual prodru(g|gs) 0 0 0 0 0 0
National Institute for Health and Care Excellence|NICE 0 0 0 0 0 0
Natural Inhibito(r|rs) 0 0 0 0 0 0
N-dealkylation 0 0 0 0 0 0
Neglected diseas(e|es) 0 0 0 0 0 0
Nephron 0 0.001 0.001 0.001 0 0
Nerve termina(l|ls) 0 0.001 0.001 0.001 0 0
Neutral antagonis(t|ts) 0 0 0 0 0 0
New Chemical Entit(y|ies) 0 0 0 0 0 0
New drug application|New Drug Application/Marketing Authorization 0 0 0 0 0 0
Nicotinamide adenine dinucleotide 0 0 0 0 0 0.001
Non-bonded energy ter(m|ms) 0 0 0 0 0 0
Non-classical isostere 0 0 0 0 0 0
Non-competitive antagonism|Noncompetitive antagonist|Non-Competitive Inhibitor
0 0 0 0 0 0
No Observed Adverse Event Level|NOAEL 0 0 0 0 0 0
Nuclear hormone recepto(r|rs) 0 0 0 0 0 0
Nuclear Medicin(e|es) 0 0 0.001 0.001 0.001 0
Nuclear recepto(r|es) 0 0 0.001 0.001 0.001 0.001
Obviousness 0 0 0 0 0 0
Off-labe(l|ls)|Off labe(l|ls) 0 0 0 0 0 0.001
Off targe(t|ts)|off-targe(t|ts)|off-target profiling|off-target effec(t|ts) 0 0 0 0 0 0.001
Organic cation transporte(r|rs) 0 0 0 0 0 0
Orphan diseas(e|es)|orphan-diseas(e|es) 0 0 0 0 0 0
Orphan dru(g|gs)|orphan-dru(g|gs) 0 0 0 0 0 0
Orphan produc(t|ts)|orphan-produc(t|ts) 0 0 0 0 0 0
Orphan recepto(r|rs)|orphan-recepto(r|rs) 0 0 0 0 0 0
Orthogonal projections to latent structur(e|es)|O-PLS 0 0 0 0 0 0
Orthosteric inhibito(r|rs) 0 0 0 0 0 0
Osmosis 0 0 0 0 0 0
Overfitting|overtraining 0 0 0 0 0 0
Oxidases 0 0 0 0 0 0
Paracellular 0 0 0 0 0 0
Parallel artificial membrane permeability assay|PAMPA 0 0 0 0 0 0
Parallel synthesis 0 0 0 0 0 0
Paramete(r|rs) space 0 0 0 0 0 0
Pareto front 0 0 0 0 0 0
Pareto optimization 0 0 0 0 0 0
Partial atomic charg(e|es) 0 0 0 0 0 0
Partnership 0 0 0.001 0.001 0.001 0.001
Passive transpor(t|ts) 0 0 0 0 0 0
Patentability 0 0 0 0 0 0
PCIL0 calculatio(n|ns) 0 0 0 0 0 0
Peptidomimetic 0 0 0 0 0 0
Peptoid 0 0 0 0 0 0
Percentage ionised 0 0 0 0 0 0
Percutaneous Administration 0 0 0 0 0 0
Perenteral dosage 0 0 0 0 0 0
Peripheral Nervous system 0 0.001 0.001 0.001 0.001 0.001
Pfeiffer's rule 0 0 0 0 0 0
Phage display 0 0 0 0.001 0 0
Pharmacogenetics|Pharmacogenomics 0 0 0 0 0.001 0.001
Pharmacological Prob(e|es) 0 0 0 0 0 0
Pharmacopoeia 0 0 0 0 0 0
Pharmacovigilance 0 0 0 0 0 0
Phase 0 clinical studies|Phase 0 clinical trial 0 0 0 0 0 0
Phase 1 metabolism 0 0 0 0 0 0
Phase 2 metabolism 0 0 0 0 0 0
Phase I clinical studies|Phase I clinical trial|Phase 1 clinical trial 0 0 0 0 0 0
Phase II clinical studies|Phase II clinical trial|Phase 2 clinical trial 0 0 0 0 0 0
Phase III clinical studies|Phase III clinical trial|Phase 3 clinical trial 0 0 0 0 0 0
Phase IV clinical studies|Phase IV clinical trial|Phase 4 clinical trial 0 0 0 0 0 0
Phase zero|Phase O 0 0 0 0 0 0
Phosphotransferase 0 0.001 0 0 0 0
Physiological antagonism 0 0 0 0 0 0
Pinocytosis 0 0 0 0 0 0
Pivotal study 0 0 0 0 0 0
PLS latent variabl(e|es) 0 0 0 0 0 0
PLS loading 0 0 0 0 0 0
Polar surface area 0 0 0 0 0 0
Polymorph 0 0 0 0 0 0
Portal system 0 0 0 0 0 0
Pose diagram 0 0 0 0 0 0
Posterior probability 0 0 0 0 0 0
Post-marketing surveillance 0 0 0 0 0 0
Post synaptic membrane 0 0 0 0 0 0
Potential genotoxic impurity 0 0 0 0 0 0
Preclinical candidat(e|es) 0 0 0 0 0 0
Prediction se(t|ts) 0 0 0 0 0 0
Pre-systemic metabolism 0 0 0 0 0 0
Principal Investigator 0 0 0 0 0 0
Principal propert(y|ies) 0 0 0 0 0 0
Prio(n|ns) 0 0 0.001 0.001 0.001 0.001
Prior probability 0 0 0 0 0 0
Privileged structur(e|es)|Privileged scaffol(d|ds) 0 0 0 0 0 0
Projection to latent structur(e|es) 0 0 0 0 0 0
Proof of Concep(t|ts) 0 0 0 0 0 0.001
Property based drug design 0 0 0 0 0 0
Proteosome 0 0 0 0 0 0
Prototype dru(g|gs) 0 0 0 0 0 0
QM/MM 0 0 0 0 0 0
QTc interval|QT Interval 0 0 0.001 0.001 0.001 0.001
Qualified Person 0 0 0 0 0 0
Q wave 0 0 0 0 0 0
Radiolabelling 0 0 0 0 0 0
Randomisation 0 0 0 0 0 0.001
Rat sarcoma protei(n|ns) 0 0 0 0 0 0
Reactive metabolit(e|es) 0 0 0 0 0 0
Receptor domai(n|ns) 0 0 0 0 0 0
Receptor mapping 0 0 0 0 0 0
Receptor reserve 0 0 0 0 0 0
Receptor tone 0 0 0 0 0 0
Recursive partitioning 0 0 0 0 0 0
Reductases 0 0 0 0 0 0
Regularization 0 0 0 0 0 0
Regulatory Affai(r|rs) 0 0 0 0 0 0
Relative bioavailability 0 0 0 0 0 0
Renal tubule 0 0 0 0 0 0
Reporter assa(y|ies) 0 0 0 0 0 0.001
Reproductive Toxicology 0 0 0 0 0 0
Repurposing 0 0 0 0 0 0
Response scrambling 0 0 0 0 0 0
Retinoid recepto(r|rs)|Retinoi(d|ds) 0 0.001 0.002 0.001 0.001 0.001
Retrosynthesis 0 0 0 0 0 0
Retrovirus(e|es) 0 0.001 0.001 0.001 0 0
R-group decomposition 0 0 0 0 0 0
Rhodopsin family 0 0 0 0 0 0
Ridge regression 0 0 0 0 0 0
RNAi therapeuti(c|cs)|RNAi-therapeuti(c|cs) 0 0 0 0 0 0
Rotamer librar(y|ies) 0 0 0 0 0 0
Rule of five|Rule of three 0 0 0 0 0 0
Safety assessment candidate 0 0 0 0 0 0
Scatchard plot 0 0 0 0 0 0
Schild equation 0 0 0 0 0 0
Scintillation proximity assay 0 0 0 0 0 0
Second messenger 0 0.002 0.001 0.001 0.001 0
Secretin 0 0 0 0 0 0
Secretory mechanism 0 0 0 0 0 0
Self-organizing ma(p|ps) 0 0 0 0 0 0
Semi-empirical metho(d|ds)|Semi-empirical quantum chemical metho(d|ds)
0 0 0 0 0 0
Sensory nervous system 0 0 0 0 0 0
Sequential simplex method 0 0 0 0 0 0
Sequest 0 0 0 0 0 0
Serious Adverse Event 0 0 0 0 0 0
SIMCA 0 0 0 0 0 0
Simulated annealing 0 0 0 0 0 0
Single compartment model 0 0 0 0 0 0
Site-specific delivery 0 0 0 0 0 0
SMARTS 0 0 0 0 0 0
SMILES|simplified molecular input line entry system 0 0 0 0 0 0
SMIRKS 0 0 0 0 0 0
Soft dru(g|gs) 0 0 0 0 0 0
Solvent-accessible surface|Solvent accessible surface|SASA 0 0 0 0 0 0
Spare receptor 0 0 0 0 0 0
Specificity of a two-class mode(l|ls) 0 0 0 0 0 0
Split-and-mix synthesis 0 0 0 0 0 0
Spray-dry 0 0 0 0 0 0
Standard error of estimates|Standard error of prediction 0 0 0 0 0 0
Standard Operating Procedure 0 0 0 0 0 0
Stater-type orbitals 0 0 0 0 0 0
Stereoisomer|Stereo-isomer 0 0 0 0 0 0
STO-3G basis set 0 0 0 0 0 0
Structural alert 0 0 0 0 0 0
Structural Homology|Structural-Homology|Structural homologue|Structural-homologue
0 0 0 0 0 0
Structural keys 0 0 0 0 0 0
SBDD|Structure-based design|Structure based drug design|Structure-based drug design|structure based drug discovery|Structure-based design|Structure guided lead optimization|Receptor-based virtual screening|Target-based drug discovery
0 0 0 0 0 0
Structure-based pharmacophor(e|es)|structure based pharmacophor(e|es)|structure based virtual screening
0 0 0 0 0 0
Structure diagram 0 0 0 0 0 0
Structure-property correlatio(n|ns) 0 0 0 0 0 0
Study of structural basis for toxicity 0 0 0 0 0 0
Subcutaneous dosing 0 0 0 0 0 0
Substructure searching 0 0 0 0 0 0
Supersaturated solution 0 0 0 0 0 0
Supervised learning 0 0 0 0 0 0
Swain-Lupton paramete(r|rs) 0 0 0 0 0 0
Sympathetic nervous system 0 0.001 0.001 0.001 0 0.001
Synaptic cleft 0 0 0 0 0 0
Taft steric paramete(r|rs) 0 0 0 0 0 0
Tanimoto|Tanimoto similarity|Tanimoto-similarity|Tanimoto coefficient
0 0 0 0 0 0
Tautomer|tautomerism 0 0 0 0 0 0
Teratogen 0 0 0 0 0 0
Terminal half-life 0 0 0 0 0 0
Thermodynamic solubility 0 0 0 0 0 0
Three-dimensional database searching|3D database searching 0 0 0 0 0 0
Tool Compoun(d|ds) 0 0 0 0 0 0
Topliss tree 0 0 0 0 0 0
Topological index 0 0 0 0 0 0
Topological polar surface area|TPSA 0 0 0 0 0 0
Transcellular absorption|Transcellular fluid 0 0 0 0 0 0
Transcytosis 0 0 0 0 0 0
Transduction mechanism 0 0 0 0 0 0
Transition-state analo(g|gs) 0 0 0 0 0 0
Transpeptidases 0 0 0 0 0 0
True negative|true-negative|True positive|True-positive 0 0 0 0 0 0
Turbidimetric solubility 0 0 0 0 0 0
Tversky similarity 0 0 0 0 0 0
T wave 0 0 0 0 0 0
Two compartment model 0 0 0 0 0 0
Two state mode(l|ls) 0 0 0 0 0 0
Type 1 human adverse drug reactions|Type 2 human adverse drug reactions
0 0 0 0 0 0
Tyrosine kinase domain 0 0 0 0 0 0
Ultra-high-throughput screening|UHTS 0 0 0 0 0 0
Uncompetitive Inhibito(r|rs) 0 0 0 0 0 0
*Normalized term frequency is used as normalized Unigram score
S1-Table 2: 2-Keyword Unigram for India and World data. Table is sorted by India Unigram score . _mix has been used for combining similar terms with the main term in the following tables.
Term Normalized Unigram Score*
Term name India World 90-95
World 96-00
World 01-05
World 06-10
World 11-15
Compound_mix 0.286 0.193 0.208 0.222 0.22 0.217
Drug 0.145 0.089 0.087 0.089 0.09 0.095
Compound 0.12 0.056 0.059 0.07 0.076 0.078
Synthesis 0.088 0.061 0.055 0.053 0.049 0.048
Target_mix 0.088 0.126 0.148 0.153 0.154 0.156
Assay 0.063 0.047 0.047 0.046 0.044 0.045
Inhibitor 0.05 0.055 0.067 0.07 0.063 0.058
Receptor 0.046 0.099 0.11 0.103 0.092 0.082
Toxicity 0.043 0.021 0.022 0.023 0.023 0.024
Lead 0.041 0.025 0.032 0.037 0.041 0.044
Target 0.037 0.027 0.037 0.047 0.057 0.067
V Screening 0.035 0.022 0.026 0.03 0.033 0.036
Cluster 0.033 0.024 0.028 0.033 0.038 0.042
LBDD 0.03 0.019 0.027 0.03 0.03 0.026
Specificity 0.029 0.03 0.031 0.028 0.027 0.028
NMR 0.026 0.011 0.012 0.014 0.014 0.013
Analog 0.023 0.025 0.023 0.021 0.019 0.018
QSAR_mix 0.023 0.011 0.014 0.017 0.02 0.025
Docking 0.019 0.003 0.005 0.007 0.008 0.01
Electron microscopy 0.019 0.012 0.011 0.01 0.01 0.012
Spectroscopic 0.018 0.002 0.004 0.005 0.006 0.006
MD 0.017 0.007 0.009 0.014 0.019 0.023
X-ray 0.016 0.003 0.006 0.009 0.011 0.009
Physicochemical 0.014 0.003 0.002 0.003 0.004 0.005
DFT 0.013 0 0 0.003 0.006 0.007
Similarity 0.013 0.01 0.011 0.01 0.009 0.009
Correlation coefficient 0.012 0.007 0.009 0.009 0.01 0.01
Precision 0.012 0.008 0.009 0.011 0.012 0.014
Regression analysis 0.012 0.007 0.01 0.012 0.014 0.017
Algorithm 0.01 0.006 0.009 0.013 0.018 0.021
H-Bonding 0.01 0.001 0.002 0.003 0.003 0.003
Selectivity 0.009 0.006 0.007 0.008 0.008 0.009
IC50 0.008 0.006 0.006 0.003 0.002 0.004
Drug discovery 0.007 0.001 0.002 0.004 0.005 0.006
Drug resistance 0.007 0.002 0.002 0.003 0.003 0.004
Scaffold-hopping 0.007 0 0.001 0.003 0.006 0.008
Alignment 0.006 0.003 0.004 0.005 0.006 0.006
ANN 0.005 0.002 0.003 0.004 0.005 0.006
Free energy 0.005 0.001 0.001 0.002 0.002 0.002
HOMO/LUMO 0.005 0.001 0.001 0.002 0.002 0.002
Homolog 0.005 0.002 0.004 0.004 0.004 0.004
Hydrophobicity 0.005 0.002 0.002 0.002 0.002 0.003
QSAR 0.005 0 0 0.001 0.001 0.001
Descriptor 0.004 0.001 0.001 0.002 0.002 0.002
Molecular modeling 0.004 0.001 0.001 0.002 0.001 0.001
Quantum chemical 0.004 0 0 0.001 0.002 0.002
SAR 0.004 0.001 0.001 0.001 0.001 0.002
BLAST 0.003 0.002 0.002 0.002 0.002 0.002
FP/FN 0.003 0.005 0.005 0.004 0.004 0.004
Ki 0.003 0.005 0.005 0.003 0.002 0.003
Pharmacophore 0.003 0 0 0.001 0.001 0.001
Area under curve 0.002 0.001 0.002 0.002 0.002 0.004
Chemical structure 0.002 0.001 0.001 0.001 0.001 0.002
Combinatorial library 0.002 0.001 0.002 0.002 0.002 0.002
Concordance 0.002 0.002 0.002 0.003 0.003 0.003
Continuum 0.002 0.001 0.002 0.002 0.003 0.003
Drug interaction 0.002 0.001 0.002 0.002 0.002 0.002
ED50 0.002 0.004 0.003 0.002 0.001 0.001
Experimental design 0.002 0.001 0.001 0.003 0.003 0.003
Factorial design 0.002 0 0 0.001 0.001 0.001
Fingerprint 0.002 0.001 0.001 0.001 0.002 0.002
HBA/HBD 0.002 0 0.001 0.001 0.001 0.001
HTS 0.002 0 0.001 0.002 0.003 0.003
Mass spectroscopy 0.002 0 0 0.001 0.001 0.001
Molecular mechanics 0.002 0.001 0.001 0.001 0.001 0.001
Monte Carlo 0.002 0.001 0.002 0.003 0.004 0.004
Normalization 0.002 0.003 0.003 0.003 0.003 0.003
PCA 0.002 0.002 0.002 0.002 0.003 0.004
PDB 0.002 0 0 0.001 0.001 0.001
Phylogeny 0.002 0.001 0.001 0.002 0.002 0.003
Training/Test 0.002 0 0 0.001 0.001 0.001
Validation 0.002 0 0.001 0.001 0.002 0.002
Chemical diversity 0.001 0 0 0 0.001 0.001
Conformational analysis 0.001 0 0 0 0 0
Discriminant analysis 0.001 0.001 0.001 0.001 0.001 0.001
Drug cocktail 0.001 0.001 0.001 0.001 0.001 0.001
EC50 0.001 0.004 0.003 0.002 0.001 0.001
Error 0.001 0 0 0 0.001 0.001
GRID 0.001 0.001 0.001 0.001 0.002 0.002
Log P 0.001 0 0 0 0 0
Pattern recognition 0.001 0 0 0.001 0.001 0.001
PLS 0.001 0 0 0.001 0.001 0.002
Rational design 0.001 0 0.001 0.001 0.001 0.001
Sensitivity analysis 0.001 0 0.001 0.001 0.001 0.002
SFR 0.001 0 0 0 0 0
AMBER 0 0 0 0 0 0
Energy minimization 0 0 0 0 0 0
Simulated annealing 0 0 0 0 0 0
Structural Homology 0 0 0 0 0 0
TP/TN 0 0 0 0 0 0
*Normalized term frequency is used as normalized Unigram score
S1-Table 3: Bigram calculation using 2-Keyword set for India and World. Table is sorted by India Bigram score
Term Combination nPMI* Score
Term 1 Term 2 India World 90-95
World 96-00
World 01-05
World 06-10
World 11-15
QSAR_mix Regression analysis 0.844 0.91 0.91 0.902 0.892 0.892
Receptor Target_mix 0.788 0.895 0.867 0.826 0.785 0.744
QSAR SAR 0.761 0.727 0.733 0.716 0.727 0.697
Target_mix Target 0.739 0.57 0.579 0.614 0.654 0.69
Correlation coefficient QSAR_mix 0.738 0.726 0.692 0.692 0.711 0.715
QSAR_mix QSAR 0.699 0.531 0.527 0.564 0.541 0.504
FP/FN TP/TN 0.651 0.596 0.622 0.622 0.618 0.621
Compound_mix Drug 0.647 0.678 0.644 0.621 0.63 0.651
Compound Compound_mix 0.589 0.569 0.553 0.566 0.588 0.6
Algorithm ANN 0.517 0.426 0.416 0.387 0.386 0.383
MD Monte Carlo 0.478 0.494 0.498 0.487 0.469 0.439
IC50 Ki 0.461 0.398 0.404 0.415 0.392 0.339
H-Bonding X-ray 0.452 0.473 0.424 0.373 0.38 0.415
NMR Spectroscopic 0.441 0.436 0.441 0.446 0.454 0.475
Compound_mix Inhibitor 0.417 0.566 0.58 0.565 0.547 0.538
MD Molecular mechanics 0.411 0.392 0.395 0.391 0.436 0.436
Drug discovery Drug 0.394 0.339 0.383 0.433 0.457 0.466
Drug Drug resistance 0.393 0.382 0.404 0.412 0.417 0.432
Specificity TP/TN 0.37 0.292 0.304 0.313 0.302 0.294
NMR Synthesis 0.365 0.098 0.155 0.199 0.24 0.258
LBDD X-ray 0.361 0.242 0.298 0.316 0.326 0.336
FP/FN Specificity 0.359 0.322 0.338 0.338 0.326 0.318
Correlation coefficient Precision 0.359 0.186 0.203 0.205 0.202 0.187
Compound_mix LBDD 0.356 0.416 0.433 0.431 0.431 0.42
Analog SAR 0.355 0.288 0.298 0.296 0.316 0.323
ANN Cluster 0.354 0.226 0.243 0.266 0.283 0.302
Chemical structure NMR 0.343 0.259 0.254 0.288 0.311 0.356
Compound Synthesis 0.342 0.168 0.2 0.222 0.244 0.263
Drug discovery Target 0.338 0.19 0.217 0.242 0.232 0.212
Cluster Discriminant analysis 0.331 0.27 0.295 0.305 0.31 0.299
Chemical structure Compound 0.326 0.417 0.411 0.4 0.392 0.394
LBDD Receptor 0.325 0.408 0.387 0.376 0.361 0.354
Inhibitor SAR 0.322 0.148 0.174 0.179 0.218 0.249
Alignment Similarity 0.322 0.285 0.257 0.266 0.257 0.22
Precision Specificity 0.316 0.05 0.089 0.13 0.166 0.198
Compound NMR 0.309 0.276 0.3 0.312 0.314 0.321
Compound Physicochemical 0.306 0.322 0.323 0.301 0.29 0.28
Drug Drug interaction 0.305 0.355 0.377 0.384 0.384 0.382
LBDD Spectroscopic 0.304 0.196 0.197 0.207 0.198 0.209
Compound SAR 0.304 0.297 0.311 0.302 0.308 0.321
Compound QSAR 0.304 0.274 0.3 0.304 0.299 0.293
Drug discovery Target_mix 0.296 0.122 0.154 0.183 0.185 0.18
Drug discovery Inhibitor 0.294 0.148 0.147 0.149 0.177 0.204
IC50 Inhibitor 0.292 0.301 0.284 0.243 0.24 0.271
Correlation coefficient Regression analysis 0.292 0.337 0.311 0.264 0.198 0.159
Compound Pharmacophore 0.29 0.262 0.271 0.278 0.277 0.284
Drug cocktail Drug 0.289 0.338 0.343 0.338 0.336 0.348
LBDD NMR 0.288 0.118 0.17 0.206 0.216 0.219
LBDD Synthesis 0.283 0.075 0.112 0.156 0.192 0.216
Inhibitor Ki 0.283 0.295 0.238 0.177 0.152 0.169
Compound Descriptor 0.271 0.127 0.188 0.242 0.213 0.181
LBDD Target_mix 0.268 0.362 0.335 0.306 0.276 0.257
Assay IC50 0.267 0.118 0.151 0.207 0.244 0.275
Hydrophobicity Physicochemical 0.266 0.375 0.395 0.382 0.355 0.333
Inhibitor Target 0.264 0.027 0.056 0.113 0.153 0.187
Inhibitor Target_mix 0.263 0.092 0.121 0.167 0.205 0.227
Algorithm Cluster 0.263 0.145 0.156 0.178 0.185 0.179
Precision QSAR_mix 0.262 0.143 0.142 0.128 0.124 0.113
LBDD Molecular modeling 0.262 0.237 0.231 0.222 0.215 0.232
Concordance Specificity 0.262 0.139 0.153 0.165 0.175 0.177
Compound HOMO/LUMO 0.261 0.101 0.104 0.115 0.12 0.131
Homolog Similarity 0.259 0.241 0.263 0.206 0.166 0.119
Compound_mix Drug discovery 0.255 0.23 0.247 0.269 0.288 0.303
Pharmacophore Target_mix 0.254 0.187 0.165 0.144 0.157 0.154
Compound_mix Drug resistance 0.254 0.259 0.26 0.256 0.262 0.281
Cluster Similarity 0.254 0.127 0.144 0.17 0.166 0.148
Analog Synthesis 0.251 0.201 0.22 0.252 0.255 0.232
Inhibitor Molecular modeling 0.249 0.112 0.108 0.115 0.156 0.175
Compound IC50 0.247 0.243 0.257 0.237 0.242 0.311
Spectroscopic Synthesis 0.244 0.046 0.082 0.117 0.135 0.163
Docking V Screening 0.241 0.149 0.127 0.141 0.164 0.162
Selectivity Synthesis 0.237 0.096 0.141 0.181 0.208 0.236
SAR Synthesis 0.237 0.213 0.228 0.244 0.272 0.293
Pharmacophore Receptor 0.233 0.21 0.186 0.159 0.159 0.15
Homolog Target_mix 0.225 0.058 0.058 0.072 0.094 0.133
IC50 Synthesis 0.224 0.152 0.175 0.155 0.166 0.225
NMR X-ray 0.223 0.338 0.331 0.319 0.293 0.309
Algorithm Monte Carlo 0.222 0.337 0.33 0.289 0.285 0.268
Drug Rational design 0.22 0.196 0.193 0.203 0.186 0.158
Compound_mix Synthesis 0.22 0.122 0.146 0.158 0.169 0.173
Compound X-ray 0.216 0.114 0.16 0.18 0.272 0.235
Compound_mix QSAR 0.213 0.163 0.176 0.182 0.188 0.19
Compound Drug discovery 0.212 0.221 0.238 0.237 0.239 0.25
H-Bonding NMR 0.209 0.339 0.335 0.295 0.257 0.246
H-Bonding LBDD 0.209 0.212 0.215 0.204 0.232 0.237
Compound Spectroscopic 0.209 0.223 0.257 0.265 0.277 0.293
Algorithm Alignment 0.208 0.262 0.241 0.245 0.228 0.183
LBDD Selectivity 0.205 0.223 0.216 0.203 0.206 0.22
Compound_mix SAR 0.205 0.174 0.184 0.185 0.199 0.21
Compound_mix Physicochemical 0.205 0.17 0.169 0.162 0.169 0.171
Analog Inhibitor 0.203 0.203 0.19 0.164 0.159 0.138
Algorithm MD 0.203 0.286 0.265 0.235 0.218 0.193
Synthesis X-ray 0.202 0.019 0.102 0.172 0.183 0.217
Compound_mix Pharmacophore 0.202 0.167 0.169 0.181 0.194 0.197
Receptor SAR 0.199 0.117 0.12 0.103 0.102 0.095
Free energy LBDD 0.199 0.19 0.168 0.144 0.157 0.202
LBDD MD 0.198 0.029 0.016 0.003 0.017 0.05
Inhibitor Receptor 0.197 0.102 0.129 0.17 0.206 0.219
Compound_mix Drug interaction 0.197 0.241 0.243 0.239 0.242 0.249
Specificity V Screening 0.196 0.172 0.176 0.187 0.191 0.192
Drug interaction Inhibitor 0.196 0.105 0.194 0.184 0.202 0.233
Assay Specificity 0.195 0.178 0.164 0.167 0.17 0.166
Docking QSAR_mix 0.194 0.14 0.104 0.118 0.124 0.115
Compound_mix NMR 0.194 0.12 0.133 0.156 0.172 0.184
Rational design Target_mix 0.193 0.102 0.09 0.118 0.11 0.086
Analog Compound 0.193 0.229 0.22 0.205 0.192 0.178
FP/FN V Screening 0.192 0.276 0.282 0.257 0.243 0.248
Chemical structure Compound_mix 0.192 0.237 0.228 0.226 0.231 0.237
Analog IC50 0.19 0.252 0.237 0.192 0.18 0.206
Molecular modeling NMR 0.189 0.31 0.319 0.296 0.262 0.246
Molecular mechanics NMR 0.186 0.362 0.335 0.274 0.214 0.191
LBDD Target 0.186 0.068 0.106 0.105 0.104 0.106
Compound_mix Drug cocktail 0.186 0.229 0.221 0.21 0.212 0.226
Chemical structure Synthesis 0.186 0.085 0.105 0.129 0.144 0.173
Compound_mix IC50 0.185 0.213 0.21 0.185 0.185 0.224
Algorithm Similarity 0.185 0.087 0.098 0.136 0.145 0.171
SAR Target_mix 0.184 0.099 0.104 0.085 0.09 0.098
Analog Molecular modeling 0.183 0.222 0.237 0.218 0.217 0.199
IC50 Selectivity 0.182 0.262 0.252 0.205 0.211 0.245
Compound H-Bonding 0.179 0.16 0.184 0.186 0.232 0.215
MD X-ray 0.177 0.234 0.148 0.098 0.09 0.112
Receptor Target 0.176 0.065 0.078 0.102 0.121 0.137
Assay Precision 0.174 0.116 0.111 0.1 0.086 0.06
Molecular modeling Target_mix 0.173 0.091 0.089 0.079 0.078 0.083
Combinatorial library Target_mix 0.171 0.081 0.081 0.087 0.091 0.092
Compound LBDD 0.169 0.111 0.128 0.149 0.181 0.185
Inhibitor LBDD 0.166 0.061 0.055 0.064 0.078 0.098
EC50 Toxicity 0.166 0.053 0.101 0.229 0.252 0.256
Drug Inhibitor 0.166 0.08 0.123 0.161 0.187 0.212
Compound_mix Descriptor 0.166 0.032 0.07 0.112 0.101 0.077
Compound Selectivity 0.164 0.211 0.231 0.218 0.223 0.224
Compound_mix Rational design 0.164 0.151 0.152 0.151 0.146 0.135
Analog Selectivity 0.163 0.219 0.215 0.212 0.193 0.172
Molecular modeling Synthesis 0.162 0.131 0.135 0.175 0.191 0.203
Compound Molecular modeling 0.162 0.204 0.195 0.185 0.185 0.203
Assay EC50 0.162 0.04 0.086 0.144 0.168 0.193
Precision Regression analysis 0.157 0.093 0.075 0.054 0.046 0.04
Compound_mix X-ray 0.156 0.093 0.119 0.132 0.181 0.164
Correlation coefficient Specificity 0.151 0.003 0.011 0.037 0.055 0.064
Compound Inhibitor 0.151 0.153 0.134 0.105 0.116 0.137
Drug resistance Inhibitor 0.149 0.071 0.098 0.14 0.182 0.217
Assay Toxicity 0.149 0.033 0.055 0.084 0.109 0.119
Homolog Receptor 0.147 0.057 0.044 0.061 0.091 0.132
Compound Molecular mechanics 0.147 0.175 0.149 0.135 0.109 0.121
Compound EC50 0.145 0.113 0.147 0.172 0.181 0.209
Inhibitor Selectivity 0.144 0.105 0.112 0.104 0.123 0.131
Compound_mix Spectroscopic 0.142 0.115 0.126 0.136 0.148 0.166
Compound_mix Molecular modeling 0.14 0.13 0.124 0.125 0.135 0.147
Compound_mix HOMO/LUMO 0.14 0.036 0.044 0.049 0.05 0.061
Compound_mix Target_mix 0.138 0.112 0.13 0.146 0.154 0.155
Alignment Cluster 0.138 0.085 0.095 0.102 0.075 0.053
Drug cocktail Toxicity 0.135 0.218 0.233 0.217 0.194 0.199
Compound_mix Target 0.132 0.012 0.043 0.074 0.094 0.107
Analog LBDD 0.132 0.162 0.15 0.145 0.126 0.122
Inhibitor X-ray 0.131 0.117 0.097 0.066 0.067 0.089
Analog Compound_mix 0.13 0.169 0.168 0.153 0.14 0.123
Ki Receptor 0.129 0.138 0.11 0.088 0.105 0.142
Assay Concordance 0.129 0.096 0.109 0.107 0.122 0.099
Drug discovery Receptor 0.128 0.072 0.06 0.067 0.08 0.085
IC50 LBDD 0.127 0.185 0.13 0.069 0.073 0.098
Analog Hydrophobicity 0.127 0.172 0.172 0.15 0.125 0.123
Drug IC50 0.126 0.097 0.114 0.13 0.116 0.157
IC50 Target 0.125 0.01 0.026 0.051 0.052 0.074
Ki Target_mix 0.124 0.115 0.087 0.06 0.075 0.103
Inhibitor Synthesis 0.124 0.225 0.212 0.176 0.151 0.122
H-Bonding Synthesis 0.123 0.052 0.074 0.112 0.131 0.144
Analog X-ray 0.123 0.163 0.164 0.17 0.137 0.137
Algorithm Specificity 0.123 0.014 0.043 0.065 0.079 0.091
Molecular modeling Receptor 0.122 0.098 0.097 0.085 0.079 0.096
Drug Toxicity 0.121 0.181 0.184 0.167 0.164 0.166
Receptor Selectivity 0.119 0.171 0.148 0.106 0.096 0.074
Compound_mix Log P 0.119 0.146 0.14 0.145 0.142 0.143
Compound_mix Mass spectroscopy 0.116 0.082 0.093 0.068 0.071 0.087
Assay V Screening 0.116 0.097 0.102 0.131 0.147 0.138
Selectivity Target_mix 0.115 0.158 0.137 0.099 0.097 0.084
Analog Ki 0.114 0.239 0.207 0.124 0.107 0.097
Compound Toxicity 0.113 0.208 0.186 0.18 0.168 0.175
Algorithm QSAR_mix 0.111 0.056 0.055 0.032 0.025 0.008
Specificity Target 0.108 0.101 0.097 0.076 0.067 0.05
IC50 Toxicity 0.108 0.052 0.093 0.115 0.107 0.15
Drug interaction Toxicity 0.108 0.203 0.206 0.186 0.193 0.171
Compound_mix Selectivity 0.107 0.136 0.144 0.136 0.142 0.144
NMR Physicochemical 0.106 0.156 0.154 0.13 0.144 0.14
Drug Physicochemical 0.106 0.035 0.082 0.085 0.104 0.121
Docking Specificity 0.106 0.088 0.102 0.101 0.119 0.124
Analog H-Bonding 0.106 0.181 0.191 0.151 0.117 0.114
Compound_mix H-Bonding 0.105 0.096 0.103 0.096 0.128 0.122
Analog Target_mix 0.103 0.132 0.097 0.07 0.053 0.03
Selectivity Target 0.102 0.07 0.083 0.073 0.091 0.094
Compound_mix Receptor 0.101 0.132 0.148 0.16 0.166 0.162
Analog Receptor 0.101 0.153 0.112 0.089 0.074 0.055
Ki LBDD 0.1 0.193 0.148 0.066 0.054 0.085
Compound Hydrophobicity 0.1 0.214 0.227 0.211 0.194 0.19
Cluster Concordance 0.1 0.109 0.093 0.081 0.082 0.081
Compound_mix Toxicity 0.099 0.158 0.144 0.142 0.145 0.154
ANN MD 0.098 0.253 0.231 0.15 0.118 0.09
Compound_mix EC50 0.097 0.116 0.131 0.125 0.132 0.149
Assay FP/FN 0.095 0.141 0.122 0.114 0.12 0.12
Compound_mix Molecular mechanics 0.091 0.095 0.078 0.058 0.048 0.061
IC50 Target_mix 0.089 0.175 0.13 0.076 0.052 0.055
Compound Ki 0.089 0.171 0.164 0.084 0.051 0.068
Combinatorial library Compound_mix 0.089 0.014 0.109 0.102 0.083 0.082
BLAST Cluster 0.089 0.122 0.096 0.107 0.101 0.078
Physicochemical Synthesis 0.088 0.056 0.073 0.076 0.091 0.113
ED50 Receptor 0.087 0.172 0.136 0.064 0.055 0.055
Drug EC50 0.087 0.036 0.051 0.064 0.083 0.108
Similarity X-ray 0.086 0.145 0.155 0.149 0.119 0.105
QSAR_mix Specificity 0.086 0.005 0.01 0.029 0.043 0.044
Selectivity Specificity 0.084 0.121 0.12 0.115 0.119 0.106
Compound_mix Ki 0.084 0.166 0.133 0.074 0.048 0.061
Analog NMR 0.084 0.135 0.141 0.13 0.127 0.13
MD NMR 0.083 0.236 0.224 0.145 0.105 0.087
Analog Target 0.083 0.019 0.032 0.026 0.022 0.007
Hydrophobicity Synthesis 0.082 0.112 0.124 0.127 0.145 0.158
Lead Toxicity 0.081 0.029 0.022 0.034 0.029 0.025
Compound Target 0.081 0.037 0.038 0.036 0.04 0.047
Assay Compound 0.081 0.085 0.088 0.098 0.106 0.116
Compound Lead 0.078 0.02 0.034 0.047 0.044 0.044
Algorithm V Screening 0.078 0.024 0.023 0.027 0.021 0.019
Compound Drug 0.075 0.105 0.113 0.097 0.096 0.116
EC50 Receptor 0.073 0.257 0.241 0.155 0.117 0.109
Assay Inhibitor 0.072 0.043 0.059 0.084 0.106 0.131
Ki Synthesis 0.069 0.094 0.105 0.056 0.046 0.063
ED50 Inhibitor 0.069 0.117 0.098 0.053 0.037 0.042
Compound_mix Hydrophobicity 0.069 0.113 0.117 0.107 0.101 0.106
QSAR_mix V Screening 0.068 0.016 0.012 0.018 0.021 0.012
LBDD Similarity 0.068 0.059 0.029 0.012 0.03 0.02
Analog Drug 0.067 0.054 0.081 0.077 0.079 0.078
EC50 Target_mix 0.066 0.224 0.204 0.12 0.088 0.084
EC50 Inhibitor 0.065 0.165 0.16 0.125 0.132 0.153
Chemical structure Drug 0.064 0.097 0.09 0.105 0.092 0.101
Drug ED50 0.063 0.104 0.122 0.11 0.08 0.073
Assay Drug resistance 0.063 0.068 0.093 0.099 0.1 0.1
Cluster FP/FN 0.062 0.033 0.035 0.041 0.038 0.028
Target Toxicity 0.061 0.059 0.052 0.05 0.047 0.047
EC50 Synthesis 0.061 0.059 0.073 0.056 0.076 0.122
Compound Free energy 0.058 0.109 0.102 0.106 0.099 0.116
Specificity Target_mix 0.052 0.049 0.035 0.022 0.021 0.013
Lead V Screening 0.052 0.005 0.013 0.021 0.015 0.015
Assay Target 0.052 0.073 0.05 0.047 0.057 0.086
Assay Synthesis 0.05 0.043 0.047 0.048 0.045 0.044
Cluster QSAR_mix 0.048 0.021 0.01 0.02 0.013 0.017
Compound_mix ED50 0.047 0.121 0.121 0.077 0.047 0.042
Assay Compound_mix 0.047 0.033 0.045 0.058 0.07 0.091
Synthesis Target 0.046 0.036 0.041 0.038 0.037 0.032
LBDD Specificity 0.046 0.121 0.09 0.059 0.037 0.033
Compound_mix Free energy 0.045 0.057 0.048 0.039 0.043 0.073
Analog Spectroscopic 0.045 0.099 0.095 0.093 0.093 0.126
Synthesis Target_mix 0.041 0.073 0.074 0.056 0.048 0.029
Drug Hydrophobicity 0.041 0.07 0.081 0.076 0.066 0.072
Cluster Regression analysis 0.041 0.019 0.007 0.008 0.002 0.007
Specificity X-ray 0.04 0.106 0.145 0.124 0.098 0.087
Assay Target_mix 0.04 0.047 0.038 0.041 0.054 0.075
Compound Target_mix 0.039 0.048 0.037 0.018 0.017 0.023
ED50 Target_mix 0.038 0.144 0.109 0.044 0.027 0.026
Compound ED50 0.037 0.153 0.156 0.091 0.051 0.038
Receptor Synthesis 0.035 0.079 0.081 0.058 0.051 0.027
Algorithm Precision 0.034 0.113 0.111 0.109 0.102 0.122
IC50 Receptor 0.033 0.2 0.153 0.085 0.049 0.034
Cluster Specificity 0.033 0.016 0.027 0.04 0.051 0.061
Assay Selectivity 0.033 0.044 0.057 0.036 0.067 0.076
FP/FN Lead 0.031 0.04 0.016 0.023 0.044 0.044
Drug resistance Toxicity 0.03 0.132 0.119 0.1 0.089 0.072
Similarity Specificity 0.026 0.035 0.048 0.05 0.035 0.017
Drug Selectivity 0.025 0.064 0.063 0.052 0.054 0.068
Inhibitor Toxicity 0.024 0.011 0.04 0.063 0.083 0.093
Compound PCA 0.024 0.021 0.025 0.055 0.067 0.061
Assay Receptor 0.023 0.034 0.03 0.035 0.046 0.059
Assay Ki 0.023 0.045 0.047 0.038 0.055 0.08
Precision V Screening 0.02 0.053 0.039 0.037 0.034 0.032
Synthesis Toxicity 0.014 0.006 0.021 0.014 0.025 0.042
Analog Toxicity 0.009 0.072 0.085 0.074 0.052 0.045
Compound Drug interaction 0.008 0.094 0.088 0.088 0.061 0.058
Analog Assay 0.008 0.047 0.042 0.026 0.024 0.013
*nPMI: Normalized Pointwise Mutual Information
S1-Table 4: Trigram calculation using 2-Keyword set for India and World. Table is sorted by India Trigram score. Due to the large table size only common entry in all six data sets are shown here.
Term Combination nPMI* Score
Term 1 Term 2 Term 3 India World 90-95
World 96-00
World 01-05
World 06-10
World 11-15
Target Compound_mix Target_mix 0.314 0.117 0.144 0.173 0.183 0.195
Target Compound Target_mix 0.305 0.061 0.116 0.283 0.327 0.292
Drug discovery Compound Drug 0.292 0.144 0.149 0.188 0.202 0.185
Receptor Compound_mix Target_mix 0.286 0.288 0.291 0.289 0.272 0.259
IC50 Assay Compound_mix 0.24 0.114 0.108 0.13 0.125 0.121
Drug discovery Compound_mix Target_mix 0.218 0.137 0.171 0.191 0.185 0.181
Receptor Compound Target_mix 0.203 0.077 0.127 0.285 0.302 0.239
Target_mix Compound_mix Receptor 0.2 0.172 0.162 0.139 0.097 0.062
Receptor Synthesis Target_mix 0.177 0.041 0.019 0.045 0.054 0.122
Pharmacophore Compound_mix Target_mix 0.177 0.176 0.153 0.132 0.145 0.144
LBDD Compound_mix Target_mix 0.173 0.389 0.365 0.318 0.276 0.258
LBDD Compound_mix Receptor 0.168 0.344 0.317 0.272 0.226 0.205
Inhibitor Compound_mix Target_mix 0.159 0.118 0.152 0.18 0.204 0.229
Chemical structure Compound Drug 0.147 0.077 0.06 0.094 0.085 0.076
Drug discovery Compound_mix Target 0.132 0.278 0.197 0.177 0.157 0.14
Pharmacophore Compound_mix Receptor 0.112 0.153 0.123 0.087 0.074 0.059
Target_mix Compound_mix Target 0.111 0.247 0.083 0.056 0.059 0.073
IC50 Compound Target_mix 0.104 0.082 0.119 0.187 0.193 0.207
SAR Compound_mix Target_mix 0.103 0.073 0.093 0.065 0.072 0.087
Drug resistance Assay Compound_mix 0.102 0.107 0.1 0.07 0.042 0.009
EC50 Assay Compound_mix 0.101 0.01 0.027 0.061 0.066 0.061
Drug discovery Drug Inhibitor 0.097 0.105 0.07 0.033 0.017 0.007
Chemical structure Compound Target_mix 0.096 0.104 0.167 0.243 0.256 0.227
Drug discovery Compound_mix Drug 0.089 0.054 0.069 0.085 0.088 0.085
Drug resistance Compound_mix Drug 0.088 0.061 0.073 0.081 0.08 0.079
LBDD Compound Target_mix 0.087 0.041 0.079 0.207 0.225 0.19
Molecular modeling Compound_mix Target_mix 0.084 0.058 0.051 0.038 0.038 0.047
SAR Analog Compound_mix 0.083 0.026 0.038 0.026 0.047 0.063
Chemical structure Compound Compound_mix 0.081 0.081 0.086 0.086 0.081 0.079
Selectivity Compound Target_mix 0.077 0.099 0.147 0.236 0.257 0.204
SAR Compound_mix Synthesis 0.076 0.099 0.088 0.079 0.086 0.105
Drug interaction Compound_mix Drug 0.068 0.057 0.068 0.076 0.074 0.07
Drug cocktail Compound_mix Drug 0.065 0.054 0.062 0.066 0.064 0.064
Drug interaction Compound Drug 0.064 0.023 0.011 0.049 0.033 0.01
Analog Compound Target_mix 0.063 0.007 0.066 0.183 0.19 0.135
Drug interaction Drug Inhibitor 0.042 0.062 0.114 0.073 0.057 0.056
Inhibitor Compound_mix Receptor 0.042 0.042 0.061 0.066 0.068 0.064
Pharmacophore Compound Compound_mix 0.031 0.002 0.002 0.013 0.01 0.018
SAR Compound Compound_mix 0.028 0.003 0.015 0.014 0.017 0.023
QSAR Compound Compound_mix 0.022 0.006 0.023 0.023 0.02 0.022
Drug Compound_mix Target_mix 0.021 0.015 0.035 0.067 0.085 0.103
Target Specificity Target_mix 0.012 0.026 0.076 0.114 0.11 0.178
Inhibitor Compound_mix Target 0.01 0.152 0.029 0.026 0.051 0.088
Spectroscopic Compound_mix NMR 0.005 0.008 0.01 0.008 0.004 0.014
*nPMI: Normalized Pointwise Mutual Information
S1-Table 5: 3-Keyword based Bigram analysis
Term 1 Term 2 nPMI
3D-QSAR CoMFA 0.829
3D-QSAR QSAR 0.805
3D-QSAR Train/Test 0.743
3D-QSAR Molecular similarity 0.74
3D-QSAR SAR 0.619
3D-QSAR Pharmacophore 0.607
3D-QSAR Descriptor 0.454
3D-QSAR Docking 0.399
3D-QSAR Molecular modeling 0.381
3D-QSAR Hydrophobic 0.372
3D-QSAR Similarity 0.358
3D-QSAR Template 0.307
3D-QSAR LBDD 0.28
3D-QSAR Scaffold 0.279
3D-QSAR Analog 0.265
3D-QSAR Receptor 0.231
3D-QSAR Kinase 0.229
3D-QSAR Target_mix 0.209
3D-QSAR Affinity 0.191
3D-QSAR Target 0.186
3D-QSAR V Screening 0.181
3D-QSAR Compound_mix 0.178
3D-QSAR Lead 0.129
3D-QSAR Enzyme 0.11
3D-QSAR Drug 0.073
ABC protein Multi drug resistance 0.5
ABC protein Drug 0.166
ABC protein Compound_mix 0.097
ADME Drug like 0.56
ADME Pharmacophore 0.463
ADME Docking 0.45
ADME in silico 0.439
ADME QSAR 0.397
ADME IC50 0.337
ADME V Screening 0.303
ADME LBDD 0.275
ADME Metabolism|Metabolite 0.245
ADME Target 0.241
ADME MD 0.231
ADME Affinity 0.227
ADME Lead 0.219
ADME Target_mix 0.217
ADME Analog 0.211
ADME Receptor 0.191
ADME Drug 0.188
ADME Compound_mix 0.171
ADME Enzyme 0.118
ADMET in silico 0.462
ADMET Docking 0.458
ADMET Target 0.295
ADMET V Screening 0.287
ADMET Affinity 0.272
ADMET LBDD 0.255
ADMET Target_mix 0.244
ADMET Metabolism|Metabolite 0.219
ADMET Drug 0.181
ADMET Lead 0.162
ADMET Compound_mix 0.155
Adverse-effect Placebo 0.158
Adverse-effect Efficacy 0.133
Adverse-effect Drug 0.085
Adverse-effect Systemic 0.041
Adverse-effect Compound_mix 0.037
Adverse-effect Metabolism|Metabolite 0.034
Adverse-effect Receptor 0.029
Adverse-effect Hormone 0.021
Adverse-effect Target_mix 0.007
Affinity Docking 0.321
Affinity LBDD 0.29
Affinity Intercalation 0.267
Affinity Molecular modeling 0.255
Affinity in silico 0.249
Affinity Receptor 0.244
Affinity Hydrophobic 0.239
Affinity QSAR 0.225
Affinity Cooperativity 0.22
Affinity Target_mix 0.214
Affinity Homolog 0.211
Affinity PDB 0.206
Affinity Ki 0.204
Affinity Drug like 0.199
Affinity Pharmacophore 0.196
Affinity CoMFA 0.196
Affinity Site-directed mutagenesis 0.192
Affinity Cheminformatics 0.192
Affinity Descriptor 0.177
Affinity SAR 0.176
Affinity MD 0.17
Affinity Train/Test 0.165
Affinity Alpha-helix 0.159
Affinity Analog 0.157
Affinity Proteinase 0.154
Affinity IC50 0.154
Affinity G Protein 0.15
Affinity Target 0.14
Affinity Template 0.137
Affinity Antagonist 0.136
Affinity Protease 0.134
Affinity Wild-type 0.132
Affinity Nucleic acid 0.132
Affinity Potency 0.131
Affinity Beta-barrel 0.129
Affinity Agonist 0.128
Affinity Enzyme 0.126
Affinity Combinatorial library 0.121
Affinity Clone 0.114
Affinity HTS 0.11
Affinity Kinase 0.094
Affinity Similarity 0.089
Affinity Assay 0.089
Affinity Scaffold 0.084
Affinity Compound_mix 0.083
Affinity Fragment 0.082
Affinity Bioinformatics 0.066
Affinity Nucleoside 0.061
Affinity Hydrophilic 0.059
Affinity V Screening 0.044
Affinity Lead 0.043
Affinity Hormone 0.036
Affinity Diversity 0.021
Affinity Cluster 0.018
Affinity Genome 0.012
Affinity Drug 0.004
Agonist Antagonist 0.592
Agonist Partial agonist 0.568
Agonist Receptor 0.482
Agonist G Protein 0.425
Agonist Nuclear hormone receptor 0.383
Agonist Target_mix 0.371
Agonist Pharmacophore 0.224
Agonist Hormone 0.219
Agonist ED50 0.218
Agonist LBDD 0.181
Agonist SAR 0.158
Agonist Placebo 0.151
Agonist Analog 0.145
Agonist Potency 0.144
Agonist QSAR 0.117
Agonist Compound_mix 0.101
Agonist Drug 0.1
Agonist Target 0.098
Agonist Kinase 0.084
Agonist Docking 0.073
Agonist Efficacy 0.058
Agonist Metabolism|Metabolite 0.046
Agonist MD 0.018
Alpha-helix Beta-barrel 0.715
Alpha-helix Hydrophobic 0.289
Alpha-helix MD 0.223
Alpha-helix Enzyme 0.066
Alpha-helix Lead 0.048
Alpha-helix Compound_mix 0.005
Analog SAR 0.355
Analog QSAR 0.318
Analog CoMFA 0.279
Analog Train/Test 0.265
Analog Descriptor 0.26
Analog Pharmacophore 0.251
Analog Molecular similarity 0.246
Analog Lipinski 0.242
Analog Double-blind study 0.231
Analog Potency 0.215
Analog Docking 0.215
Analog Medicinal chemistry 0.21
Analog Lipophilicity 0.21
Analog IC50 0.19
Analog Placebo 0.187
Analog Molecular modeling 0.183
Analog Drug like 0.173
Analog Scaffold 0.157
Analog Prodrug 0.148
Analog PDB 0.139
Analog Combinatorial library 0.138
Analog LBDD 0.132
Analog Hydrophobic 0.13
Analog Compound_mix 0.13
Analog Efficacy 0.126
Analog Ki 0.115
Analog Nucleic acid 0.114
Analog Nucleoside 0.104
Analog in silico 0.104
Analog Target_mix 0.103
Analog Receptor 0.101
Analog Antagonist 0.096
Analog Target 0.092
Analog Template 0.088
Analog Hormone 0.082
Analog Homolog 0.082
Analog Drug 0.067
Analog Lead 0.061
Analog Pharmacokinetics 0.052
Analog MD 0.042
Analog Kinase 0.036
Analog Similarity 0.025
Analog Protease 0.02
Analog V Screening 0.018
Analog Assay 0.008
Analog Enzyme 0.001
Antagonist Receptor 0.511
Antagonist Target_mix 0.396
Antagonist G Protein 0.343
Antagonist ED50 0.215
Antagonist Hormone 0.173
Antagonist SAR 0.15
Antagonist LBDD 0.13
Antagonist QSAR 0.125
Antagonist Potency 0.121
Antagonist Kinase 0.099
Antagonist Compound_mix 0.095
Antagonist Placebo 0.089
Antagonist Drug 0.089
Antagonist Docking 0.073
Antagonist Target 0.055
Antagonist Efficacy 0.022
Antagonist Metabolism|Metabolite 0.017
Antagonist Polymorphism 0.014
Assay IC50 0.267
Assay Hapten 0.208
Assay Enzyme 0.193
Assay Mutagen 0.19
Assay HTS 0.179
Assay EC50 0.162
Assay Potency 0.136
Assay V Screening 0.116
Assay Biomarker 0.102
Assay Nucleic acid 0.098
Assay Chemical database 0.091
Assay Intercalation 0.085
Assay Therapeutic index 0.081
Assay Scaffold 0.08
Assay Pharmacokinetics 0.071
Assay Proteinase 0.066
Assay Chemokine 0.065
Assay siRNA 0.062
Assay Multi drug resistance 0.059
Assay P-glycoprotein 0.058
Assay Docking 0.055
Assay Protease 0.052
Assay ED50 0.05
Assay Targeted drug delivery 0.047
Assay Compound_mix 0.047
Assay Target 0.046
Assay in silico 0.046
Assay Carcinogen 0.046
Assay Clone 0.045
Assay SAR 0.042
Assay Pharmacophore 0.042
Assay Target_mix 0.04
Assay Fragment 0.037
Assay Oncogene 0.036
Assay Molecular target 0.036
Assay Kinase 0.035
Assay Combinatorial library 0.035
Assay Wild-type 0.034
Assay Nucleoside 0.029
Assay Cytochrome 0.025
Assay Receptor 0.023
Assay Drug 0.021
Assay Genome 0.018
Assay Ki 0.016
Assay Hydrophilic 0.016
Assay Template 0.014
Assay Molecular modeling 0.013
Assay Beta-barrel 0.012
Assay RNAi 0.011
Assay Efficacy 0.007
Assay Microarray 0.004
Assay Polymorphism 0.003
Assay Hormone 0.002
Beta-barrel Hydrophobic 0.307
Beta-barrel Protease 0.221
Beta-barrel Homolog 0.213
Beta-barrel MD 0.211
Beta-barrel Similarity 0.186
Beta-barrel Fragment 0.101
Beta-barrel Docking 0.093
Beta-barrel Cluster 0.093
Beta-barrel LBDD 0.08
Beta-barrel Target 0.052
Beta-barrel Enzyme 0.045
Beta-barrel Target_mix 0.018
Beta-barrel Lead 0.014
Beta-barrel Genome 0.013
Bioinformatics in silico 0.344
Bioinformatics Genome 0.331
Bioinformatics microRNA 0.322
Bioinformatics PDB 0.282
Bioinformatics Microarray 0.279
Bioinformatics Homolog 0.253
Bioinformatics Docking 0.205
Bioinformatics Target 0.195
Bioinformatics Nucleoside 0.187
Bioinformatics Similarity 0.186
Bioinformatics Target_mix 0.147
Bioinformatics Kinase 0.109
Bioinformatics Diversity 0.099
Bioinformatics Cluster 0.08
Bioinformatics MD 0.074
Bioinformatics LBDD 0.064
Bioinformatics Receptor 0.061
Bioinformatics Hydrophobic 0.061
Bioinformatics V Screening 0.052
Bioinformatics Metabolism|Metabolite 0.051
Bioinformatics Enzyme 0.035
Bioinformatics Lead 0.027
Bioinformatics Drug 0.018
Biological agent Compound_mix 0.069
Biomarker microRNA 0.254
Biomarker Carcinogen 0.244
Biomarker Microarray 0.227
Biomarker Epigenetic 0.227
Biomarker Oncogene 0.224
Biomarker Xenobiotic 0.223
Biomarker Chemokine 0.175
Biomarker Target 0.108
Biomarker Enzyme 0.092
Biomarker Target_mix 0.085
Biomarker Metabolism|Metabolite 0.084
Biomarker Genome 0.077
Biomarker Kinase 0.072
Biomarker V Screening 0.062
Biomarker Polymorphism 0.045
Biomarker Lead 0.044
Biomarker in silico 0.04
Biomarker Receptor 0.03
Biomarker Systemic 0.023
Biomarker Hormone 0.016
Biomarker Nucleoside 0.014
Biotransformation Cytochrome 0.437
Biotransformation Carcinogen 0.338
Biotransformation Metabolism|Metabolite 0.294
Biotransformation Enzyme 0.2
Biotransformation Compound_mix 0.073
Biotransformation Drug 0.066
Carcinogen Mutagen 0.46
Carcinogen Xenobiotic 0.422
Carcinogen Cytochrome 0.343
Carcinogen Enzyme 0.193
Carcinogen Metabolism|Metabolite 0.161
Carcinogen Efficacy 0.069
Carcinogen Compound_mix 0.038
Carcinogen Target 0.006
Catabolism Metabolism|Metabolite 0.294
Catabolism Enzyme 0.196
Catabolism Receptor 0.052
Catabolism Lead 0.035
Catabolism Target_mix 0.032
Catabolism Compound_mix 0.028
Chemical database Pharmacophore 0.485
Chemical database QSAR 0.388
Chemical database V Screening 0.367
Chemical database Docking 0.359
Chemical database Scaffold 0.343
Chemical database in silico 0.322
Chemical database Target 0.279
Chemical database Lead 0.236
Chemical database LBDD 0.231
Chemical database Target_mix 0.227
Chemical database Drug 0.191
Chemical database Compound_mix 0.17
Chemical database Receptor 0.125
Chemical database Enzyme 0.108
Chemical diversity Diversity 0.617
Chemical diversity Similarity 0.256
Chemical diversity Cluster 0.223
Chemical diversity LBDD 0.138
Chemical diversity V Screening 0.131
Chemical diversity Genome 0.129
Chemical diversity Compound_mix 0.079
Chemical diversity Target 0.069
Chemical diversity Target_mix 0.036
Chemical diversity Drug 0.03
Cheminformatics Docking 0.319
Cheminformatics in silico 0.301
Cheminformatics MD 0.258
Cheminformatics Target 0.235
Cheminformatics V Screening 0.197
Cheminformatics Target_mix 0.197
Cheminformatics LBDD 0.173
Cheminformatics Genome 0.158
Cheminformatics Receptor 0.135
Cheminformatics Lead 0.119
Cheminformatics Drug 0.114
Cheminformatics Compound_mix 0.085
Cheminformatics Enzyme 0.052
Chemokine Receptor 0.336
Chemokine Target_mix 0.263
Chemokine LBDD 0.214
Chemokine Kinase 0.165
Chemokine Polymorphism 0.153
Chemokine Target 0.143
Chemokine Nucleoside 0.1
Chemokine Systemic 0.056
Chemokine Lead 0.04
Chemokine Compound_mix 0.022
CLOGP Compound_mix 0.133
Clone Genome 0.252
Clone Diversity 0.234
Clone Fragment 0.229
Clone Similarity 0.22
Clone Nucleoside 0.204
Clone Homolog 0.187
Clone V Screening 0.119
Clone Cluster 0.113
Clone Enzyme 0.076
Clone Target 0.006
Cluster Diversity 0.308
Cluster Similarity 0.29
Cluster Polymorphism 0.181
Cluster Genome 0.177
Cluster Microarray 0.167
Cluster Fingerprint 0.165
Cluster Fragment 0.156
Cluster Nucleoside 0.12
Cluster microRNA 0.112
Cluster Descriptor 0.099
Cluster in silico 0.085
Cluster Hydrophobic 0.073
Cluster MD 0.069
Cluster LBDD 0.069
Cluster Codon 0.067
Cluster Stem cell 0.058
Cluster Homolog 0.044
Cluster Elimination 0.044
Cluster Template 0.037
Cluster Hydrophilic 0.011
Codon Nucleoside 0.348
Codon Polymorphism 0.337
Codon Genome 0.312
Codon Wild-type 0.202
Codon Fragment 0.199
Codon in silico 0.147
Codon Diversity 0.143
Codon V Screening 0.074
Codon Hydrophobic 0.07
Coenzyme Metabolism|Metabolite 0.212
Coenzyme Enzyme 0.212
Coenzyme Kinase 0.14
Coenzyme Target 0.087
Coenzyme Target_mix 0.058
Coenzyme Efficacy 0.058
Coenzyme Compound_mix 0.054
Coenzyme Drug 0.041
Combinatorial library Descriptor 0.35
Combinatorial library Pharmacophore 0.317
Combinatorial library QSAR 0.305
Combinatorial library in silico 0.229
Combinatorial library Scaffold 0.219
Combinatorial library Target 0.197
Combinatorial library Docking 0.191
Combinatorial library Target_mix 0.171
Combinatorial library V Screening 0.17
Combinatorial library Kinase 0.162
Combinatorial library Diversity 0.132
Combinatorial library Receptor 0.121
Combinatorial library Lead 0.118
Combinatorial library LBDD 0.113
Combinatorial library Genome 0.108
Combinatorial library Drug 0.09
Combinatorial library Compound_mix 0.089
Combinatorial library Efficacy 0.043
Combinatorial library Enzyme 0.028
CoMFA Molecular similarity 0.865
CoMFA Train/Test 0.728
CoMFA QSAR 0.725
CoMFA SAR 0.56
CoMFA Similarity 0.464
CoMFA Pharmacophore 0.418
CoMFA Descriptor 0.375
CoMFA Docking 0.369
CoMFA Hydrophobic 0.354
CoMFA Template 0.333
CoMFA LBDD 0.269
CoMFA Target_mix 0.204
CoMFA Target 0.198
CoMFA Receptor 0.195
CoMFA Kinase 0.185
CoMFA Compound_mix 0.166
CoMFA Enzyme 0.111
CoMFA Drug 0.05
Compound_mix Drug 0.647
Compound_mix LBDD 0.356
Compound_mix Drug delivery 0.291
Compound_mix QSAR 0.213
Compound_mix SAR 0.205
Compound_mix Pharmacophore 0.202
Compound_mix Targeted drug delivery 0.186
Compound_mix Drug cocktail 0.186
Compound_mix IC50 0.185
Compound_mix Drug like 0.182
Compound_mix Drug targeting 0.175
Compound_mix Docking 0.172
Compound_mix Solubility 0.17
Compound_mix New Chemical Entity 0.169
Compound_mix Descriptor 0.166
Compound_mix SBDD 0.164
Compound_mix Pharmacokinetics 0.164
Compound_mix Multi drug resistance 0.163
Compound_mix Lipinski 0.162
Compound_mix Prodrug 0.16
Compound_mix Train/Test 0.156
Compound_mix P-glycoprotein 0.156
Compound_mix Drug disposition 0.155
Compound_mix Lead optimization 0.153
Compound_mix Molecular similarity 0.152
Compound_mix Medicinal chemistry 0.152
Compound_mix Efflux pump 0.152
Compound_mix Lipophilicity 0.151
Compound_mix Rule of five 0.149
Compound_mix Target 0.147
Compound_mix Drug safety|Drug-safety 0.143
Compound_mix Potency 0.142
Compound_mix Molecular modeling 0.14
Compound_mix Target_mix 0.138
Compound_mix Site-specific delivery 0.137
Compound_mix Druggability 0.136
Compound_mix pharmacogenetic 0.131
Compound_mix Molecular target 0.127
Compound_mix Therapeutic index 0.121
Compound_mix Log P 0.119
Compound_mix Intercalation 0.117
Compound_mix Peptidomimetic 0.112
Compound_mix in silico 0.11
Compound_mix Volume of distribution 0.102
Compound_mix Kinase 0.102
Compound_mix Hydrophilic 0.102
Compound_mix Receptor 0.101
Compound_mix Peptidase 0.1
Compound_mix PDB 0.1
Compound_mix Nuclear hormone receptor 0.099
Compound_mix Protease 0.098
Compound_mix EC50 0.097
Compound_mix Partial agonist 0.095
Compound_mix Hydrophobic 0.095
Compound_mix Scaffold 0.092
Compound_mix Cytochrome 0.092
Compound_mix G Protein 0.089
Compound_mix HTS 0.087
Compound_mix Off target 0.086
Compound_mix Multiple target 0.086
Compound_mix Disposition 0.082
Compound_mix Ki 0.078
Compound_mix Proteinase 0.077
Compound_mix Green chemistry 0.071
Compound_mix Xenobiotic 0.066
Compound_mix De novo design 0.066
Compound_mix Metabolism|Metabolite 0.064
Compound_mix Homolog 0.064
Compound_mix Efficacy 0.064
Compound_mix Congener 0.062
Compound_mix Pipeline 0.057
Compound_mix Elimination 0.052
Compound_mix ED50 0.044
Compound_mix Tautomer|Tautomerism 0.039
Compound_mix V Screening 0.037
Compound_mix Mutagen 0.037
Compound_mix Lead 0.035
Compound_mix Enzyme 0.035
Compound_mix Fingerprint 0.032
Compound_mix Template 0.03
Compound_mix Placebo 0.028
Compound_mix siRNA 0.027
Compound_mix Proof of concept 0.023
Compound_mix Site-directed mutagenesis 0.013
Compound_mix Second messenger 0.013
Compound_mix Systems biology 0.01
Compound_mix Double-blind study 0.009
Compound_mix Hapten 0.004
Compound_mix Cooperativity 0.004
Compound_mix MD 0.002
Cooperativity Enzyme 0.065
Cooperativity Target_mix 0.057
Cytochrome Xenobiotic 0.504
Cytochrome Metabolism|Metabolite 0.325
Cytochrome Enzyme 0.283
Cytochrome Polymorphism 0.261
Cytochrome Pharmacokinetics 0.236
Cytochrome Drug 0.122
Cytochrome Fragment 0.112
Cytochrome Docking 0.097
Cytochrome Hormone 0.071
Cytochrome Nucleoside 0.061
Cytochrome Lead 0.041
Cytochrome Target_mix 0.039
Cytochrome Receptor 0.039
Cytochrome Target 0.036
Cytochrome LBDD 0.033
Cytochrome Genome 0.027
Cytochrome V Screening 0.024
Descriptor QSAR 0.737
Descriptor Train/Test 0.573
Descriptor SAR 0.563
Descriptor Lipophilicity 0.427
Descriptor Pharmacophore 0.35
Descriptor Neural network 0.308
Descriptor Molecular modeling 0.238
Descriptor Docking 0.232
Descriptor Hydrophobic 0.224
Descriptor in silico 0.204
Descriptor Potency 0.195
Descriptor Similarity 0.193
Descriptor LBDD 0.172
Descriptor Scaffold 0.158
Descriptor Fragment 0.14
Descriptor Receptor 0.112
Descriptor Target_mix 0.109
Descriptor V Screening 0.108
Descriptor Kinase 0.105
Descriptor Target 0.104
Descriptor MD 0.094
Descriptor Diversity 0.085
Descriptor Drug 0.051
Descriptor Lead 0.048
Disposition Drug disposition 0.643
Disposition Volume of distribution 0.551
Disposition Pharmacokinetics 0.422
Disposition Elimination 0.357
Disposition Metabolism|Metabolite 0.204
Disposition Drug 0.128
Disposition Systemic 0.108
Disposition Enzyme 0.009
Diversity Similarity 0.303
Diversity Polymorphism 0.298
Diversity Genome 0.281
Diversity Fingerprint 0.229
Diversity Nucleoside 0.226
Diversity Fragment 0.176
Diversity Scaffold 0.128
Diversity in silico 0.128
Diversity Protease 0.058
Diversity V Screening 0.046
Diversity QSAR 0.045
Diversity Homolog 0.036
Diversity Metabolism|Metabolite 0.002
Docking in silico 0.506
Docking Pharmacophore 0.468
Docking Molecular modeling 0.451
Docking Lipinski 0.446
Docking Drug like 0.415
Docking PDB 0.414
Docking Rule of five 0.413
Docking Homolog 0.411
Docking SBDD 0.375
Docking MD 0.363
Docking QSAR 0.359
Docking LBDD 0.337
Docking Train/Test 0.323
Docking Molecular similarity 0.323
Docking SAR 0.293
Docking IC50 0.291
Docking Target 0.289
Docking Hydrophobic 0.265
Docking Ki 0.259
Docking Target_mix 0.253
Docking Molecular target 0.242
Docking V Screening 0.241
Docking Template 0.24
Docking Scaffold 0.221
Docking Site-directed mutagenesis 0.216
Docking Kinase 0.193
Docking HTS 0.188
Docking Receptor 0.181
Docking G Protein 0.18
Docking Potency 0.168
Docking Intercalation 0.165
Docking Similarity 0.152
Docking Drug 0.145
Docking Lead 0.129
Docking Enzyme 0.118
Docking Protease 0.114
Docking Fingerprint 0.114
Docking Multi drug resistance 0.099
Docking Wild-type 0.087
Docking Nucleoside 0.031
Docking Metabolism|Metabolite 0.024
Docking Pharmacokinetics 0.011
Double-blind study Placebo 0.421
Double-blind study Efficacy 0.268
Double-blind study Drug 0.088
Drug Targeted drug delivery 0.288
Drug Drug like 0.282
Drug Drug targeting 0.27
Drug Multi drug resistance 0.268
Drug Pharmacokinetics 0.258
Drug Solubility 0.252
Drug SBDD 0.238
Drug P-glycoprotein 0.233
Drug Drug safety|Drug-safety 0.222
Drug Prodrug 0.22
Drug Site-specific delivery 0.218
Drug Lipinski 0.215
Drug pharmacogenetic 0.214
Drug Rule of five 0.21
Drug Efflux pump 0.207
Drug Druggability 0.204
Drug Target 0.198
Drug New Chemical Entity 0.189
Drug Therapeutic index 0.185
Drug Lead optimization 0.177
Drug Medicinal chemistry 0.176
Drug Volume of distribution 0.17
Drug Pharmacophore 0.166
Drug Efficacy 0.161
Drug Hydrophilic 0.158
Drug Molecular target 0.154
Drug Lipophilicity 0.139
Drug Target_mix 0.137
Drug Off target 0.137
Drug in silico 0.132
Drug IC50 0.126
Drug Log P 0.12
Drug Placebo 0.119
Drug Multiple target 0.115
Drug Molecular modeling 0.112
Drug Potency 0.111
Drug HTS 0.11
Drug Pipeline 0.108
Drug Elimination 0.097
Drug SAR 0.093
Drug EC50 0.087
Drug QSAR 0.086
Drug PDB 0.079
Drug Scaffold 0.074
Drug Hydrophobic 0.074
Drug Nuclear hormone receptor 0.065
Drug Intercalation 0.064
Drug Peptidase 0.062
Drug Metabolism|Metabolite 0.061
Drug Homolog 0.06
Drug G Protein 0.059
Drug Systems biology 0.058
Drug ED50 0.058
Drug Systemic 0.053
Drug V Screening 0.049
Drug Molecular similarity 0.042
Drug Receptor 0.041
Drug Train/Test 0.037
Drug Lead 0.028
Drug LBDD 0.028
Drug Xenobiotic 0.025
Drug Protease 0.024
Drug Fingerprint 0.019
Drug Ki 0.014
Drug Kinase 0.007
Drug cocktail Drug 0.289
Drug cocktail Drug delivery 0.276
Drug cocktail Efficacy 0.182
Drug cocktail Receptor 0.102
Drug cocktail Target 0.092
Drug cocktail Target_mix 0.084
Drug cocktail Lead 0.03
Drug delivery Targeted drug delivery 0.64
Drug delivery Drug 0.45
Drug delivery Drug targeting 0.436
Drug delivery Site-specific delivery 0.431
Drug delivery Solubility 0.375
Drug delivery Prodrug 0.353
Drug delivery Hydrophilic 0.331
Drug delivery Therapeutic index 0.293
Drug delivery Pharmacokinetics 0.249
Drug delivery Hydrophobic 0.193
Drug delivery Systemic 0.176
Drug delivery Scaffold 0.141
Drug delivery Efficacy 0.135
Drug delivery Target 0.105
Drug delivery Elimination 0.103
Drug delivery Target_mix 0.061
Drug delivery IC50 0.031
Drug delivery Placebo 0.025
Drug delivery LBDD 0.021
Drug delivery Receptor 0.014
Drug delivery Metabolism|Metabolite 0.009
Drug disposition Drug 0.241
Drug like Lipinski 0.678
Drug like Rule of five 0.656
Drug like Pharmacophore 0.446
Drug like in silico 0.372
Drug like QSAR 0.34
Drug like Scaffold 0.32
Drug like V Screening 0.28
Drug like Target 0.241
Drug like LBDD 0.237
Drug like MD 0.217
Drug like Hydrophobic 0.209
Drug like Target_mix 0.2
Drug like Lead 0.18
Drug like Receptor 0.127
Drug like Enzyme 0.064
Drug like Efficacy 0.04
Drug targeting Target 0.172
Drug targeting LBDD 0.169
Drug targeting Target_mix 0.162
Drug targeting Receptor 0.138
Drug targeting Efficacy 0.122
Druggability Target 0.294
Druggability Target_mix 0.246
EC50 Potency 0.256
EC50 Efficacy 0.078
EC50 Receptor 0.073
EC50 Target_mix 0.066
EC50 Target 0.043
ED50 Efficacy 0.11
ED50 Receptor 0.082
ED50 Enzyme 0.036
ED50 Target_mix 0.034
Efficacy Placebo 0.331
Efficacy Therapeutic index 0.178
Efficacy Pharmacokinetics 0.151
Efficacy Prodrug 0.115
Efficacy pharmacogenetic 0.107
Efficacy Targeted drug delivery 0.105
Efficacy Potency 0.089
Efficacy Peptidase 0.088
Efficacy Lipophilicity 0.083
Efficacy siRNA 0.058
Efficacy Xenobiotic 0.043
Efficacy IC50 0.043
Efficacy Solubility 0.039
Efficacy Elimination 0.037
Efficacy Molecular target 0.036
Efficacy Systemic 0.035
Efficacy Multi drug resistance 0.025
Efficacy Target 0.019
Efficacy Intercalation 0.004
Efflux pump P-glycoprotein 0.543
Efflux pump Multi drug resistance 0.543
Efflux pump Target 0.136
Efflux pump Target_mix 0.09
Elimination Volume of distribution 0.553
Elimination Pharmacokinetics 0.422
Elimination Metabolism|Metabolite 0.092
Elimination Systemic 0.06
Elimination Lead 0.026
Elimination Fragment 0.025
Elimination Target 0.021
Enzyme Xenobiotic 0.259
Enzyme Protease 0.244
Enzyme Metabolism|Metabolite 0.217
Enzyme Peptidase 0.177
Enzyme Ki 0.153
Enzyme Site-directed mutagenesis 0.149
Enzyme SBDD 0.147
Enzyme Homolog 0.132
Enzyme IC50 0.118
Enzyme Proteinase 0.116
Enzyme Lead optimization 0.116
Enzyme Kinase 0.113
Enzyme Molecular modeling 0.107
Enzyme in silico 0.099
Enzyme PDB 0.098
Enzyme Pharmacophore 0.094
Enzyme Wild-type 0.087
Enzyme Polymorphism 0.085
Enzyme Prodrug 0.082
Enzyme pharmacogenetic 0.08
Enzyme Target 0.072
Enzyme SAR 0.07
Enzyme HTS 0.07
Enzyme QSAR 0.069
Enzyme Nucleic acid 0.059
Enzyme Potency 0.058
Enzyme Template 0.054
Enzyme Hydrophobic 0.048
Enzyme Nucleoside 0.046
Enzyme Molecular target 0.042
Enzyme Train/Test 0.041
Enzyme Medicinal chemistry 0.041
Enzyme Fragment 0.041
Enzyme Target_mix 0.04
Enzyme Hormone 0.031
Enzyme Similarity 0.029
Enzyme Lead 0.018
Enzyme Epigenetic 0.012
Enzyme V Screening 0.007
Enzyme P-glycoprotein 0.006
Enzyme RNAi 0.005
Enzyme Genome 0.005
Epigenetic microRNA 0.4
Epigenetic Oncogene 0.332
Epigenetic Genome 0.284
Epigenetic Stem cell 0.217
Epigenetic Target 0.144
Epigenetic Polymorphism 0.128
Epigenetic Target_mix 0.117
Epigenetic Kinase 0.113
Epigenetic Lead 0.1
Epigenetic Metabolism|Metabolite 0.094
Epigenetic Nucleoside 0.08
Epigenetic Receptor 0.057
Epigenetic V Screening 0.035
Fingerprint Fragment 0.233
Fingerprint Similarity 0.212
Fingerprint Polymorphism 0.206
Fingerprint Genome 0.143
Fingerprint V Screening 0.137
Fingerprint Target 0.042
Fingerprint Receptor 0.018
Fingerprint Target_mix 0.012
Fragment Polymorphism 0.535
Fragment Nucleoside 0.281
Fragment Genome 0.217
Fragment Similarity 0.165
Fragment QSAR 0.135
Fragment Wild-type 0.124
Fragment PDB 0.1
Fragment Template 0.097
Fragment Pharmacophore 0.084
Fragment in silico 0.084
Fragment Protease 0.082
Fragment Homolog 0.064
Fragment Nucleic acid 0.059
Fragment SAR 0.057
Fragment Receptor 0.055
Fragment LBDD 0.051
Fragment Target_mix 0.036
Fragment V Screening 0.013
Fragment Hydrophobic 0.013
Fragment MD 0.01
Fragment Target 0.004
G Protein Receptor 0.434
G Protein Target_mix 0.339
G Protein LBDD 0.3
G Protein Homolog 0.243
G Protein Kinase 0.216
G Protein Target 0.209
G Protein MD 0.154
G Protein Hormone 0.128
G Protein V Screening 0.082
G Protein Metabolism|Metabolite 0.056
G Protein Lead 0.055
Genome Nucleoside 0.363
Genome Microarray 0.335
Genome Systems biology 0.307
Genome microRNA 0.285
Genome Phosphotransferase 0.274
Genome in silico 0.268
Genome Similarity 0.262
Genome Polymorphism 0.261
Genome Pipeline 0.261
Genome pharmacogenetic 0.247
Genome HTS 0.228
Genome Homolog 0.204
Genome RNAi 0.185
Genome Oncogene 0.173
Genome Target 0.166
Genome siRNA 0.165
Genome Nucleic acid 0.148
Genome Wild-type 0.131
Genome Template 0.112
Genome Target_mix 0.112
Genome Molecular target 0.099
Genome Metabolism|Metabolite 0.088
Genome PDB 0.08
Genome G Protein 0.08
Genome Kinase 0.073
Genome Xenobiotic 0.069
Genome V Screening 0.036
Genome Protease 0.029
Genome Scaffold 0.019
Genome Molecular modeling 0.014
Genome Stem cell 0.013
Genome Receptor 0.005
Homolog Template 0.406
Homolog PDB 0.393
Homolog Molecular modeling 0.372
Homolog in silico 0.362
Homolog Site-directed mutagenesis 0.314
Homolog MD 0.288
Homolog Oncogene 0.26
Homolog Similarity 0.245
Homolog Target 0.243
Homolog Pharmacophore 0.223
Homolog Target_mix 0.208
Homolog LBDD 0.199
Homolog Kinase 0.198
Homolog Wild-type 0.178
Homolog Nucleoside 0.172
Homolog SAR 0.166
Homolog Hydrophobic 0.153
Homolog Protease 0.152
Homolog QSAR 0.147
Homolog Receptor 0.129
Homolog Scaffold 0.11
Homolog V Screening 0.094
Homolog Lead 0.083
Homolog Metabolism|Metabolite 0.04
Hormone Nuclear hormone receptor 0.319
Hormone Receptor 0.268
Hormone Peptidase 0.192
Hormone Target_mix 0.183
Hormone Metabolism|Metabolite 0.115
Hormone Microarray 0.092
Hormone Potency 0.04
Hormone Kinase 0.038
Hormone Target 0.028
HTS V Screening 0.375
HTS Target 0.208
HTS in silico 0.183
HTS Target_mix 0.162
HTS Lead 0.123
HTS LBDD 0.117
HTS Kinase 0.112
HTS Nucleoside 0.111
HTS Metabolism|Metabolite 0.106
HTS Receptor 0.084
Hydrophilic Hydrophobic 0.524
Hydrophilic Solubility 0.286
Hydrophilic Scaffold 0.202
Hydrophilic MD 0.128
Hydrophilic Similarity 0.092
Hydrophilic LBDD 0.021
Hydrophobic QSAR 0.38
Hydrophobic Pharmacophore 0.362
Hydrophobic Train/Test 0.35
Hydrophobic Molecular similarity 0.344
Hydrophobic SAR 0.307
Hydrophobic Molecular modeling 0.261
Hydrophobic MD 0.25
Hydrophobic PDB 0.213
Hydrophobic Solubility 0.209
Hydrophobic Intercalation 0.203
Hydrophobic Site-directed mutagenesis 0.2
Hydrophobic LBDD 0.187
Hydrophobic in silico 0.153
Hydrophobic Scaffold 0.152
Hydrophobic Potency 0.141
Hydrophobic Similarity 0.128
Hydrophobic Protease 0.122
Hydrophobic Template 0.11
Hydrophobic Wild-type 0.083
Hydrophobic Target 0.062
Hydrophobic Target_mix 0.052
Hydrophobic Nucleic acid 0.046
Hydrophobic Receptor 0.045
Hydrophobic IC50 0.045
Hydrophobic Kinase 0.04
Hydrophobic Lead 0.035
Hydrophobic Nucleoside 0.012
IC50 Ki 0.467
IC50 Potency 0.286
IC50 SAR 0.264
IC50 Scaffold 0.22
IC50 Molecular modeling 0.21
IC50 in silico 0.205
IC50 Pharmacophore 0.194
IC50 QSAR 0.161
IC50 V Screening 0.149
IC50 Kinase 0.132
IC50 LBDD 0.127
IC50 Target 0.126
IC50 Lead 0.106
IC50 Target_mix 0.089
IC50 Protease 0.082
IC50 Metabolism|Metabolite 0.05
IC50 MD 0.038
IC50 Receptor 0.033
in silico PDB 0.366
in silico Molecular modeling 0.347
in silico Pharmacophore 0.345
in silico Lipinski 0.342
in silico Target 0.284
in silico MD 0.272
in silico QSAR 0.269
in silico microRNA 0.269
in silico Template 0.242
in silico Target_mix 0.239
in silico LBDD 0.216
in silico V Screening 0.215
in silico SAR 0.214
in silico Similarity 0.193
in silico Nucleoside 0.187
in silico Ki 0.185
in silico Microarray 0.174
in silico Kinase 0.172
in silico Multi drug resistance 0.167
in silico Scaffold 0.156
in silico Receptor 0.144
in silico Lead 0.125
in silico Protease 0.119
in silico Wild-type 0.118
in silico Polymorphism 0.112
in silico Potency 0.111
in silico Metabolism|Metabolite 0.101
Intercalation LBDD 0.3
Ki Protease 0.215
Ki Potency 0.191
Ki Receptor 0.133
Ki Target_mix 0.124
Ki Target 0.102
Ki Kinase 0.09
Ki LBDD 0.087
Ki Metabolism|Metabolite 0.033
Kinase Second messenger 0.29
Kinase Receptor 0.287
Kinase Target_mix 0.286
Kinase Oncogene 0.258
Kinase siRNA 0.246
Kinase Target 0.245
Kinase Pharmacophore 0.209
Kinase Molecular target 0.206
Kinase QSAR 0.18
Kinase Wild-type 0.169
Kinase Microarray 0.169
Kinase Train/Test 0.16
Kinase PDB 0.156
Kinase RNAi 0.151
Kinase LBDD 0.133
Kinase SAR 0.129
Kinase Molecular modeling 0.11
Kinase microRNA 0.101
Kinase Metabolism|Metabolite 0.098
Kinase Lead 0.095
Kinase Nucleoside 0.093
Kinase Stem cell 0.083
Kinase Potency 0.07
Kinase MD 0.068
Kinase Scaffold 0.057
Kinase Similarity 0.046
Kinase Protease 0.025
Kinase V Screening 0.009
Kinase Template 0.007
LBDD Pharmacophore 0.334
LBDD Receptor 0.325
LBDD Nuclear hormone receptor 0.322
LBDD SBDD 0.289
LBDD Lipinski 0.283
LBDD PDB 0.275
LBDD Target_mix 0.268
LBDD Molecular modeling 0.262
LBDD Molecular similarity 0.248
LBDD QSAR 0.245
LBDD Train/Test 0.228
LBDD MD 0.198
LBDD Pattern recognition 0.189
LBDD Target 0.183
LBDD SAR 0.17
LBDD Template 0.157
LBDD Molecular target 0.157
LBDD Targeted drug delivery 0.134
LBDD Scaffold 0.11
LBDD Potency 0.105
LBDD V Screening 0.081
LBDD Nucleic acid 0.072
LBDD Oncogene 0.069
LBDD Similarity 0.068
LBDD Lead 0.06
LBDD Protease 0.047
LBDD Nucleoside 0.021
LBDD Multi drug resistance 0.014
LBDD Wild-type 0.009
Lead Lead optimization 0.347
Lead Rule of five 0.211
Lead Pharmacophore 0.204
Lead Lipinski 0.186
Lead SBDD 0.147
Lead SAR 0.14
Lead Medicinal chemistry 0.134
Lead New Chemical Entity 0.129
Lead Molecular target 0.121
Lead Target 0.107
Lead QSAR 0.098
Lead Therapeutic index 0.082
Lead Scaffold 0.082
Lead Target_mix 0.08
Lead Oncogene 0.073
Lead Molecular modeling 0.069
Lead Train/Test 0.066
Lead Potency 0.064
Lead MD 0.064
Lead siRNA 0.06
Lead microRNA 0.055
Lead V Screening 0.048
Lead PDB 0.048
Lead Metabolism|Metabolite 0.048
Lead Template 0.045
Lead Wild-type 0.042
Lead Receptor 0.04
Lead Xenobiotic 0.036
Lead RNAi 0.029
Lead Stem cell 0.005
Lead Multi drug resistance 0.005
Lead Nucleic acid 0.004
Lead Microarray 0.002
Lead Neural network 0.001
Lead optimization V Screening 0.261
Lead optimization Target 0.23
Lead optimization Target_mix 0.162
Lipinski Rule of five 0.904
Lipinski Pharmacophore 0.475
Lipinski V Screening 0.299
Lipinski Target 0.26
Lipinski Target_mix 0.213
Lipinski Receptor 0.175
Lipophilicity QSAR 0.446
Lipophilicity SAR 0.377
Lipophilicity Solubility 0.334
Lipophilicity Target_mix 0.077
Log P QSAR 0.396
Log P Receptor 0.166
Log P Target_mix 0.121
MD Molecular modeling 0.319
MD PDB 0.266
MD Pharmacophore 0.21
MD Template 0.164
MD Wild-type 0.122
MD Target 0.111
MD Neural network 0.111
MD Nucleic acid 0.102
MD Target_mix 0.085
MD QSAR 0.078
MD Protease 0.071
MD Nucleoside 0.064
MD Receptor 0.046
MD SAR 0.039
MD V Screening 0.038
MD Similarity 0.036
MD Scaffold 0.033
Medicinal chemistry Scaffold 0.345
Medicinal chemistry Target 0.202
Medicinal chemistry Target_mix 0.168
Metabolism|Metabolite Xenobiotic 0.299
Metabolism|Metabolite Pharmacokinetics 0.229
Metabolism|Metabolite Nuclear hormone receptor 0.227
Metabolism|Metabolite pharmacogenetic 0.198
Metabolism|Metabolite Volume of distribution 0.196
Metabolism|Metabolite Systems biology 0.171
Metabolism|Metabolite Prodrug 0.17
Metabolism|Metabolite P-glycoprotein 0.149
Metabolism|Metabolite Microarray 0.124
Metabolism|Metabolite microRNA 0.076
Metabolism|Metabolite Polymorphism 0.067
Metabolism|Metabolite Nucleic acid 0.067
Metabolism|Metabolite Target 0.062
Metabolism|Metabolite Target_mix 0.06
Metabolism|Metabolite Positron emission tomography 0.057
Metabolism|Metabolite Solubility 0.052
Metabolism|Metabolite Receptor 0.052
Metabolism|Metabolite Oncogene 0.045
Metabolism|Metabolite Protease 0.039
Metabolism|Metabolite PDB 0.035
Metabolism|Metabolite Wild-type 0.033
Metabolism|Metabolite Nucleoside 0.028
Metabolism|Metabolite Systemic 0.009
Metabolism|Metabolite Potency 0.009
Metabolism|Metabolite Similarity 0.004
Microarray microRNA 0.361
Microarray Target 0.174
Microarray Nucleoside 0.164
Microarray Target_mix 0.154
Microarray Receptor 0.101
Microarray V Screening 0.009
microRNA RNAi 0.393
microRNA Target 0.384
microRNA Oncogene 0.348
microRNA siRNA 0.312
microRNA Target_mix 0.3
microRNA Nucleoside 0.208
microRNA Receptor 0.022
Molecular modeling QSAR 0.343
Molecular modeling Pharmacophore 0.332
Molecular modeling Train/Test 0.309
Molecular modeling SAR 0.3
Molecular modeling PDB 0.295
Molecular modeling Template 0.274
Molecular modeling Potency 0.21
Molecular modeling Target 0.201
Molecular modeling Target_mix 0.173
Molecular modeling Solubility 0.157
Molecular modeling Similarity 0.154
Molecular modeling Scaffold 0.148
Molecular modeling Protease 0.127
Molecular modeling Receptor 0.122
Molecular modeling V Screening 0.087
Molecular modeling Nucleoside 0.079
Molecular similarity Train/Test 0.698
Molecular similarity QSAR 0.657
Molecular similarity Similarity 0.572
Molecular similarity SAR 0.554
Molecular similarity Receptor 0.168
Molecular similarity Target_mix 0.166
Molecular similarity Target 0.156
Molecular target Target 0.467
Molecular target Target_mix 0.374
Molecular target Receptor 0.19
Multi drug resistance P-glycoprotein 0.568
Multi drug resistance Target 0.101
Multi drug resistance Nucleoside 0.083
Multi drug resistance V Screening 0.076
Multi drug resistance Polymorphism 0.076
Multi drug resistance Target_mix 0.054
Multiple target Target 0.374
Multiple target Target_mix 0.303
Neural network Train/Test 0.391
Neural network QSAR 0.232
Neural network V Screening 0.04
New Chemical Entity QSAR 0.373
New Chemical Entity V Screening 0.178
New Chemical Entity Target 0.13
New Chemical Entity Target_mix 0.127
Nuclear hormone receptor Receptor 0.424
Nuclear hormone receptor Target_mix 0.334
Nuclear hormone receptor Target 0.224
Nucleic acid siRNA 0.254
Nucleic acid Nucleoside 0.234
Nucleic acid Target 0.145
Nucleic acid Target_mix 0.086
Nucleic acid V Screening 0.061
Nucleoside Polymorphism 0.448
Nucleoside pharmacogenetic 0.286
Nucleoside Similarity 0.23
Nucleoside Oncogene 0.158
Nucleoside Wild-type 0.152
Nucleoside Template 0.118
Nucleoside Target_mix 0.1
Nucleoside Protease 0.089
Nucleoside Receptor 0.088
Nucleoside Target 0.087
Nucleoside V Screening 0.014
Off target siRNA 0.533
Off target Target 0.371
Off target Target_mix 0.297
Oncogene Target 0.222
Oncogene Target_mix 0.185
Oncogene Polymorphism 0.131
Oncogene Receptor 0.112
P-glycoprotein Pharmacokinetics 0.412
P-glycoprotein Target_mix 0.004
Partial agonist Receptor 0.331
Partial agonist Target_mix 0.262
Pattern recognition Receptor 0.299
Pattern recognition Target_mix 0.229
PDB Template 0.377
PDB Target 0.229
PDB Similarity 0.217
PDB Target_mix 0.177
PDB V Screening 0.103
PDB Receptor 0.101
Peptidase Target 0.146
Peptidase Target_mix 0.127
Peptidase Receptor 0.117
pharmacogenetic Polymorphism 0.352
pharmacogenetic Target 0.154
pharmacogenetic Target_mix 0.125
Pharmacokinetics Volume of distribution 0.623
Pharmacokinetics Solubility 0.278
Pharmacokinetics Systemic 0.166
Pharmacokinetics Placebo 0.105
Pharmacokinetics Receptor 0.039
Pharmacokinetics Target 0.037
Pharmacokinetics Target_mix 0.033
Pharmacophore QSAR 0.575
Pharmacophore Train/Test 0.54
Pharmacophore SAR 0.436
Pharmacophore Scaffold 0.358
Pharmacophore V Screening 0.356
Pharmacophore Target 0.271
Pharmacophore Target_mix 0.255
Pharmacophore Receptor 0.233
Pharmacophore Potency 0.211
Pharmacophore Similarity 0.183
Pipeline Target 0.163
Pipeline Target_mix 0.114
Placebo Systemic 0.057
Polymorphism Xenobiotic 0.237
Polymorphism Similarity 0.158
Polymorphism Receptor 0.151
Polymorphism Wild-type 0.115
Polymorphism Target_mix 0.081
Polymorphism V Screening 0.024
Positron emission tomography Receptor 0.007
Potency SAR 0.33
Potency QSAR 0.3
Potency Scaffold 0.166
Potency Protease 0.11
Potency Target_mix 0.106
Potency Target 0.099
Potency Receptor 0.097
Potency V Screening 0.084
Potency Similarity 0.033
Prodrug Solubility 0.326
Prodrug Systemic 0.183
Prodrug Target 0.07
Prodrug Target_mix 0.048
Protease Proteinase 0.349
Protease QSAR 0.101
Protease Scaffold 0.1
Protease Target 0.099
Protease Similarity 0.088
Protease Wild-type 0.074
Protease Target_mix 0.069
Protease V Screening 0.032
Protease Receptor 0.021
QSAR SAR 0.761
QSAR Train/Test 0.704
QSAR Similarity 0.286
QSAR Scaffold 0.271
QSAR Receptor 0.238
QSAR Target_mix 0.222
QSAR Template 0.182
QSAR Target 0.181
QSAR V Screening 0.169
Receptor Target_mix 0.788
Receptor Second messenger 0.247
Receptor SAR 0.199
Receptor Target 0.195
Receptor Train/Test 0.19
Receptor SBDD 0.175
Receptor siRNA 0.151
Receptor Targeted drug delivery 0.109
Receptor RNAi 0.067
Receptor Wild-type 0.057
Receptor Stem cell 0.05
Receptor Xenobiotic 0.041
Receptor Scaffold 0.039
Receptor Template 0.024
Receptor Similarity 0.014
RNAi siRNA 0.64
RNAi Target 0.25
RNAi Target_mix 0.198
Rule of five V Screening 0.281
Rule of five Target 0.238
Rule of five Target_mix 0.189
SAR Train/Test 0.563
SAR Scaffold 0.251
SAR Similarity 0.202
SAR Target_mix 0.184
SAR Target 0.145
SAR V Screening 0.119
SBDD Target 0.296
SBDD Target_mix 0.251
SBDD V Screening 0.236
Scaffold Stem cell 0.237
Scaffold Target 0.127
Scaffold Template 0.118
Scaffold V Screening 0.105
Scaffold Target_mix 0.09
Scaffold Similarity 0.069
Second messenger Target_mix 0.176
Similarity Train/Test 0.321
Similarity Template 0.172
Similarity Target 0.054
Similarity Target_mix 0.034
Similarity V Screening 0.02
siRNA Target 0.273
siRNA Target_mix 0.24
siRNA Systemic 0.049
Site-directed mutagenesis Wild-type 0.401
Site-directed mutagenesis Target 0.125
Site-directed mutagenesis Target_mix 0.085
Site-specific delivery Target_mix 0.164
Solubility Systemic 0.016
Stem cell Target 0.069
Stem cell Target_mix 0.059
Stem cell Systemic 0
Systemic Volume of distribution 0.205
Systemic Targeted drug delivery 0.132
Systems biology Target 0.168
Systems biology Target_mix 0.114
Target Template 0.145
Target Train/Test 0.132
Target Therapeutic index 0.109
Target V Screening 0.106
Target Wild-type 0.067
Target Xenobiotic 0.041
Target_mix Target 0.801
Target_mix Train/Test 0.164
Target_mix Therapeutic index 0.101
Target_mix Template 0.096
Target_mix Wild-type 0.069
Target_mix V Screening 0.052
Target_mix Xenobiotic 0.038
Targeted drug delivery Target 0.182
Targeted drug delivery Target_mix 0.148
Template Train/Test 0.253
Template V Screening 0.031
Train/Test V Screening 0.144
S1-Table 6: Trigram analysis using 3-Keyword terms
Term 1 Term 2 Term 3 nPMI
Docking Compound_mix MD 0.652
LBDD Compound_mix MD 0.534
Molecular modeling Compound_mix MD 0.503
Homolog Compound_mix MD 0.483
in silico Compound_mix MD 0.481
ADME Compound_mix MD 0.464
Pharmacophore Compound_mix MD 0.464
PDB Compound_mix MD 0.459
Drug like Compound_mix MD 0.454
QSAR Analog Enzyme 0.451
SAR Analog Enzyme 0.45
Docking Analog Enzyme 0.441
Lead optimization Compound_mix Lead 0.416
Hydrophobic Compound_mix MD 0.413
Docking Affinity Drug 0.409
Affinity Compound_mix MD 0.403
Drug like Affinity Drug 0.389
Target Compound_mix MD 0.38
Lead optimization Drug Lead 0.372
G Protein Compound_mix MD 0.365
Chemical database Enzyme V Screening 0.363
Target_mix Compound_mix MD 0.362
Chemical database Compound_mix V Screening 0.355
Drug Compound_mix MD 0.353
Descriptor Analog Enzyme 0.352
ADME Enzyme V Screening 0.347
Pharmacophore Compound_mix V Screening 0.344
Target Compound_mix Target_mix 0.343
HTS Enzyme V Screening 0.341
IC50 Analog Enzyme 0.331
HTS Compound_mix V Screening 0.331
Template Compound_mix MD 0.33
Pharmacophore Enzyme V Screening 0.328
Cytochrome Compound_mix Enzyme 0.322
Beta-barrel Alpha-helix Compound_mix 0.322
in silico Affinity Drug 0.321
Potency Analog Enzyme 0.32
QSAR Compound_mix MD 0.314
Affinity Analog Enzyme 0.311
Target Analog Enzyme 0.311
PDB Affinity Drug 0.31
Descriptor Compound_mix MD 0.309
in silico Analog Enzyme 0.306
Chemical database Compound_mix Lead 0.303
Protease Compound_mix MD 0.303
Lead optimization Enzyme Lead 0.302
Kinase Compound_mix MD 0.3
Molecular similarity Receptor Similarity 0.299
ADME Compound_mix V Screening 0.296
Rule of five Drug Lead 0.292
Lipinski Compound_mix V Screening 0.292
ADME Compound_mix Lead 0.289
Molecular modeling Affinity Drug 0.289
Receptor Compound_mix MD 0.288
Pharmacophore Affinity Drug 0.287
Hydrophobic Analog Enzyme 0.287
V Screening Compound_mix MD 0.286
Receptor Compound_mix Target_mix 0.286
Nucleoside Analog Enzyme 0.285
LBDD Analog Enzyme 0.285
Fragment Assay Polymorphism 0.284
ADMET Compound_mix V Screening 0.28
Compound_mix Analog Enzyme 0.279
Molecular similarity Similarity Target_mix 0.278
LBDD Affinity Drug 0.278
Drug like Drug Lead 0.277
Chemical database Drug Lead 0.275
Pharmacophore Compound_mix Lead 0.275
Target Affinity Drug 0.274
Rule of five Compound_mix V Screening 0.274
Rule of five Compound_mix Lead 0.274
Drug like Compound_mix V Screening 0.273
SBDD Drug LBDD 0.271
SBDD Compound_mix Enzyme 0.27
Target_mix Analog Enzyme 0.267
IC50 Compound_mix MD 0.267
Chemical database Drug V Screening 0.265
G Protein Genome Receptor 0.265
Docking Compound_mix Enzyme 0.263
Hydrophilic Compound_mix MD 0.263
Xenobiotic Compound_mix Enzyme 0.26
Lipinski Drug Lead 0.258
Target Enzyme Target_mix 0.257
Lead optimization Compound_mix V Screening 0.254
Lipinski Compound_mix Lead 0.252
Drug like Compound_mix Lead 0.25
Lipinski Drug LBDD 0.247
Drug Compound_mix Enzyme 0.245
ADME Drug Lead 0.245
Lead Compound_mix MD 0.245
Hydrophobic Affinity Drug 0.245
Drug like Drug LBDD 0.244
Targeted drug delivery Drug delivery Receptor 0.244
Protease Compound_mix Enzyme 0.243
Homolog Affinity Drug 0.243
ADME Compound_mix Enzyme 0.242
Wild-type Compound_mix MD 0.242
Docking Enzyme V Screening 0.241
Chemical database Target_mix V Screening 0.241
3D-QSAR Compound_mix Enzyme 0.241
Bioinformatics Enzyme Genome 0.24
IC50 Assay Compound_mix 0.24
Ki Compound_mix Enzyme 0.239
Drug like Drug V Screening 0.238
ADMET Drug LBDD 0.237
Target_mix Affinity Drug 0.237
Molecular similarity Analog Similarity 0.235
CoMFA Compound_mix Enzyme 0.234
Nuclear hormone receptor Compound_mix Receptor 0.234
Molecular target Compound_mix Target_mix 0.233
IC50 Compound_mix Enzyme 0.232
MD Affinity Drug 0.231
Analog Compound_mix MD 0.231
SBDD Drug Lead 0.23
Pharmacophore Compound_mix Enzyme 0.23
Lead optimization Compound_mix Enzyme 0.23
Chemical database Compound_mix Enzyme 0.229
Volume of distribution Compound_mix Elimination 0.229
SBDD Compound_mix V Screening 0.229
Drug Analog Enzyme 0.228
G Protein Compound_mix Receptor 0.228
Biotransformation Compound_mix Enzyme 0.227
Enzyme Compound_mix MD 0.226
ADMET Compound_mix Lead 0.225
Lead optimization Lead V Screening 0.225
Molecular target Compound_mix Target 0.224
Microarray Enzyme Genome 0.224
ADME Drug LBDD 0.223
3D-QSAR Compound_mix QSAR 0.223
Antagonist Drug Receptor 0.223
QSAR Affinity Drug 0.221
Pharmacophore Drug LBDD 0.22
Pharmacophore Kinase V Screening 0.216
QSAR Compound_mix Enzyme 0.215
Antagonist Compound_mix Receptor 0.215
SAR Compound_mix Lead 0.214
HTS Drug V Screening 0.214
G Protein Drug Receptor 0.214
IC50 Assay Drug 0.213
Chemical database Lead V Screening 0.212
Nuclear hormone receptor Drug Receptor 0.212
ADMET Drug V Screening 0.211
Target Drug Target_mix 0.211
SBDD Compound_mix Lead 0.211
Peptidase Compound_mix Enzyme 0.21
Partial agonist Agonist Compound_mix 0.21
Rule of five Compound_mix Lipinski 0.209
Lipinski Drug V Screening 0.209
Nucleoside Assay Polymorphism 0.208
in silico Enzyme V Screening 0.207
SAR Compound_mix Enzyme 0.206
CoMFA Similarity Target_mix 0.205
Kinase Analog Enzyme 0.205
Pharmacophore Drug Lead 0.204
Pharmacophore Drug Kinase 0.204
Molecular modeling Compound_mix Enzyme 0.204
Carcinogen Compound_mix Enzyme 0.203
Descriptor Affinity Drug 0.202
Target_mix Genome Receptor 0.202
V Screening Analog Enzyme 0.201
Target Drug Kinase 0.201
PDB Drug Kinase 0.201
Target_mix Compound_mix Receptor 0.2
Docking Compound_mix V Screening 0.199
Coenzyme Compound_mix Enzyme 0.198
Target Compound_mix Enzyme 0.198
in silico Enzyme Genome 0.197
IC50 Affinity Drug 0.197
Docking Compound_mix Lead 0.196
Agonist Compound_mix Receptor 0.196
Targeted drug delivery Drug delivery Target_mix 0.195
Agonist Drug Receptor 0.195
Metabolism|Metabolite Compound_mix Enzyme 0.194
ADMET Target_mix V Screening 0.193
SBDD Compound_mix Target_mix 0.193
Nuclear hormone receptor Compound_mix Target_mix 0.193
Molecular similarity CoMFA Compound_mix 0.193
Docking Drug Kinase 0.192
PDB Compound_mix Enzyme 0.192
Partial agonist Compound_mix Receptor 0.192
ADME Drug V Screening 0.191
Pharmacophore Target_mix V Screening 0.191
CoMFA Compound_mix QSAR 0.19
Homolog Compound_mix Enzyme 0.19
Medicinal chemistry Compound_mix Lead 0.189
SBDD Drug V Screening 0.188
Nucleoside Enzyme Genome 0.188
Nuclear hormone receptor Metabolism|Metabolite Receptor 0.188
New Chemical Entity Compound_mix Lead 0.188
ADMET Compound_mix Target_mix 0.187
Drug like Compound_mix Enzyme 0.187
Docking Drug LBDD 0.187
3D-QSAR Compound_mix Lead 0.186
Drug disposition Compound_mix Disposition 0.185
SBDD Drug Target_mix 0.185
Lead Analog Enzyme 0.185
in silico Compound_mix Enzyme 0.185
G Protein Compound_mix Target_mix 0.185
Drug cocktail Compound_mix Efficacy 0.184
Targeted drug delivery Compound_mix Drug delivery 0.183
Druggability Compound_mix Target_mix 0.182
pharmacogenetic Compound_mix Enzyme 0.181
Analog Affinity Drug 0.181
ADMET Compound_mix Docking 0.18
ADME Compound_mix Metabolism|Metabolite 0.18
Pharmacophore Drug V Screening 0.18
Compound_mix Affinity Drug 0.178
Pharmacophore Compound_mix Target_mix 0.178
Prodrug Compound_mix Enzyme 0.177
Nucleoside Compound_mix MD 0.177
Drug targeting Drug LBDD 0.176
Similarity Compound_mix MD 0.176
Druggability Drug Target_mix 0.175
Polymorphism Enzyme Genome 0.175
LBDD Compound_mix Enzyme 0.175
3D-QSAR Compound_mix V Screening 0.174
Molecular target Efficacy Target 0.174
Metabolism|Metabolite Analog Enzyme 0.174
Lead optimization Lead Target_mix 0.174
IC50 Enzyme V Screening 0.174
ADME Target_mix V Screening 0.173
V Screening Affinity Drug 0.173
SBDD Enzyme Target_mix 0.173
Receptor Affinity Drug 0.173
Assay Analog Enzyme 0.173
LBDD Compound_mix Target_mix 0.173
Receptor Analog Enzyme 0.172
in silico Compound_mix V Screening 0.172
HTS Target_mix V Screening 0.172
Off target Compound_mix Target_mix 0.171
Nuclear hormone receptor Metabolism|Metabolite Target_mix 0.171
New Chemical Entity Compound_mix V Screening 0.171
CoMFA 3D-QSAR Compound_mix 0.17
QSAR Compound_mix Lead 0.17
Molecular similarity Compound_mix QSAR 0.17
Antagonist Compound_mix Target_mix 0.17
Fragment Enzyme Genome 0.169
Multiple target Compound_mix Target_mix 0.169
Cytochrome Compound_mix Metabolism|Metabolite 0.168
Chemical database Enzyme Target_mix 0.168
Chemical database Compound_mix Target_mix 0.168
Targeted drug delivery Drug delivery LBDD 0.168
Targeted drug delivery Assay Drug 0.168
Lipinski Compound_mix Docking 0.168
LBDD Compound_mix Receptor 0.168
in silico Compound_mix Lead 0.168
Target_mix Drug Receptor 0.167
QSAR Drug Kinase 0.167
IC50 Compound_mix Lead 0.167
ADMET Compound_mix in silico 0.166
Drug Compound_mix Efficacy 0.164
Cheminformatics Drug Lead 0.164
Train/Test Compound_mix Enzyme 0.164
Target_mix Compound_mix Target 0.164
Similarity Enzyme Genome 0.164
SBDD Drug Receptor 0.164
Off target Compound_mix Target 0.164
ADMET Docking Drug 0.163
in silico Drug Kinase 0.163
HTS Compound_mix Lead 0.163
ADME Compound_mix Docking 0.162
ADME Lead V Screening 0.162
CoMFA Analog Similarity 0.162
Combinatorial library Compound_mix Lead 0.162
ADME Compound_mix Target_mix 0.161
Molecular target Drug Target_mix 0.161
ADMET Compound_mix Target 0.159
ADMET Compound_mix Metabolism|Metabolite 0.159
Cheminformatics Compound_mix V Screening 0.159
Combinatorial library Drug Lead 0.158
Scaffold Affinity Drug 0.158
Rule of five Compound_mix Docking 0.158
QSAR Compound_mix V Screening 0.158
Partial agonist Compound_mix Target_mix 0.158
Homolog Enzyme Genome 0.158
SBDD Compound_mix Target 0.157
Rule of five Drug Lipinski 0.157
HTS Assay Compound_mix 0.157
Lipinski Compound_mix Target_mix 0.156
LBDD Compound_mix Lead 0.156
3D-QSAR Enzyme QSAR 0.155
Multiple target Compound_mix Target 0.155
Molecular similarity LBDD Similarity 0.155
HTS Compound_mix Enzyme 0.155
ADMET Drug Target_mix 0.154
CoMFA Compound_mix Train/Test 0.154
Molecular similarity Compound_mix Train/Test 0.154
IC50 Assay Efficacy 0.154
HTS Assay Drug 0.154
Agonist Compound_mix Target_mix 0.154
Druggability Compound_mix Target 0.153
Drug Compound_mix Lead 0.153
Rule of five Docking Drug 0.153
Receptor Enzyme Target_mix 0.153
Molecular target Drug Lead 0.153
Molecular target Compound_mix Lead 0.153
Target_mix Drug Kinase 0.152
Potency Compound_mix Enzyme 0.152
PDB Drug LBDD 0.152
Affinity Compound_mix Enzyme 0.151
Drug targeting Drug Receptor 0.151
Target_mix Compound_mix Enzyme 0.151
Multi drug resistance Assay Drug 0.151
Molecular target Enzyme Target_mix 0.151
Lipinski Target_mix V Screening 0.151
Homolog Enzyme V Screening 0.151
Cheminformatics Compound_mix Lead 0.15
Drug like Docking Drug 0.149
Train/Test Compound_mix QSAR 0.149
Drug like Target_mix V Screening 0.148
Site-directed mutagenesis Compound_mix Enzyme 0.148
Metabolism|Metabolite Enzyme Genome 0.148
Descriptor Drug Kinase 0.147
Lipinski Docking Drug 0.147
Molecular similarity Similarity Target 0.144
in silico Drug Lead 0.144
Drug like Drug Target_mix 0.143
Drug delivery Assay Drug 0.143
3D-QSAR Compound_mix Target_mix 0.143
Off target Drug Target_mix 0.143
Homolog Drug Kinase 0.143
Drug like Compound_mix Target_mix 0.142
Catabolism Compound_mix Enzyme 0.142
Therapeutic index Compound_mix Efficacy 0.142
3D-QSAR Compound_mix Hydrophobic 0.142
Xenobiotic Compound_mix Metabolism|Metabolite 0.141
Targeted drug delivery Drug LBDD 0.141
Receptor Assay Hormone 0.141
Pharmacokinetics Metabolism|Metabolite Systemic 0.141
Lead optimization Lead Target 0.141
Drug like Drug Receptor 0.14
Docking Drug Lead 0.14
3D-QSAR Drug QSAR 0.14
ADME Drug Metabolism|Metabolite 0.139
Volume of distribution Drug Elimination 0.139
Rule of five Compound_mix Target_mix 0.139
CoMFA Compound_mix Target_mix 0.138
Placebo Compound_mix Efficacy 0.138
Molecular similarity 3D-QSAR Compound_mix 0.138
Fragment Compound_mix MD 0.137
Drug delivery Compound_mix Efficacy 0.137
Docking Compound_mix Target_mix 0.137
CoMFA Enzyme QSAR 0.137
Target_mix Fragment Target 0.137
SAR Analog Assay 0.137
Assay Enzyme V Screening 0.137
ADME Enzyme Target_mix 0.136
Chemical database Compound_mix Target 0.136
QSAR Compound_mix Target_mix 0.136
3D-QSAR Compound_mix Train/Test 0.136
Molecular similarity QSAR Similarity 0.136
HTS Drug Lead 0.136
Molecular similarity Compound_mix Hydrophobic 0.135
Lipinski Compound_mix Rule of five 0.135
CoMFA Compound_mix Hydrophobic 0.134
Cheminformatics Compound_mix Enzyme 0.134
SAR Compound_mix QSAR 0.134
Proteinase Compound_mix Enzyme 0.134
ADME Compound_mix in silico 0.133
CoMFA Compound_mix Molecular similarity 0.133
Target Compound_mix Lead 0.133
Pharmacophore Compound_mix Docking 0.133
Pharmacophore Lead V Screening 0.133
Lipinski Drug Target_mix 0.133
G Protein Drug LBDD 0.132
Combinatorial library Compound_mix V Screening 0.131
Chemical database Target V Screening 0.131
Drug disposition Disposition Drug 0.13
Target_mix Efficacy Target 0.129
Metabolism|Metabolite Compound_mix MD 0.129
CoMFA Enzyme Target_mix 0.128
Biotransformation Compound_mix Metabolism|Metabolite 0.128
Scaffold Compound_mix Lead 0.128
ADME Lead Target_mix 0.127
Nuclear hormone receptor Compound_mix Metabolism|Metabolite 0.127
Drug like Compound_mix Docking 0.126
Target Assay Target_mix 0.126
ADMET Affinity Compound_mix 0.125
3D-QSAR Compound_mix Receptor 0.125
Lipinski Compound_mix Target 0.125
Drug targeting Compound_mix Efficacy 0.124
Train/Test Compound_mix V Screening 0.124
Rule of five Drug Target_mix 0.124
3D-QSAR Enzyme Target_mix 0.124
Pharmacophore Enzyme Target_mix 0.124
Pharmacophore Enzyme Lead 0.124
Catabolism Compound_mix Metabolism|Metabolite 0.123
Train/Test Compound_mix Hydrophobic 0.123
Targeted drug delivery Drug Receptor 0.123
pharmacogenetic Drug Metabolism|Metabolite 0.123
in silico Drug LBDD 0.122
Protease Affinity Drug 0.121
Analog Compound_mix Enzyme 0.121
Lead Affinity Drug 0.121
SAR Drug Lead 0.12
Potency Compound_mix Lead 0.12
IC50 Drug Kinase 0.12
CoMFA Enzyme Train/Test 0.119
Pharmacophore Compound_mix Hydrophobic 0.119
Double-blind study Compound_mix Efficacy 0.118
Chemical database Drug Target_mix 0.118
Targeted drug delivery Drug delivery Drug 0.118
SBDD Drug Target 0.118
pharmacogenetic Compound_mix Metabolism|Metabolite 0.118
Cluster Compound_mix MD 0.117
SBDD Docking Drug 0.117
Drug targeting Drug delivery Target_mix 0.116
Drug cocktail Drug Lead 0.116
Descriptor Compound_mix QSAR 0.116
Rule of five Compound_mix Target 0.116
Pharmacokinetics Compound_mix Efficacy 0.116
Multiple target Drug Target_mix 0.116
IC50 Compound_mix V Screening 0.116
Drug cocktail Drug Receptor 0.115
Cytochrome Drug Metabolism|Metabolite 0.115
Drug like Lead V Screening 0.114
Target Enzyme Genome 0.114
RNAi Compound_mix siRNA 0.114
QSAR Compound_mix Hydrophobic 0.114
3D-QSAR CoMFA Compound_mix 0.114
Molecular modeling Drug LBDD 0.114
Kinase Compound_mix Enzyme 0.114
QSAR Compound_mix SAR 0.113
Lead optimization Compound_mix Target_mix 0.113
LBDD Drug Kinase 0.113
QSAR Compound_mix Descriptor 0.112
Protease Enzyme V Screening 0.112
Pharmacophore Compound_mix Receptor 0.112
Molecular similarity Hydrophobic Similarity 0.112
Kinase Affinity Drug 0.112
Diversity Enzyme Genome 0.111
Scaffold Enzyme V Screening 0.111
SBDD Compound_mix Docking 0.111
Molecular target Drug Target 0.111
Molecular modeling Compound_mix Lead 0.111
Druggability Drug Target 0.11
ADME Docking Drug 0.11
Chemical database Lead Target_mix 0.11
Molecular target Compound_mix Enzyme 0.11
Drug targeting Drug Target_mix 0.109
Compound_mix Assay Drug 0.109
CoMFA Hydrophobic Target_mix 0.109
Volume of distribution Compound_mix Pharmacokinetics 0.109
SAR Compound_mix V Screening 0.109
3D-QSAR Drug LBDD 0.109
Drug targeting Compound_mix Target_mix 0.108
Cheminformatics Drug V Screening 0.108
Target Enzyme V Screening 0.108
Pharmacophore Compound_mix Target 0.108
HTS Enzyme Lead 0.108
ADME Drug Target_mix 0.107
3D-QSAR Compound_mix Template 0.107
Polymorphism Genome Receptor 0.107
Pharmacokinetics Compound_mix Metabolism|Metabolite 0.107
Molecular similarity Compound_mix Target_mix 0.107
ADME Compound_mix Target 0.106
Train/Test Compound_mix Lead 0.106
Targeted drug delivery Compound_mix Efficacy 0.106
MD Drug Kinase 0.106
in silico Compound_mix Target_mix 0.106
Hydrophobic Compound_mix Enzyme 0.106
Hydrophilic Compound_mix Hydrophobic 0.106
HTS Lead V Screening 0.106
Target Drug Lead 0.105
Pharmacokinetics Assay Drug 0.105
P-glycoprotein Compound_mix Enzyme 0.105
Lead optimization Compound_mix Target 0.105
Chemical diversity Compound_mix V Screening 0.104
Descriptor Compound_mix Enzyme 0.103
Cytochrome Enzyme Lead 0.103
SAR Compound_mix Target_mix 0.103
QSAR Compound_mix Receptor 0.103
Nucleoside Genome Receptor 0.103
Medicinal chemistry Compound_mix Target_mix 0.103
Lipinski LBDD V Screening 0.102
Intercalation Assay Compound_mix 0.102
EC50 Assay Compound_mix 0.101
Drug like Compound_mix Target 0.101
Drug delivery Compound_mix Drug 0.101
CoMFA Drug QSAR 0.101
Receptor Assay Target_mix 0.101
3D-QSAR Compound_mix Docking 0.101
3D-QSAR Hydrophobic Target_mix 0.101
Off target Drug Target 0.101
Homolog Enzyme Target_mix 0.101
ADME Compound_mix Receptor 0.1
Drug delivery Affinity Drug 0.1
Chemical diversity Diversity V Screening 0.1
Targeted drug delivery Compound_mix Enzyme 0.1
siRNA Efficacy Target 0.1
Analog Compound_mix Lead 0.1
Descriptor Compound_mix Lead 0.099
Partial agonist Agonist Target_mix 0.099
Fingerprint Compound_mix V Screening 0.098
ADMET Target V Screening 0.098
Chemical database Enzyme Target 0.098
Potency Assay Compound_mix 0.098
3D-QSAR Similarity Target_mix 0.098
Pharmacophore Analog V Screening 0.098
Pharmacophore Hydrophobic Target_mix 0.098
ADMET Drug Target 0.097
Prodrug Compound_mix Efficacy 0.096
IC50 Analog Assay 0.096
Genome Compound_mix MD 0.096
ADMET Drug in silico 0.095
CoMFA Compound_mix Receptor 0.095
PDB Compound_mix Template 0.095
Docking Enzyme Target_mix 0.094
IC50 Enzyme Lead 0.094
Docking Enzyme Lead 0.093
Targeted drug delivery Drug Target_mix 0.093
Rule of five Compound_mix Drug like 0.093
Potency Assay Drug 0.093
Pharmacophore Drug Receptor 0.093
PDB Compound_mix Target_mix 0.093
Alpha-helix Beta-barrel Enzyme 0.093
Drug cocktail Compound_mix Lead 0.092
Targeted drug delivery Compound_mix Target_mix 0.092
3D-QSAR Compound_mix SAR 0.092
Pharmacokinetics Drug Metabolism|Metabolite 0.092
Molecular similarity Compound_mix SAR 0.092
Chemokine Compound_mix Receptor 0.091
Template Compound_mix Enzyme 0.091
Receptor Drug Kinase 0.091
PDB Enzyme Target_mix 0.091
Molecular target Lead Target_mix 0.091
Molecular similarity SAR Similarity 0.091
in silico Enzyme Lead 0.091
IC50 Drug Lead 0.091
G Protein Lead Receptor 0.091
Cheminformatics Target_mix V Screening 0.09
Chemical database Compound_mix Docking 0.09
Peptidase Compound_mix Efficacy 0.09
PDB Compound_mix V Screening 0.09
Cheminformatics Compound_mix Target_mix 0.089
Volume of distribution Compound_mix Metabolism|Metabolite 0.089
Scaffold Compound_mix V Screening 0.089
Prodrug Compound_mix Metabolism|Metabolite 0.089
PDB Compound_mix Lead 0.089
Lipinski Compound_mix Receptor 0.089
ADMET Docking Target_mix 0.088
Docking Kinase V Screening 0.088
CoMFA Compound_mix Docking 0.088
Train/Test Compound_mix Target_mix 0.088
Targeted drug delivery Drug delivery Target 0.088
SBDD Compound_mix Receptor 0.088
Prodrug Drug Systemic 0.087
3D-QSAR Enzyme Train/Test 0.087
PDB Compound_mix Docking 0.087
Lead optimization Drug Target_mix 0.087
ADME LBDD Lead 0.086
Molecular target Assay Target_mix 0.086
Descriptor Compound_mix V Screening 0.085
Target_mix Compound_mix Lead 0.085
3D-QSAR QSAR Target_mix 0.085
Pharmacophore LBDD V Screening 0.085
Molecular similarity Docking Similarity 0.085
Homolog Compound_mix Lead 0.085
Disposition Compound_mix Elimination 0.084
CoMFA Similarity Target 0.084
CoMFA LBDD Similarity 0.084
Multi drug resistance Drug Lead 0.084
Molecular modeling Compound_mix Target_mix 0.084
Lipinski Compound_mix Drug like 0.084
in silico Compound_mix Docking 0.084
Drug Assay Compound_mix 0.083
Train/Test 3D-QSAR Compound_mix 0.083
Target_mix Assay Receptor 0.083
SAR Analog Compound_mix 0.083
Site-specific delivery Compound_mix Drug delivery 0.082
Bioinformatics Compound_mix Enzyme 0.081
Rule of five Lipinski Target_mix 0.081
QSAR Drug Lead 0.081
Pharmacokinetics Compound_mix Elimination 0.081
pharmacogenetic Compound_mix Efficacy 0.081
Molecular target Enzyme Target 0.081
Molecular modeling Drug Lead 0.081
Efficacy Analog Enzyme 0.08
Chemical database LBDD V Screening 0.08
Molecular modeling Enzyme Target_mix 0.08
Combinatorial library Compound_mix Enzyme 0.079
Targeted drug delivery Assay Compound_mix 0.079
3D-QSAR Drug Train/Test 0.079
Kinase Compound_mix Lead 0.079
Homolog Compound_mix Template 0.079
Drug delivery Drug Systemic 0.078
Rule of five Drug Target 0.078
Kinase Compound_mix Target_mix 0.078
Genome Assay Polymorphism 0.078
ADME Affinity Compound_mix 0.077
Lipinski Drug Rule of five 0.077
Disposition Compound_mix Metabolism|Metabolite 0.076
CoMFA 3D-QSAR Drug 0.076
Target Drug LBDD 0.076
QSAR Enzyme Target_mix 0.076
QSAR Hydrophobic Target_mix 0.076
New Chemical Entity Compound_mix Target_mix 0.076
Molecular modeling Compound_mix Docking 0.076
in silico Enzyme Target_mix 0.076
Drug like Compound_mix in silico 0.075
Coenzyme Enzyme Target_mix 0.075
Train/Test Compound_mix Receptor 0.075
Scaffold Drug Lead 0.075
SAR Assay Compound_mix 0.075
Hydrophilic Drug Hydrophobic 0.075
Homolog Enzyme Lead 0.075
Homolog Drug LBDD 0.075
CoMFA Compound_mix SAR 0.074
CoMFA QSAR Target_mix 0.074
Polymorphism Fragment Target 0.074
Pharmacophore Lead Target_mix 0.074
P-glycoprotein Compound_mix Metabolism|Metabolite 0.074
Lipinski Drug Target 0.074
Homolog Compound_mix Target_mix 0.074
V Screening Compound_mix Enzyme 0.073
Scaffold Compound_mix Enzyme 0.073
3D-QSAR Lead QSAR 0.073
Polymorphism Enzyme Fragment 0.073
P-glycoprotein Assay Compound_mix 0.073
Compound_mix Drug Kinase 0.072
Nuclear hormone receptor Drug Target_mix 0.072
MD Compound_mix Enzyme 0.072
LBDD Compound_mix V Screening 0.072
HTS Assay Target_mix 0.072
Affinity Enzyme V Screening 0.071
Enzyme Affinity Drug 0.071
Enzyme Assay Hormone 0.071
Efficacy Compound_mix MD 0.071
ADMET Docking Lead 0.071
Antagonist Assay Receptor 0.071
MD Drug LBDD 0.071
Efflux pump Compound_mix Multi drug resistance 0.07
Target_mix Assay Hormone 0.07
SAR Compound_mix Receptor 0.07
QSAR Descriptor Drug 0.07
QSAR Receptor Similarity 0.07
Multiple target Drug Target 0.07
Molecular target Assay Target 0.07
Molecular similarity Compound_mix Docking 0.07
Molecular similarity Compound_mix Receptor 0.07
Molecular modeling Compound_mix V Screening 0.07
Docking Enzyme Genome 0.069
QSAR Drug LBDD 0.069
Pharmacophore Assay Compound_mix 0.069
Assay Compound_mix Enzyme 0.069
Kinase Genome Receptor 0.069
Homolog Drug Lead 0.069
Drug cocktail Drug Efficacy 0.068
V Screening Compound_mix Lead 0.068
ADME Target V Screening 0.067
Chemokine Compound_mix Target_mix 0.066
Pharmacophore Hydrophobic Lead 0.066
PDB Drug Lead 0.066
Molecular similarity Similarity Train/Test 0.066
Lipinski Docking Target_mix 0.066
LBDD Enzyme V Screening 0.066
Agonist Antagonist Compound_mix 0.066
ADME LBDD V Screening 0.065
Drug delivery Assay Efficacy 0.065
Drug cocktail Compound_mix Drug 0.065
Xenobiotic Drug Metabolism|Metabolite 0.065
SAR Enzyme Target_mix 0.065
3D-QSAR CoMFA Drug 0.065
3D-QSAR Target_mix V Screening 0.065
Partial agonist Agonist Receptor 0.065
MD Enzyme V Screening 0.065
in silico Drug V Screening 0.065
Homolog Compound_mix V Screening 0.065
Drug like Drug Target 0.064
Docking Compound_mix Target 0.064
Train/Test Hydrophobic Target_mix 0.064
Targeted drug delivery Compound_mix Drug 0.064
Multi drug resistance Assay Compound_mix 0.064
Drug like Compound_mix Drug 0.063
Chemical database Lead Target 0.063
Molecular target Drug Receptor 0.063
Molecular similarity CoMFA Similarity 0.063
Medicinal chemistry Drug Target_mix 0.063
Lipinski Compound_mix in silico 0.063
Hormone Genome Receptor 0.063
ADME Lead Target 0.062
Docking Target_mix V Screening 0.062
CoMFA Analog Compound_mix 0.062
Chemical database Drug Target 0.062
Train/Test Compound_mix Descriptor 0.062
Train/Test Compound_mix Template 0.062
Target_mix Enzyme Genome 0.062
Pharmacophore Drug Target_mix 0.062
Multi drug resistance Compound_mix Lead 0.062
Medicinal chemistry Compound_mix Target 0.062
Lipinski Docking Lead 0.062
G Protein Drug Target_mix 0.062
ADME Docking Lead 0.061
Docking Drug V Screening 0.061
Drug targeting Compound_mix Drug 0.06
Drug like Lead Target_mix 0.06
Chemical database Compound_mix Scaffold 0.06
Biotransformation Drug Metabolism|Metabolite 0.06
Targeted drug delivery Drug Systemic 0.06
3D-QSAR Enzyme Hydrophobic 0.06
Nuclear hormone receptor Compound_mix Target 0.06
Antagonist Agonist Compound_mix 0.06
ADME Docking Enzyme 0.059
Train/Test Similarity Target_mix 0.059
ADME Drug in silico 0.058
Disposition Drug Metabolism|Metabolite 0.058
CoMFA 3D-QSAR Enzyme 0.058
Target Compound_mix V Screening 0.058
Target Lead Target_mix 0.058
SAR Compound_mix Hydrophobic 0.058
Prodrug Drug Metabolism|Metabolite 0.058
Pattern recognition Compound_mix Receptor 0.058
Nuclear hormone receptor Receptor Target 0.058
Multi drug resistance Compound_mix Enzyme 0.058
HTS Compound_mix Target_mix 0.058
ADMET Docking Target 0.057
Docking Affinity Compound_mix 0.057
Docking Assay Compound_mix 0.057
CoMFA Compound_mix Target 0.057
QSAR 3D-QSAR Compound_mix 0.057
Potency Drug Lead 0.057
3D-QSAR Hydrophobic Receptor 0.057
Peptidase Compound_mix Target_mix 0.057
Molecular similarity 3D-QSAR Similarity 0.057
Lead Compound_mix Enzyme 0.057
HTS Target V Screening 0.057
G Protein Compound_mix Lead 0.057
Affinity Compound_mix Lead 0.056
Drug like Drug Scaffold 0.056
SAR Drug QSAR 0.056
Pharmacophore Assay Drug 0.056
PDB Compound_mix Target 0.056
CoMFA Hydrophobic Similarity 0.055
Potency Compound_mix V Screening 0.055
P-glycoprotein Drug Metabolism|Metabolite 0.055
Molecular target Lead Target 0.055
Metabolism|Metabolite Affinity Drug 0.055
in silico Kinase V Screening 0.055
CoMFA QSAR Similarity 0.054
Cheminformatics Compound_mix Target 0.054
Chemical database Docking Drug 0.054
Nuclear hormone receptor Hormone Target_mix 0.054
in silico Compound_mix Target 0.054
ADMET Docking V Screening 0.053
Drug like Drug in silico 0.053
Drug like Analog Drug 0.053
Drug disposition Compound_mix Drug 0.053
Drug delivery Drug Lead 0.053
Cheminformatics Drug Target_mix 0.053
Beta-barrel Compound_mix Enzyme 0.053
P-glycoprotein Compound_mix Multi drug resistance 0.053
LBDD Affinity Compound_mix 0.053
Compound_mix Drug Lead 0.052
Combinatorial library Drug V Screening 0.052
Receptor Drug Target_mix 0.052
Pharmacophore Target V Screening 0.052
pharmacogenetic Drug Target_mix 0.052
Nuclear hormone receptor LBDD Target_mix 0.052
Nuclear hormone receptor Agonist Compound_mix 0.052
Molecular target Compound_mix Receptor 0.052
Antagonist Drug Target_mix 0.052
in silico Target_mix V Screening 0.052
Drug targeting Compound_mix Drug delivery 0.051
Drug like Target V Screening 0.051
Rule of five Docking Target_mix 0.051
pharmacogenetic Compound_mix Target_mix 0.051
Assay Compound_mix MD 0.051
LBDD Genome Receptor 0.051
HTS Enzyme Target_mix 0.051
G Protein Compound_mix V Screening 0.051
Drug targeting Compound_mix Receptor 0.05
Cluster Enzyme Genome 0.05
QSAR Hydrophobic Receptor 0.05
Pharmacophore Lead Receptor 0.05
Medicinal chemistry Compound_mix Scaffold 0.05
Lipinski Analog Compound_mix 0.05
Affinity Drug LBDD 0.049
Receptor Compound_mix Enzyme 0.049
Intercalation Affinity Compound_mix 0.049
IC50 Drug Ki 0.049
G Protein Agonist Compound_mix 0.049
Genome Diversity Metabolism|Metabolite 0.049
ED50 Compound_mix Enzyme 0.048
Drug safety|Drug-safety Compound_mix Drug 0.048
Drug like Affinity Compound_mix 0.048
Train/Test Enzyme QSAR 0.048
3D-QSAR Compound_mix Pharmacophore 0.048
PDB Compound_mix Homolog 0.048
Nucleic acid Compound_mix Enzyme 0.048
Multi drug resistance Compound_mix V Screening 0.048
Drug like Drug Hydrophobic 0.047
Descriptor Drug Lead 0.047
CoMFA Affinity Compound_mix 0.047
Train/Test CoMFA Compound_mix 0.047
Targeted drug delivery Compound_mix Target 0.047
Lead optimization Drug Target 0.047
Combinatorial library Compound_mix Target_mix 0.046
Chemical database Compound_mix in silico 0.046
Target_mix Enzyme V Screening 0.046
Pharmacophore Hydrophobic Receptor 0.046
Log P Compound_mix Target_mix 0.046
Rule of five Drug Drug like 0.045
QSAR Compound_mix Train/Test 0.045
Molecular modeling Enzyme Lead 0.045
in silico Drug Target_mix 0.045
Drug targeting Compound_mix Target 0.044
Cytochrome Compound_mix Lead 0.044
Scaffold Assay Drug 0.044
3D-QSAR Compound_mix Target 0.044
Cytochrome Enzyme Target_mix 0.043
Train/Test Compound_mix SAR 0.043
SAR Enzyme QSAR 0.043
Rule of five Lipinski Target 0.043
QSAR Analog Compound_mix 0.043
Pharmacophore Docking Drug 0.043
Pharmacokinetics Assay Compound_mix 0.043
Molecular similarity CoMFA Target_mix 0.043
Molecular similarity Analog Compound_mix 0.043
Metabolism|Metabolite Enzyme Lead 0.043
Drug like Compound_mix Efficacy 0.042
Chemical database Docking Lead 0.042
SBDD Compound_mix Drug 0.042
HTS Assay V Screening 0.042
G Protein MD Receptor 0.042
ED50 Compound_mix Efficacy 0.041
ABC protein Compound_mix Multi drug resistance 0.041
Rule of five Docking Lipinski 0.041
Molecular similarity QSAR Target_mix 0.041
ADME Docking Target_mix 0.04
Pharmacokinetics Compound_mix Enzyme 0.04
microRNA Genome Target_mix 0.04
LBDD Drug Receptor 0.04
in silico Docking Metabolism|Metabolite 0.04
G Protein Compound_mix Target 0.04
Descriptor Drug QSAR 0.039
Chemical database Compound_mix Receptor 0.039
Site-specific delivery Compound_mix Drug 0.039
3D-QSAR Analog Compound_mix 0.039
Affinity Drug Kinase 0.038
Epigenetic Compound_mix Lead 0.038
Drug like Compound_mix Receptor 0.038
Docking Drug Target_mix 0.038
QSAR Similarity Target_mix 0.038
Proteinase Assay Compound_mix 0.038
3D-QSAR Compound_mix Kinase 0.038
ADMET in silico Target_mix 0.037
Drug Compound_mix V Screening 0.037
ADME Drug Target 0.037
Docking Drug Receptor 0.037
Target Genome Receptor 0.037
SAR Enzyme Lead 0.037
3D-QSAR Drug V Screening 0.037
Target Target_mix V Screening 0.036
Pattern recognition Compound_mix Target_mix 0.036
Off target siRNA Target_mix 0.036
in silico Assay Drug 0.036
Chemokine Lead Receptor 0.035
Solubility Drug delivery Metabolism|Metabolite 0.035
Molecular similarity Compound_mix Target 0.035
Enzyme Assay Polymorphism 0.034
Docking Compound_mix in silico 0.034
Train/Test Hydrophobic Receptor 0.034
Pharmacophore Compound_mix QSAR 0.034
Molecular target Target_mix Target 0.034
Lipinski Docking V Screening 0.034
Kinase Enzyme Target_mix 0.034
Train/Test Compound_mix Docking 0.033
Target_mix Drug Lead 0.033
Site-specific delivery Drug delivery Drug 0.033
Rule of five Lipinski V Screening 0.033
Nucleoside Compound_mix Enzyme 0.033
Lipinski Drug Drug like 0.033
Drug like Compound_mix Scaffold 0.032
Drug cocktail Drug Target_mix 0.032
Descriptor Drug LBDD 0.032
CoMFA Target_mix Train/Test 0.032
Cheminformatics Compound_mix Docking 0.032
Rule of five Compound_mix Drug 0.032
Receptor Drug LBDD 0.032
QSAR Affinity Compound_mix 0.032
3D-QSAR Affinity Compound_mix 0.032
3D-QSAR Hydrophobic Target 0.032
Nuclear hormone receptor Receptor Target_mix 0.032
Lead Enzyme V Screening 0.032
G Protein Enzyme Target_mix 0.032
Drug cocktail Compound_mix Target_mix 0.031
Wild-type Compound_mix Enzyme 0.031
V Screening Drug Lead 0.031
Volume of distribution Drug Pharmacokinetics 0.031
Train/Test Drug QSAR 0.031
Template Compound_mix Lead 0.031
3D-QSAR Compound_mix Molecular similarity 0.031
Affinity Compound_mix Target_mix 0.03
Drug like Drug QSAR 0.03
Drug delivery Drug Receptor 0.03
Drug delivery Drug LBDD 0.03
Drug delivery Assay Compound_mix 0.03
Chemokine Compound_mix Lead 0.03
Target Drug Receptor 0.03
Target_mix Drug LBDD 0.03
Solubility Compound_mix Lead 0.03
QSAR Compound_mix Docking 0.03
Molecular modeling Compound_mix Target 0.03
MD Compound_mix Lead 0.03
Lipinski Docking Target 0.03
Agonist Drug Target_mix 0.03
Train/Test Descriptor Drug 0.029
Train/Test Analog Compound_mix 0.029
Assay Affinity Drug 0.029
Antagonist Compound_mix Enzyme 0.029
LBDD Assay Compound_mix 0.029
Kinase Compound_mix Receptor 0.029
Ki Enzyme Target_mix 0.029
Hydrophobic Compound_mix Lead 0.029
Drug Assay Efficacy 0.028
siRNA Compound_mix Lead 0.028
SAR Hydrophobic Target_mix 0.028
Polymorphism Fragment Target_mix 0.028
Nuclear hormone receptor LBDD Receptor 0.028
Analog Drug Lead 0.028
G Protein Target_mix V Screening 0.028
Druggability Compound_mix Drug 0.027
Chemokine Drug Receptor 0.027
Target Enzyme Lead 0.027
Systems biology Compound_mix Target_mix 0.027
siRNA Assay Target_mix 0.027
Pharmacophore MD V Screening 0.027
Pharmacokinetics Drug Lead 0.027
HTS Compound_mix Target 0.027
Efflux pump Compound_mix Target_mix 0.026
Docking Assay Drug 0.026
CoMFA 3D-QSAR Target_mix 0.026
V Screening Assay Drug 0.026
PDB Docking Drug 0.026
Kinase Enzyme Genome 0.026
in silico Drug Receptor 0.026
HTS Assay Target 0.026
Homolog Compound_mix Target 0.026
Drug delivery Compound_mix Enzyme 0.025
Docking Analog Assay 0.025
Solubility Drug Lead 0.025
siRNA Compound_mix Target_mix 0.025
Similarity Compound_mix Enzyme 0.025
Scaffold Assay Compound_mix 0.025
Off target Target_mix Target 0.025
Molecular modeling Assay Compound_mix 0.025
Ki Compound_mix Lead 0.025
Adverse-effect Compound_mix Efficacy 0.024
V Screening Drug Kinase 0.024
Template Drug LBDD 0.024
QSAR Drug SAR 0.024
Pharmacophore Compound_mix Scaffold 0.024
Pharmacophore LBDD Lead 0.024
pharmacogenetic Compound_mix Target 0.024
Analog Enzyme V Screening 0.024
in silico Docking Drug 0.024
ADME Docking V Screening 0.023
Drug delivery Compound_mix Lead 0.023
Docking Compound_mix Receptor 0.023
Xenobiotic Enzyme Polymorphism 0.023
Receptor Compound_mix Lead 0.023
3D-QSAR Drug SAR 0.023
Multi drug resistance Compound_mix Drug 0.023
Molecular modeling Assay Drug 0.023
Antagonist Enzyme Target_mix 0.023
Lipinski Compound_mix Drug 0.023
Descriptor Compound_mix Target_mix 0.022
V Screening Enzyme Genome 0.022
V Screening Assay Compound_mix 0.022
3D-QSAR QSAR Target 0.022
Pharmacophore Enzyme Hydrophobic 0.022
Assay Enzyme Genome 0.022
Off target siRNA Target 0.022
New Chemical Entity Drug Target_mix 0.022
Agonist Assay Receptor 0.022
Drug Compound_mix Target_mix 0.021
CoMFA Docking Similarity 0.021
Therapeutic index Drug Efficacy 0.021
3D-QSAR Lead Target_mix 0.021
Pharmacophore Compound_mix in silico 0.021
P-glycoprotein Compound_mix Drug 0.021
Multiple target Target_mix Target 0.021
Multi drug resistance Drug LBDD 0.021
Molecular modeling Affinity Compound_mix 0.021
IC50 Drug LBDD 0.021
Cytochrome Drug Lead 0.02
CoMFA QSAR Target 0.02
Targeted drug delivery Compound_mix Receptor 0.02
SAR Assay Drug 0.02
QSAR Enzyme SAR 0.02
3D-QSAR QSAR Receptor 0.02
3D-QSAR LBDD Lead 0.02
PDB Target_mix V Screening 0.02
Affinity Enzyme Genome 0.019
Drug targeting Drug Efficacy 0.019
Drug like Compound_mix Hydrophobic 0.019
Targeted drug delivery Drug delivery Efficacy 0.019
QSAR Compound_mix Target 0.019
Pharmacophore Affinity Compound_mix 0.019
Pharmacokinetics Compound_mix Lead 0.019
Molecular modeling Compound_mix Homolog 0.019
Lipinski Docking Receptor 0.019
G Protein Receptor Target 0.019
Epigenetic Compound_mix Enzyme 0.018
SBDD Docking Target_mix 0.018
QSAR Target_mix V Screening 0.018
Pipeline Compound_mix Target_mix 0.018
Pharmacophore Drug QSAR 0.018
IC50 Enzyme Target_mix 0.018
Template Enzyme Target_mix 0.017
Target_mix Enzyme Target 0.017
Systems biology Drug Target_mix 0.017
Pharmacophore Enzyme Target 0.017
Pharmacophore Hydrophobic Target 0.017
PDB Compound_mix in silico 0.017
Nuclear hormone receptor Compound_mix LBDD 0.017
Molecular modeling Compound_mix Template 0.017
Analog Drug Kinase 0.017
Homolog Compound_mix Docking 0.017
Agonist Compound_mix Lead 0.017
CoMFA SAR Similarity 0.016
Target Assay Drug 0.016
Solubility Compound_mix Efficacy 0.016
Similarity Enzyme V Screening 0.016
SAR Hydrophobic Receptor 0.016
Molecular modeling Drug Target_mix 0.016
Kinase Enzyme Lead 0.016
HTS Affinity V Screening 0.016
Drug like Lead Target 0.015
Systems biology Compound_mix Target 0.015
QSAR Enzyme Hydrophobic 0.015
QSAR Drug Receptor 0.015
Pharmacophore Analog Compound_mix 0.015
pharmacogenetic Compound_mix Drug 0.015
Lipinski Rule of five Target_mix 0.015
IC50 Compound_mix Efficacy 0.015
Drug like Docking Lead 0.014
Biomarker Compound_mix Enzyme 0.014
Therapeutic index Compound_mix Target_mix 0.014
QSAR Enzyme Lead 0.014
Pipeline Drug Target_mix 0.014
PDB Affinity Compound_mix 0.014
Homolog Enzyme Target 0.014
Homolog Drug Target_mix 0.014
ADME Analog Compound_mix 0.013
Drug cocktail Compound_mix Receptor 0.013
Combinatorial library Target_mix V Screening 0.013
Combinatorial library Lead V Screening 0.013
Coenzyme Compound_mix Metabolism|Metabolite 0.013
Template Compound_mix Homolog 0.013
SAR Compound_mix Descriptor 0.013
Proteinase Compound_mix Protease 0.013
Protease Enzyme Target_mix 0.013
3D-QSAR Enzyme SAR 0.013
Pharmacophore Similarity Target_mix 0.013
Pharmacophore Drug Hydrophobic 0.012
Pharmacophore Docking Enzyme 0.012
PDB Enzyme Target 0.012
Lipinski Compound_mix Pharmacophore 0.012
Lead Drug Kinase 0.012
Hydrophilic Assay Drug 0.012
G Protein Lead Target_mix 0.012
Efflux pump Drug Target_mix 0.011
Efflux pump Compound_mix Drug 0.011
Drug Enzyme V Screening 0.011
Train/Test Enzyme Hydrophobic 0.011
Targeted drug delivery Drug Target 0.011
SAR Drug LBDD 0.011
3D-QSAR LBDD QSAR 0.011
Pharmacokinetics Drug Receptor 0.011
Metabolism|Metabolite Genome Receptor 0.011
Hydrophobic Enzyme V Screening 0.011
G Protein Antagonist Compound_mix 0.011
Adverse-effect Compound_mix Enzyme 0.01
Drug targeting Drug Target 0.01
Double-blind study Drug Efficacy 0.01
QSAR Drug V Screening 0.01
Potency Compound_mix Efficacy 0.01
3D-QSAR Enzyme Target 0.01
Pharmacophore Affinity V Screening 0.01
Pharmacokinetics Drug Systemic 0.01
Peptidase Compound_mix Receptor 0.01
PDB Drug Target_mix 0.01
Molecular target Receptor Target 0.01
Antagonist Assay Target_mix 0.01
Hydrophobic Drug LBDD 0.01
Affinity Genome Receptor 0.009
Enzyme Assay Efficacy 0.009
Drug delivery Metabolism|Metabolite Systemic 0.009
CoMFA Compound_mix Kinase 0.009
QSAR Drug Train/Test 0.009
PDB Drug V Screening 0.009
Partial agonist Receptor Target_mix 0.009
Nuclear hormone receptor Hormone Receptor 0.009
New Chemical Entity Compound_mix Target 0.009
Multi drug resistance Drug V Screening 0.009
Metabolism|Metabolite Enzyme V Screening 0.009
Metabolism|Metabolite Compound_mix Lead 0.009
Genome Metabolism|Metabolite Similarity 0.009
Efflux pump Drug Multi drug resistance 0.008
Efficacy Affinity Drug 0.008
Drug like Compound_mix Lipinski 0.008
Docking Assay Efficacy 0.008
Chemical database Compound_mix Pharmacophore 0.008
Wild-type Enzyme Lead 0.008
Train/Test Target_mix V Screening 0.008
Pharmacophore Drug Train/Test 0.008
Lipinski LBDD Target 0.008
Drug like Docking Target_mix 0.007
Chemical database Docking Target_mix 0.007
Prodrug Compound_mix Drug 0.007
Multi drug resistance Compound_mix Efficacy 0.007
Medicinal chemistry Analog Compound_mix 0.007
in silico Assay Compound_mix 0.007
Agonist Lead Receptor 0.007
G Protein LBDD Target_mix 0.007
3D-QSAR Docking QSAR 0.006
3D-QSAR Target_mix Train/Test 0.006
Pharmacokinetics Efficacy Target 0.006
Affinity Enzyme Lead 0.005
Affinity Compound_mix V Screening 0.005
Disposition Drug Elimination 0.005
Train/Test QSAR Target_mix 0.005
Target Assay Efficacy 0.005
SAR Analog Drug 0.005
Pharmacophore Compound_mix Kinase 0.005
Pharmacophore Analog Drug 0.005
Analog Assay Compound_mix 0.005
Lipophilicity Compound_mix Target_mix 0.005
HTS Drug Target_mix 0.005
Hormone Enzyme Genome 0.005
Drug like Docking Enzyme 0.004
CoMFA LBDD QSAR 0.004
Combinatorial library Compound_mix Target 0.004
Potency Drug LBDD 0.004
Pharmacophore Docking Target_mix 0.004
Hormone Compound_mix Enzyme 0.004
Efflux pump Compound_mix Target 0.003
Drug delivery Efficacy Target 0.003
Docking Compound_mix Homolog 0.003
Clone Compound_mix Enzyme 0.003
Chemical database Docking V Screening 0.003
Train/Test Compound_mix Pharmacophore 0.003
Potency Enzyme Lead 0.003
Oncogene Compound_mix Target_mix 0.003
Molecular modeling Docking Drug 0.003
Antagonist Compound_mix Lead 0.003
HTS Lead Target_mix 0.003
Template Drug Lead 0.002
Target_mix Lead Receptor 0.002
3D-QSAR Docking Enzyme 0.002
Polymorphism Fragment V Screening 0.002
Molecular similarity LBDD QSAR 0.002
Medicinal chemistry Drug Target 0.002
Affinity Drug Lead 0.001
Protease Compound_mix Lead 0.001
3D-QSAR LBDD Similarity 0.001
Molecular modeling Drug Receptor 0.001
Lipophilicity Analog Compound_mix 0.001
Kinase Enzyme V Screening 0.001
Train/Test Drug Hydrophobic 0
Metabolism|Metabolite Drug Kinase 0
References:
S1-1.van de Waterbeemd, H., Carter, R. E., Grassy, G., Kubinyi, H., Martin, Y. C., Tute, M. S., and Willett, P. (1997). Glossary of terms used in computational drug design (IUPAC Recommendations 1997). Pure Appl. Chem.69(5), 1137–1152.
S1-2. Martin, Y.C., Abagyan, R., Ferenczy, G.G., Gillet, V.J., Oprea, T.I., Ulander, J., Winkler, D. and Zefirov, N.S. (2016). Glossary of terms used in computational drug design, part II (IUPAC Recommendations 2015).Pure Appl. Chem.88(3), 239–264.
S1-3. Leelananda, S. P., and Lindert, S. (2016). Computational methods in drug discovery.Beilstein J. Org. Chem.12, 2694–2718.
S1-4. Song, C. M., Lim, S. J., and Tong, J. C. (2009). Recent advances in computer-aided drug design. Brief Bioinform.10(5), 579–591.
S1-5. Tanrikulu, Y., and Schneider, G. (2008). Pseudoreceptor models in drug design: bridging ligand- and receptor-based virtual screening. Nat. Rev. Drug Discov.7(8), 667–677.
S1-6. Wilson, G. L., and Lill, M. A. (2011). Integrating structure-based and ligand-based approaches for computational drug design. Future Med. Chem.3(6), 735–750.
S1-7.Njogu, P. M., Guantai, E. M., Pavadai, E., and Chibale, K. (2016). Computer-Aided Drug Discovery Approaches against the Tropical Infectious Diseases Malaria , Tuberculosis , Trypanosomiasis , and Leishmaniasis.ACS Infect Dis. 2(1), 8-31.
S1-8. Zhang, W., Pei, J., and Lai, L. (2017). Computational Multitarget Drug Design. J. Chem. Inf. Model.57(3), 403–412.
S1-9. Taft, C. A., Da Silva, V. B., and De Paula Da Silva, C. H. T. (2008). Current topics in computer-aided drug design. J. Pharm. Sci.97(3),1089-1098.
S1-10. Oprea, T. I., and Matter, H. (2004). Integrating virtual screening in lead discovery. Curr Opin Chem Biol.8(4), 349–358.
S1-11. Ganellin, C. R., Lindberg, P., and Mitscher, L. A. (1998). Glossary of terms used in medicinal chemistry. Pure Appl Chem. 70, 1129-1143.
S1-12. Buckle, D. R., Erhardt, P. W., Ganellin, C. R., Kobayashi, T., Perun, T. J., Proudfoot, J., and Senn-Bilfinger, J. (2013). Glossary of Terms Used in Medicinal Chemistry Part II. Pure Appl Chem. 48(8), 387–418.